Canada Gazette, Part I, Volume 151, Number 2: GOVERNMENT NOTICES

January 14, 2017

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice of intent concerning Significant New Activity Notice No. 13712a (variation to Significant New Activity Notice No. 13712)

Notice of intent: Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health (the ministers) have assessed information in respect of the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and poly-methylene polyphenylene isocyanate, Chemical Abstracts Service Registry No. 68920-56-9, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the Minister of the Environment published on June 18, 2005, Significant New Activity Notice No. 13712 in Part I of the Canada Gazette, Vol. 139, No. 25;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby proposes to vary Significant New Activity Notice No. 13712, pursuant to subsection 85(2) of the Canadian Environmental Protection Act, 1999, in accordance with the following Annex.

George Enei
Assistant Deputy Minister Science and Technology Branch
On behalf of the Minister of the Environment

ANNEX

1. The Annex to Significant New Activity Notice No. 13712 is proposed to be replaced by the following:

ANNEX

Information Requirements

(Section 85 of the Canadian Environmental Protection Act, 1999)

EXPLANATORY NOTE

(This explanatory note is not part of the notice of intent.)

Description

The notice of intent (NOI) is an opportunity for the public to comment on proposed variations to the Significant New Activity (SNAc) Notice issued by the Minister of the Environment to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (Chemical Abstracts Service [CAS] Registry No. 68920-56-9), pursuant to section 85 of CEPA.

In January 2015, a public commitment was made by Environment Canada and Health Canada to review all orders and notices that were adopted between 2001 and 2014 (see footnote 1) to impose SNAc requirements. The purpose of the review is to ensure that SNAc orders and notices are consistent with current information, policies and approaches. (see footnote 2) Resulting changes to SNAc orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. This NOI reflects the results of the review of the SNAc Notice on the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate identified by stakeholders as a priority.

Within 60 days of publication of the NOI, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the final notice to vary the SNAc requirements in relation to this substance.

A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related orders and notices that pertain to consumer products.

Current SNAc requirements (see footnote 3) remain in effect until such time as the variations proposed in this NOI are published as a final notice.

Applicability of the proposed SNAc Notice

At this time it is proposed that the notice would require any person (individual or corporation) engaging in a significant new activity in relation to Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (CAS Registry No. 68920-56-9), to submit a Significant New Activity Notification (SNAN) containing all of the information prescribed in the notice at least 90 days prior to any use of the substance for the significant new activity.

In order to address human health concerns, the notice would target the use of the substance in consumer products to which the Canada Consumer Product Safety Act (CCPSA) (see footnote 4) applies. Notification would be required for any manufacture of such products with the substance. For any other consumer product–related activity, notification would also be required if the total quantity of the substance used that is contained in the product is greater than 10 kg, for any given calendar year. The substance is not known to be currently used in consumer products in Canada.

Activities not subject to the SNAc Notice

Industrial or commercial activities not related to consumer products are proposed to be excluded from the variation to the notice.

Any activity involving a consumer product that contains the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate, other than the manufacture of such a product, would not be subject to the SNAc Notice if the product contains a total quantity of the substance of 10 kg or less in a calendar year.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the SNAc Notice, as the potential exposure concerns related to health are from the use of consumer products. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote 5) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

The proposed SNAc Notice would not apply to products to which the CCPSA does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions) or to uses of the substance that are regulated under the acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The SNAc Notice would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to the substance when it is in items such as, but not limited to, wastes or manufactured items.

Furthermore, it should be noted that individual components of a mixture may be subject to notification under the SNAc Notice. See subsection 81(6) and section 3 of CEPA and section 3.2 of the Guidelines for the Notification and Testing of New Substances (Chemicals and Polymers) for additional information. (see footnote 6)

Information to be submitted

The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90 days before the day on which the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate is used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct a human health and environmental assessment within 90 days after the complete information is received.

The information requirements in the proposed SNAc Notice relate to general information in respect of the substance, details surrounding its use, and exposure information.

As an outcome of the assessment of the substance, potential concerns related to irritation, skin sensitization, and carcinogenicity to humans from potential new activities were identified. The test prescribed under section 3 of the SNAc Notice will allow the characterization of the aforementioned toxicity endpoints, and will address the areas of potential concern.

Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.

Compliance

When assessing whether or not a substance is subject to the SNAc provisions, (see footnote 7) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier's offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant Safety Data Sheet (SDS). (see footnote 8)

Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all substances that may be subject to a notice due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.

If any information becomes available that reasonably supports the conclusion that this substance is toxic or capable of becoming toxic, the person who is in possession or has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.

A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if their activities were covered by the original SNAN. The Substances Management Advisory Note Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999 provides more detail on this subject. (see footnote 9)

Under section 86 of CEPA, any person who transfers the physical possession or control of a substance subject to a notice shall notify all persons to whom the physical possession or control is transferred of the obligation to comply with the notice, including the obligation to notify the Minister of any significant new activity and to provide all the required information outlined above.

A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.

Where a person has questions concerning their obligations to comply with a notice, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote 10)

CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote 11) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.

ANNEX A: “Consumer product” definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 12)

In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:

Consumer products

4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.

Tobacco products

(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.

Natural health products

(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.

CCPSA, Schedule 1 (Subsection 4(1) and paragraph 37(1)(c))

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice of intent to amend the Domestic Substances List under subsection 87(3) of the Canadian Environmental Protection Act, 1999

Whereas the 26 substances set out in this Notice are specified on the Domestic Substances List; (see footnote a)

Whereas the Minister of the Environment previously published Orders in the Canada Gazette, Part II, pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, (see footnote b) amending the Domestic Substances List to indicate that subsection 81(3) of that Act applies to those substances; (see footnote c), (see footnote d), (see footnote e), (see footnote f), (see footnote g), (see footnote h), (see footnote i), (see footnote j), (see footnote k), (see footnote l), (see footnote m), (see footnote n), (see footnote o), (see footnote p)

Whereas the Minister of the Environment and the Minister of Health (the ministers) are satisfied that the 26 substances are only being manufactured in or imported into Canada by any person for a limited number of uses;

And whereas the ministers suspect that the information concerning a significant new activity in relation to 24 of those substances may contribute to determining the circumstances in which these substances are toxic or capable of becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999;

Therefore, notice is hereby given that the Minister of the Environment intends to amend the Domestic Substances List pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, by varying or rescinding the significant new activities in relation to those substances set out in this Notice.

Public comment period

Any person may, within 60 days of publication of this Notice, file with the Minister of the Environment comments with respect to this proposal. All comments must cite the Canada Gazette, Part I, and the date of publication of this Notice and be sent by mail to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819-938-5212, or by email to eccc.substances.eccc@canada.ca.

The final screening assessments for these substances may be obtained from the Government of Canada's Chemical Substances website (www.chemicalsubstanceschimiques.gc.ca).

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this Notice may submit with the information a request that it be treated as confidential.

George Enei
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment

Mike Beale
Assistant Deputy Minister
Environmental Protection Branch
On behalf of the Minister of the Environment

ANNEX

1. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “64-67-5 S′”, “75-56-9 S′”, “77-78-1 S′”, “100-44-7 S′”, “106-88-7 S′”, “106-89-8 S′”, and “123-31-9 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

64-67-5 S′

75-56-9 S′

77-78-1 S′

100-44-7 S′

106-88-7 S′

106-89-8 S′

123-31-9 S′

  • 1. In relation to any substance in column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
2. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “62-56-6 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

62-56-6 S′

  • 1. In relation to the substance thiourea,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, other than its use in the manufacture of a silver polish or metal cleaner that contains the substance at a concentration equal to or less than 7% by weight and that is to be used with gloves; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies — other than a silver polish or metal cleaner that contains the substance at a concentration of less than 7% by weight and that is to be used with gloves — that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
3. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “79-46-9 S′” and “115-96-8 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

79-46-9 S′

115-96-8 S′

  • 1. In relation to any substance in Column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
4. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “90-94-8 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

90-94-8 S'

  • 1. In relation to the substance methanone, bis[4-(dimethylamino) phenyl]-,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, other than its use in the manufacture of:
      • (i) dyes or pigments that contain the substance at a concentration of less than 5% by weight, or
      • (ii) inks that contain the substance at a concentration of less than 3% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg, other than an activity involving:
      • (i) a dye or pigment that contains the substance at a concentration of less than 5% by weight, or
      • (ii) an ink that contains the substance at a concentration of less than 3% by weight.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity, if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
5. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “93-15-2 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

93-15-2 S′

  • 1. In relation to the substance benzene, 1,2-dimethoxy-4-(2-propenyl)-,
    • (a) the use of the substance in its isolated form in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.0002% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.0002% by weight, if the isolated form of the substance was used to manufacture this product and if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • In this section, the expression “isolated form of the substance” refers to the substance when it is extracted from its naturally occurring sources or when it is manufactured.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
    • (k) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
6. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “111-15-9 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

111-15-9 S'

  • 1. In relation to the substance ethanol, 2-ethoxy-, acetate,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

7. The note to Group B in Part 2 of the Domestic Substances List is proposed to be amended by deleting the following:

122-60-1 S′

8. Part 2 of the Domestic Substances List is proposed to be amended by adding the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

122-60-1 S′

  • 1. In relation to the substance oxirane, (phenoxymethyl)-,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act;
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (c) any other activity involving, during any one calendar year, more than 100 kg of the substance.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in paragraphs 8(f) and (g) of Schedule 5 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) a summary of all other information or test data concerning the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards to the environment and human health and the degree of environmental and public exposure to the substance;
    • (e) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (f) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf;
    • (g) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf;
    • (h) for each proposed significant new activity described in 1(a) or 1(b), the following information must also be provided to the Minister at least 90 days before the commencement of the proposed new activity:
      • (i) a description of the product that contains the substance and the intended use of that product and the function of the substance in that product,
      • (ii) a description of how the product is intended to be used or applied,
      • (iii) the total quantity of the product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity; and
    • (i) for each proposed significant new activity described in 1(c), the following information must also be provided to the Minister at least 90 days before the commencement of the proposed new activity:
      • (i) if known, the three sites in Canada where the greatest quantity of the substance, in relation to the significant new activity, is anticipated to be used or processed and the estimated quantity by site,
      • (ii) the information specified in Schedule 6 to the New Substances Notification Regulations (Chemicals and Polymers),
      • (iii) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers), and
      • (iv) when the quantity of substance used for the significant new activity is expected to exceed 1 000 kg in a calendar year the information specified in Schedule 5 to the New Substances Notification Regulations (Chemicals and Polymers) other than items 6 and 7 and paragraph 8(f) and 8(g).
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.
9. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “1314-62-1 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

1314-62-1 S′

  • 1. Any activity involving, during any one calendar year, the use of more than 100 kg of the substance vanadium pentoxide, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, other than an activity involving its use
    • (a) in a ferrovanadium alloy;
    • (b) as a catalyst for an industrial process;
    • (c) as an oxidizing agent;
    • (d) as a corrosion inhibitor;
    • (e) in a chemical fertilizer; or
    • (f) in a bismuth vanadate pigment.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the day on which the quantity of the substance exceeds 100 kg during any one calendar year:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used;
    • (c) if known, the three sites in Canada where the greatest quantity of the substance is anticipated to be used or processed and the estimated quantity by site;
    • (d) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (e) the products and, if known, end-use products that are anticipated to contain the substance, the intended use of those products and the function of the substance in those products;
    • (f) the information specified in paragraphs 2(d) to (f) and 8(a), (b) and (d) to (g) of Schedule 5 to those Regulations;
    • (g) the quantity of the substance anticipated to be released in each component of the environment;
    • (h) the information specified in item 11 of Schedule 6 to those Regulations;
    • (i) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (j) the identification of every other government agency, either outside or within Canada, to which the person proposing the significant new activity has provided information regarding the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (k) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (l) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 180 days after the day on which it is received by the Minister.
10. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “2425-85-6 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

2425-85-6 S'

  • 1. In relation to the substance -naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]-,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 1% by weight, other than its use in the manufacture of paint; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies — other than a paint — that contains the substance at a concentration equal to or greater than 1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
    • (k) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
11. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “2426-08-6 S′” and “7328-97-4 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

2426-08-6 S′

7328-97-4 S′

  • 1. In relation to any substance in Column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies that is to be sold in a container larger than 250 mL, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies that is to be sold in a container larger than 250 mL, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
12. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “3445-11-2 N-S” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

3445-11-2 N-S

  • 1. In relation to the substance 2-pyrrolidinone, 1-(2-hydroxyethyl)-,
    • (a) the use of the substance in the manufacture of a cosmetic or drug as defined in section 2 of the Food and Drugs Act or in any natural health product as defined in subsection 1(1) of the Natural Health Products Regulations; or
    • (b) any activity involving a cosmetic or drug as defined in section 2 of the Food and Drugs Act or in any natural health product as defined in subsection 1(1) of the Natural Health Products Regulations, if the cosmetic, drug or product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in item 7 of Schedule 4 of the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the test data and test reports from a 90-day repeated dose dermal toxicity study, which is conducted according to the methodology described in OECD Test Guideline 411 and in conformity with the OECD Principles of Good Laboratory Practice, or other similar study or information, which will permit assessment of the dermal toxicity of the substance and its ability to be dermally absorbed;
    • (d) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (e) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (f) the name, civic and postal addresses and telephone number and, if any, fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (g) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.
13. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “6786-83-0 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

6786-83-0 S'

  • 1. Any activity involving, during any one calendar year, the use of more than 1 000 kg of the substance 1-naphthalenemethanol, α,α-bis[4-(dimethylamino)phenyl]-4-(phenylamino)-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in items 2, 3 and 11 of Schedule 6 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in items 3 to 9 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in items 2 to 5, 8 and 9 of Schedule 5 to those Regulations;
    • (e) the test data and the test report obtained from a sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (f) the concentration in percent of the substance methanone, bis[4-(dimethylamino)phenyl]- (Michler's ketone) found in the substance;
    • (g) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (h) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (i) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (j) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 90 days after the day on which it is received by the Minister.
14. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “7758-01-2 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

7758-01-2 S′

  • 1. In relation to the substance bromic acid, potassium salt,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight;
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg; or
    • (c) any other activity involving, during any one calendar year, the use of more than 1 000 kg of the substance, other than an activity involving its use as
      • (i) an oxidizer in flour milling for export,
      • (ii) a component of an industrial or commercial cleaning product, or
      • (iii) a component of an industrial or commercial paint or coating.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.
15. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “10448-09-6 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

10448-09-6 S'

  • 1. Any activity involving, during any one calendar year, the use of more than 1 000 kg of the substance cyclotetrasiloxane, heptamethylphenyl-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers) or as an export-only substance.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in item 2, paragraphs 3(a), (b), (e) and (f) and items 6 to 9 of Schedule 5 to those Regulations where
      • (i) the information specified in those paragraphs is obtained from an experimental study and excludes modelling or alternative data, and
      • (ii) the information specified in paragraph 3(f) is obtained according to the methodology described in the Organisation for Economic Co-operation and Development (“OECD”) Test Guidelines for the Testing of Chemicals No. 123, entitled Partition Coefficient (1-Octanol/Water): Slow-Stirring Method;
    • (d) the information specified in item 5 of Schedule 6 to those Regulations;
    • (e) the test data and the test report obtained from a study to determine the adsorption-desorption in respect of the substance and excluding modelling or alternative data;
    • (f) the data and report from a study to determine the hydrolysis rate as a function of pH of the substance and, if known, the hydrolysis products resulting from that study, and excluding modelling or alternative data;
    • (g) the data and the reports obtained from the following tests, and excluding modelling or alternative data:
      • (i) acute algae toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 201, entitled Freshwater Alga and Cyanobacteria, Growth Inhibition Test that is current at the time the test data are developed,
      • (ii) early-life stage toxicity test with rainbow trout conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 210, entitled Fish, Early-Life Stage Toxicity Test that is current at the time the test data are developed,
      • (iii) fish reproduction test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 229, entitled Fish Short Term Reproduction Assay that is current at the time the test data are developed,
      • (iv) daphnia reproduction test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 211, entitled Daphnia magna Reproduction Test that is current at the time the test data are developed, and
      • (v) sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 90 days after the day on which it is received by the Minister.
16. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “17540-75-9 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

17540-75-9 S′

  • 1. Any activity involving, during any one calendar year, the use of more than 100 kg of the substance phenol, 2,6-bis(1,1-dimethylethyl)-4-(1-methylpropyl)-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers) or as an export-only substance, but excluding any activity involving its use in brake fluid at a concentration of less than or equal to 1% by weight.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) if known, the three sites in Canada where the greatest quantity of the substance is anticipated to be used or processed and the estimated quantity by site;
    • (e) the products and, if known, end-use products that are anticipated to contain the substance, the intended use of those products and the function of the substance in those products;
    • (f) the information specified in paragraphs 2(d) to (f), 3(a) to (d), 3(f) and 8(a) to (g) of Schedule 5 to those Regulations;
    • (g) the information specified in paragraph 3(e) of Schedule 5 to those Regulations — following the modifications for slow-stirring techniques and equilibration study in accordance with the flask method described in Section R.7.1.7 (Water solubility) of the document entitled Guidance on information requirements and chemical safety assessment, Chapter R.7a: Endpoint specific guidance, published by the European Chemicals Agency in 2012;
    • (h) the information specified in item 11 of Schedule 6 to those Regulations, including a description of the procedures for cleaning empty containers and disposing of the rinsate;
    • (i) the test data and the test report obtained from a sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (j) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (k) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (l) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (m) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 180 days after the day on which it is received by the Minister.
17. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “72102-55-7 S′” in column 1, is proposed to be replaced by the following:

Column 1

Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

72102-55-7 S′

  • 1. In relation to the substance methylium, [4-(dimethylamino)phenyl]bis[4-(ethylamino)-3-methylphenyl]-, acetate,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 1% by weight, other than its use as a dye in the manufacture of wood products or pulp or paper products:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products — other than a wood product or pulp or paper product — containing the substance at a concentration equal to or greater than 1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) the data and report from an acute mammalian toxicity test in respect of the substance, administered orally, dermally or by inhalation based on the most significant route of potential human exposure to the substance;
    • (i) if the substance is administered by inhalation for the purposes of the test referred to in paragraph (h), the data and report from a second acute mammalian toxicity test that is administered orally or dermally based on the most significant route of potential human exposure to the substance;
    • (j) the following additional information in respect of each of the tests referred to in paragraphs (h) and (i):
      • (i) the age, sex, number, species, strain and source of the animals tested,
      • (ii) the route by which the substance is administered and the conditions under which the test is conducted, and
      • (iii) the dose of the substance, the vehicle by means of which the substance is administered and the concentration of the substance in the vehicle;
    • (k) the mutagenicity data obtained from one in vitro test for chromosomal aberrations in mammalian cells in respect of the substance, with and without metabolic activation;
    • (l) the mutagenicity data obtained from at least two in vitro tests for gene mutations in both bacterial and mammalian cells in respect of the substance, with and without metabolic activation;
    • (m) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (n) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (o) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (p) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The tests referred to in paragraphs 2(h), (i), (k) and (l) must be conducted in conformity with the laboratory practices described in OECD Principles of Good Laboratory Practice, set out in Annex II of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals adopted by the Organization for Economic Co-operation and Development on May 12, 1981, that are current at the time the test is conducted.
  • 5. The above information will be assessed within 180 days after the day on which it is received by the Minister.

18. Part 1 of the Domestic Substances List is proposed to be amended by adding the following in numerical order:

19. Part 2 of the Domestic Substances List is proposed to be amended by deleting the following in numerical order:

Coming into Force

20. This Order would come into force on the day on which it is registered.

EXPLANATORY NOTE

(This explanatory note is not part of the Notice of Intent.)

Description

The Notice of Intent (NOI) is an opportunity for the public to comment on proposed amendments to the Domestic Substances List (DSL), to vary the significant new activity (SNAc) requirements of the Canadian Environmental Protection Act, 1999 (CEPA), for 24 substances and to rescind the SNAc requirements for 2 substances, pursuant to subsection 87(3).

In January 2015, Environment Canada and Health Canada published a document outlining an initiative to review all Orders and notices that were adopted between 2001 and 2014 to impose SNAc requirements. (see footnote q) The purpose of the review is to ensure that SNAc Orders and notices are consistent with current information, policies and approaches. (see footnote r) Resulting changes to SNAc Orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. Key elements of the review include the following:

This NOI reflects the results of the review of SNAc requirements identified by stakeholders as priorities, as well as SNAc requirements targeting the use of existing substances in consumer products (Consumer Product SNAc Review Group (see footnote 13).

Within 60 days of publication of the Notice of Intent, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the Order amending the DSL to vary the SNAc requirements for 24 substances and to rescind the SNAc requirements for 2 substances.

A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related Orders and notices that pertain to consumer products.

The DSL amendments are not in force until the Order is adopted by the Minister pursuant to subsection 87(3) of CEPA. The Order must be published in the Canada Gazette, Part II. Any current SNAc requirements remain in effect until such time as an Order is published.

Applicability of the proposed Order

At this time, it is proposed that the Order amending the DSL would require any person (individual or corporation) engaging in a significant new activity in relation to the substances listed in the tables below, to submit a SNAN containing all of the information prescribed in the Order at least 90 or 180 days, as specified in the Order, prior to the import, manufacture or use of the substance for the significant new activity. Potential activities with respect to the substances requiring a SNAN submission would include, but would not be limited to, the activities summarized in Tables 1–5. Tables 1–5 also summarize whether activities involving the use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance (i.e. special categories) would require the submission of a SNAN. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote t) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

Activities not subject to the proposed Order

Tables 1–5 provide a summary of substance-specific activities that would not be subject to the Order amending the DSL. Tables 1–5 also summarize whether special categories (i.e. use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance) would be excluded from the proposed Order.

For activities in relation to consumer products the proposed Order would not apply to products to which the Canada Consumer Product Safety Act (CCPSA) does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions), with the exception of cosmetics (in some cases) within the meaning of section 2 of the Food and Drugs Act. The Order would not apply to uses of the substances that are regulated under any of the following Acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The Order would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to items such as, but not limited to, wastes, mixtures or manufactured items. However, it should be noted that individual components of a mixture may be notifiable under the Order. See subsection 81(6) and section 3 of CEPA, and section 3 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers for additional information on the activities and conditions described above. (see footnote 14)

Table 1: List of substances under review where the original SNAc Order targets consumer products

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Methyl eugenol (93-15-2)

Diethyl sulfate (64-67-5)

Dimethyl sulfate (77-78-1)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in its isolated (synthesized or extracted) form, in consumer products.

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product.

Given the concerns for human health, the Orders are proposed to be varied to clarify the consumer products to which the Orders apply.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the Canada Consumer Product Safety Act (CCPSA). (see footnote u)

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with the safety data sheet (SDS) disclosure concentration threshold. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. In the case of methyl eugenol, the proposed concentration threshold is ≥0.0002% to align with the limit set by the Pest Management Regulatory Agency for methyl eugenol in pest control products applied to the skin and with Health Canada's Cosmetic Ingredient Hotlist entry that describes a limit of 0.0002% for methyl eugenol in other leave-on and oral hygiene products.

For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold would enable all other activities to be subject to notification and thus would be protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. See section 2 and Schedule 1 of the Act for the definition of "consumer product" and exemptions.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. The terms "research and development substance" and "site-limited intermediate substance" are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

Potassium bromate (7758-01-2)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product, as well as any industrial or commercial activity involving, in any one calendar year, more than 1 000 kg of the substance, with a few exclusions.

It is proposed that the Order for this substance be applicable in the same fashion as for the above substances.

In addition, the Order would maintain the requirement for notification of use of the substance in any other activities not involving consumer products above 1 000 kg with some exceptions.

Any industrial or commercial activity relating to cleaning products, paints and coatings, and as an oxidizer in flour milling would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order, as the potential exposure concerns related to health are from use of consumer products.

n-BGE (2426-08-6)

TGOPE (7328-97-4)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in the manufacture of consumer products.

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, in its uncured or undried form, in consumer products, other than an activity involving its use in an epoxy-based paint, epoxy-based coating or epoxy-based adhesive.

Given the concerns for human health, the SNAc Orders are proposed to be varied to clarify the consumer products to which the SNAc Orders apply, which includes cosmetics.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA, while the application of the term "cosmetic" in SNAc definitions is consistent with the meaning of section 2 of the Food and Drugs Act.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

There would also be an additional notification threshold (250 mL) for the size of the consumer product containing these substances.

For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus would be protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from the use of consumer products or cosmetics.

Table 2: List of substances under review where amendments are proposed to target activities relating to consumer products

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Methyloxirane (75-56-9)

Epichlorohydrin (106-89-8)

Benzyl chloride (100-44-7)

Hydroquinone (123-31-9)

Ethyloxirane (106-88-7)

Thiourea (62-56-6)

2-EEA (111-15-9)

Pigment Red 3 (2425-85-6)

The current Order applies to activities involving, in any one calendar year, more than 1 000 kg of the substance as a component in polyurethane foam, as well as other activities involving, in any one calendar year, more than 100 kg of the substance. Use as a stabilizer in benzyl chloride is excluded.

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance with some exclusions.

Given the concerns for human health, the Orders are proposed to be varied to be more targeted and to only require notification for activities related to consumer products.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

For thiourea, the use of the substance in a silver polish or metal cleaner that contains the substance at a concentration equal to or less than 7% with proper labelling (i.e. instructions to wear gloves when using the product) would also be excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a paint containing the substance would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Michler's ketone (90-94-8)

   

Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a dye or pigment containing the substance at a concentration of less than 5%, or to an ink containing the substance at a concentration of less than 3%, would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

TCEP (115-96-8)

2-Nitropropane (79-46-9)

MAPBAP acetate (72102-55-7)

Phenoxymethyl oxirane (122-60-1)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance, with some exclusions.

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance with exceptions for use in drugs.

Given the concerns for human health, the SNAc Orders are proposed to be varied to be more targeted and to require notification for activities related to consumer products and cosmetics.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health.

In addition, the Order for phenoxymethyl oxirane would also maintain the requirement for notification of use of the substance in any other activities not involving consumer products or cosmetics above the notification threshold of 100 kg.

Industrial and commercial activities not related to consumer products or cosmetics are excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act.

The use of the substance MAPBAP acetate in wood products or pulp and paper products would also be excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products or cosmetics.

Table 3: List of substances under review where notification thresholds are proposed to be increased

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Solvent Blue 4 (6786-83-0)

Phenyl-D4 (10448-09-6)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The quantity threshold for these SNAcs is proposed to be increased from 100 kg/year to 1 000 kg/year, which would still be considered protective of the environment.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN.

There are no additional exclusions.

Table 4: List of substances under review to clarify SNAc definition

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from proposed Order

DTBSBP (17540-75-9)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than an activity involving its use as an antioxidant or corrosion inhibitor in brake fluid at a concentration of less than or equal to 1% by weight.

Given the potential risks to the environment of this substance, it is proposed to clarify the SNAc definition and remove any functional descriptor while maintaining the applicability of any activity involving the substance. Significant new activities could include, but are not limited to, its use in polyurethane foam, or in PVC resin.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns associated with the substance, the above-mentioned activities would require the submission of a SNAN.

Any activity related to brake fluid containing the substance at a concentration of less than or equal to 1% is excluded.

2-Pyrrolidinone, 1-(2-hydroxyethyl)(3445-11-2)

The current Order applies to any activity involving the substance as a component in personal care products.

Given the potential human health risks of this substance and potential use in cosmetics and personal care products, it is proposed to replace reference to "personal care products" with any activity relating to "cosmetics, drugs or natural health products." Significant new activities could include, but are not limited to, cosmetics and personal care products that are applied dermally.

Industrial and commercial activities and activities related to the use of the substance in consumer products other than in cosmetics, drugs or natural health products are excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Vanadium pentoxide (1314-62-1)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than its use in a ferrovanadium alloy, as a catalyst for an industrial process, as an oxidizing agent, as a corrosion inhibitor, in a chemical fertilizer, or in a bismuth vanadate pigment.

Given that the SNAc requirements are still considered relevant for this substance, it is proposed to maintain the same definition of significant new activities, which could include, but are not limited to, its use in production of other metals or as a medicinal ingredient.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export–only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN.

Any activity related to use in an alloy, fertilizer, pigment, or as an oxidizing agent or corrosion inhibitor is excluded.

Table 5: List of substances under review to be rescinded

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from proposed Order

MDnM-hydride (69430-47-3)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The review concluded that no environmental risk would be identified related to notification of new uses of these two substances. Therefore, the SNAc Orders are proposed to be rescinded.

There are no additional exclusions.

FAZ (68551-44-0)

Information to be submitted

The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90–180 days, as specified in the Order, before the day on which the substances are imported, manufactured or used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct human health and environmental assessments within 90–180 days after the complete information is received.

The information requirements in the proposed Order relate to general information in respect of the substance, details surrounding its use, and to exposure information.

As an outcome of the review process, specific information requirements for a toxicity study with a dermal mode of action and sediment toxicity studies are being proposed for the substances bearing the following CAS RNs: 3445-11-2, 6786-83-0, and 17540-75-9. The data from these tests will help to assess human use scenarios that could lead to high exposures and risk to human health (for 3445-11-2) or clarify if the substance would partition to sediments if released to water (for 6786-83-0 and 17540-75-9).

Similarly, the information requirements for acute and chronic toxicity, reproductive and developmental toxicity, mutagenicity, and sediment toxicity studies, are being maintained for the substances bearing CAS RNs 10448-09-6, and 72102-55-7, since the review confirmed that there was concern for future uses to the environment and human health given the hazardous nature of and potential for exposure to these substances.

Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.

Compliance

When assessing whether or not a substance is subject to the SNAc provisions, (see footnote v) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier's offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant SDS. (see footnote w)

Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all product ingredients that may be subject to an order due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.

If any information becomes available that reasonably supports the conclusion that a substance is toxic or capable of becoming toxic, the person who is in possession or who has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.

A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if the activities were covered by the original SNAN. The Substances Management Advisory Note “Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” provides more detail on this subject. (see footnote x)

Any person who transfers the physical possession or control of a substance subject to an order should notify all persons to whom the physical possession or control is transferred of the obligation to comply with the order, including the obligation to notify the Minister of any significant new activity and to provide all of the required information outlined above.

A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.

Where a person has questions concerning their obligations to comply with an order, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote y)

CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote z) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.

ANNEX A

Consumer Product Definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 15)

In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:

Consumer products

4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.

Tobacco products

(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.

Natural health products

(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.

Schedule 1 of the CCPSA (Subsection 4(1) and paragraph 37(1)(c))

  1. Explosives within the meaning of section 2 of the Explosives Act.
  2. Cosmetics within the meaning of section 2 of the Food and Drugs Act.
  3. Devices within the meaning of section 2 of the Food and Drugs Act.
  4. Drugs within the meaning of section 2 of the Food and Drugs Act.
  5. Food within the meaning of section 2 of the Food and Drugs Act.
  6. Pest control products within the meaning of subsection 2(1) of the Pest Control Products Act.
  7. Vehicles within the meaning of section 2 of the Motor Vehicle Safety Act and a part of a vehicle that is integral to it — as it is assembled or altered before its sale to the first retail purchaser — including a part of a vehicle that replaces or alters such a part.
  8. Feeds within the meaning of section 2 of the Feeds Act.
  9. Fertilizers within the meaning of section 2 of the Fertilizers Act.
  10. Vessels within the meaning of section 2 of the Canada Shipping Act, 2001.
  11. Firearms within the meaning of section 2 of the Criminal Code.
  12. Ammunition within the meaning of subsection 84(1) of the Criminal Code.
  13. Cartridge magazines within the meaning of subsection 84(1) of the Criminal Code.
  14. Cross-bows within the meaning of subsection 84(1) of the Criminal Code.
  15. Prohibited devices within the meaning of paragraphs (a) to (d) of the definition “prohibited device” in subsection 84(1) of the Criminal Code.
  16. Plants within the meaning of section 3 of the Plant Protection Act, except for Jequirity beans (abrus precatorius).
  17. Seeds within the meaning of section 2 of the Seeds Act, except for Jequirity beans (abrus precatorius).
  18. Controlled substances within the meaning of subsection 2(1) of the Controlled Drugs and Substances Act.
  19. Aeronautical products within the meaning of subsection 3(1) of the Aeronautics Act.
  20. Animals within the meaning of subsection 2(1) of the Health of Animals Act.

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice with respect to substances included as part of the 2017 Inventory Update

Pursuant to paragraph 71(1)(b) of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”), notice is hereby given that the Minister of the Environment requires, for the purpose of assessing whether the substances listed in Schedule 1 to this notice are toxic or are capable of becoming toxic, or for the purpose of assessing whether to control, or the manner in which to control the listed substances, any person described in Schedule 2 to this notice who possesses or who may reasonably be expected to have access to the information required in Schedule 3 to this notice to provide that information no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time.

Responses to this notice shall be submitted to the Minister of the Environment, using the online reporting system available through Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/. Inquiries concerning the notice may be directed to the Substances Management Coordinator at 1-800-567-1999 (toll-free in Canada), 819-938-3232 (outside of Canada) [telephone], or eccc.substances.eccc@canada.ca (email).

Pursuant to section 313 of the Act, any person who provides information in response to this notice may submit, with the information, a written request that the information or part of it be treated as confidential.

Pursuant to subsection 71(4) of the Act, the Minister of the Environment may, on request in writing from any person to whom this notice applies, extend the time or times within which the person shall comply with this notice. The person seeking such extension shall submit, prior to the deadline, a request to the Minister of the Environment, to the attention of the Substances Management Coordinator, Chemicals Management Plan, Gatineau, Quebec K1A 0H3 or eccc.substances.eccc@canada.ca (email).

Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment

SCHEDULE 1

Substances

Part 1
CAS RN (see footnote 16) Name of the substance Nom de la substance
52-68-6 Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester Acide phosphonique, (2,2,2-trichloro-1-hydroxyéthyl)-, diester méthylique
75-15-0 Carbon disulfide Disulfure de carbone
80-08-0 Benzenamine, 4,4′-sulfonylbis- Dapsone
84-76-4 1,2-Benzenedicarboxylic acid, dinonyl ester Phtalate de dinonyle
84-77-5 1,2-Benzenedicarboxylic acid, didecyl ester Phtalate de didécyle
84-78-6 1,2-Benzenedicarboxylic acid, butyl octyl ester Phtalate de butyle et d'octyle
85-69-8 1,2-Benzenedicarboxylic acid, butyl 2-ethylhexyl ester Phtalate de butyle et de 2-éthylhexyle
94-96-2 1,3-Hexanediol, 2-ethyl- 2-Éthylhexane-1,3-diol
98-56-6 Benzene, 1-chloro-4-(trifluoromethyl)- 4-Chloro-α,α,α-trifluorotoluène
101-20-2 Urea, N-(4-chlorophenyl)-N′-(3,4-dichlorophenyl)- Triclocarban
110-82-7 Cyclohexane Cyclohexane
111-30-8 Pentanedial Glutaral
119-07-3 1,2-Benzenedicarboxylic acid, decyl octyl ester Phtalate de décyle et d'octyle
120-56-9 Ethanol, 2,2′-[1,2-ethanediylbis(oxy)]bis-, dibenzoate Dibenzoate de éthylènebis(oxyéthylène)
121-75-5 Butanedioic acid, [(dimethoxyphosphinothioyl)thio]-, diethyl ester Malathion
123-33-1 3,6-Pyridazinedione, 1,2-dihydro- Pyridazine-3,6-diol
131-54-4 Methanone, bis(2-hydroxy-4-methoxyphenyl)- 2,2′-Dihydroxy-4,4′-diméthoxybenzophénone
142-59-6 Carbamodithioic acid, 1,2-ethanediylbis-, disodium salt Nabame
142-82-5 Heptane Heptane
540-84-1 Pentane, 2,2,4-trimethyl- 2,2,4-Triméthylpentane
1071-93-8 Hexanedioic acid, dihydrazide Adipohydrazide
1312-46-5 Iridium oxide (Ir2O3) Tétrahydroxyde d'iridium
1314-08-5 Palladium oxide (PdO) Monoxyde de palladium
1314-15-4 Platinum oxide (PtO2) Dioxyde de platine
1322-94-7 1,2-Benzenedicarboxylic acid, mono(dimethylcyclohexyl) ester Hydrogénophtalate de (diméthylcyclohexyle)
1461-25-2 Stannane, tetrabutyl- Tétrabutylstannane
2164-17-2 Urea, N,N-dimethyl-N′-[3-(trifluoromethyl)phenyl]- Fluométuron
2226-96-2 1-Piperidinyloxy, 4-hydroxy-2,2,6,6-tetramethyl- 4-Hydroxy-2,2,6,6-tétraméthylpipéridinoxyle
2432-90-8 1,2-Benzenedicarboxylic acid, didodecyl ester Phtalate de didodécyle
3741-80-8 2-Benzothiazolesulfenamide, N-(2-benzothiazolylthio)-N-(1,1-dimethylethyl)- N-(2-Benzothiazolylthio)-N-(tert-butyl)-2-benzothiazolsulfénamide
7439-88-5 Iridium Iridium
7440-04-2 Osmium Osmium
7440-05-3 Palladium Palladium
7440-06-4 Platinum Platine
7440-16-6 Rhodium Rhodium
7440-18-8 Ruthenium Ruthénium
7647-10-1 Palladium chloride (PdCl2) Dichlorure de palladium
10025-65-7 Platinum chloride (PtCl2) Dichlorure de platine
10025-83-9 Iridium chloride (IrCl3) Trichlorure d'iridium
10025-99-7 Platinate(2-), tetrachloro-, dipotassium, (SP-4-1)- Tétrachloroplatinate de dipotassium
10026-00-3 Platinate(2-), tetrachloro-, disodium, (SP-4-1)- Tétrachloroplatinate de disodium
10049-07-7 Rhodium chloride (RhCl3) Trichlorure de rhodium
10049-08-8 Ruthenium chloride (RuCl3) Trichlorure de ruthénium
10102-05-3 Nitric acid, palladium(2++) salt Dinitrate de palladium
10489-46-0 Sulfuric acid, rhodium(3++) salt (3:2) Trisulfate de dirhodium
12030-49-8 Iridium oxide (IrO2) Dioxyde d'iridium
12035-82-4 Platinum oxide (PtO) Oxyde de platine
12036-10-1 Ruthenium oxide (RuO2) Oxyde de ruthénium (IV)
12036-35-0 Rhodium oxide (Rh2O3) Trioxyde de dirhodium
12044-52-9 Platinum arsenide (PtAs2) Arséniure de platine (PtAs2)
12135-42-1 Ruthenium hydroxide (Ru(OH)3) Trihydroxyde de ruthénium
12137-21-2 Platinum oxide (PtO2), monohydrate Monohydrate d'oxyde de platine (PtO2)
12137-76-7 Palladium selenide (PdSe) Séléniure de palladium (PdSe)
12237-63-7 C.I. Pigment Red 169 Hexakis(cyano-C)ferrate(4-)/2-[6-(éthylamino)-3-(éthylimino)-2,7-diméthyl-3H-xanthén-9-yl]benzoate d'éthyle et de cuivre(2++)
12307-90-3 Rhodium, chloro[(1,2,5,6-<C)-1,3,5,7-cyclooctatetraene](pyridine)- Chloro[(1,2,5,6-<C)cycloocta-1,3,5,7-tétraène](pyridine)rhodium
13444-93-4 Osmium chloride (OsCl3) Trichlorure d'osmium
13454-96-1 Platinum chloride (PtCl4), (SP-4-1)- Tétrachlorure de platine
13569-65-8 Rhodium chloride (RhCl3), trihydrate Trihydrate de chlorure de rhodium (RhCl3)
13820-53-6 Palladate(2-), tetrachloro-, disodium, (SP-4-1)- Tétrachloropalladate de disodium
14024-41-0 Iridate(3-), hexachloro-, tripotassium, (OC-6-11)- Hexachloroiridate de tripotassium
14284-93-6 Ruthenium, tris(2,4-pentanedionato-O,O′)-, (OC-6-11)- Tris(pentane-2,4-dionato-O,O')ruthénium
14898-67-0 Ruthenium chloride (RuCl3), hydrate Trihydrate de chlorure de ruthénium (RuCl3)
14972-70-4 Rhodate(3-), hexachloro-, trisodium, (OC-6-11)- Hexachlororhodate de trisodium
14996-60-2 Osmium chloride (OsCl3), hydrate Hydrate de chlorure d'osmium (OsCl3)
14996-61-3 Iridium chloride (IrCl3), hydrate Hydrate de chlorure d'iridium (IrCl3)
15231-91-1 2-Naphthalenol, 6-bromo- 6-Bromonapht-2-ol
15336-18-2 Rhodate(3-), hexachloro-, triammonium, (OC-6-11)- Hexachlororhodate de triammonium
15752-05-3 Iridate(3-), hexachloro-, triammonium, (OC-6-11)- Hexachloroiridate de triammonium
15869-63-3 Platinum chloride (PtCl4), pentahydrate Pentahydrate de chlorure de platine (PtCl4)
16871-54-8 Platinate(2-), hexachloro-, (OC-6-11)- Hexachloroplatinate(2-) (OC-6-11)
16919-58-7 Platinate(2-), hexachloro-, diammonium, (OC-6-11)- Hexachloroplatinate de diammonium
16921-30-5 Platinate(2-), hexachloro-, dipotassium, (OC-6-11)- Hexachloroplatinate de dipotassium
16923-58-3 Platinate(2-), hexachloro-, disodium, (OC-6-11)- Hexachloroplatinate de disodium
16940-92-4 Iridate(2-), hexachloro-, diammonium, (OC-6-11)- Hexachloroiridate de diammonium
16941-12-1 Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)- Acide hexachloroplatinique
16941-92-7 Iridate(2-), hexachloro-, dihydrogen, (OC-6-11)- Acide hexachloroiridique
18497-13-7 Platinate (2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)- Hexahydrate d'acide (OC-6-11)-hexachloroplatinique
19186-97-1 Tris[2,2-bis(bromomethyl)-3-bromopropyl]-phosphate 3-Bromo-2,2-bis(bromométhyl)propan-1-ol, phosphate (3:1)
19223-55-3 1-Propanaminium, 2-hydroxy-N,N-dimethyl-N-[3-[(1-oxododecyl)amino]propyl]-3-sulfo-, hydroxide, inner salt Hydroxyde de (2-hydroxy-3-sulfopropyl)diméthyl[3-[(1-oxododécyl)amino]propyl]ammonium
20765-98-4 Rhodium chloride (RhCl3), hydrate Hydrate de chlorure de rhodium (RhCl3),
20816-12-0 Osmium oxide (OsO4), (ß-4)- Tétraoxyde d'osmium
20845-92-5 Hexanoic acid, 2-ethyl-, rhodium(3++) salt Tris(2-éthylhexanoate) de rhodium
21360-80-5 Rhodium(2++), pentaamminechloro-, (OC-6-22)-, sulfate (1:1) Sulfate de pentaamminechlororhodium
21656-02-0 Rhodium hydroxide (Rh(OH)3) Trihydroxyde de rhodium
23013-82-3 Ruthenate(2-), hexachloro-, dipotassium, (OC-6-11)- Hexachlororuthénate de dipotassium
25057-89-0 1H-2,1,3-Benzothiadiazin-4(3H)-one, 3-(1-methylethyl)-, 2,2-dioxide Bentazone
25085-20-5 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine Acide adipique polymérisé avec la N-(2-aminoéthyl)éthane-1,2-diamine
25724-58-7 1,2-Benzenedicarboxylic acid, decyl hexyl ester Phtalate de décyle et d'hexyle
25973-55-1 Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl)- 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphénol
26023-84-7 Platinate (2-), hexachloro-, dihydrogen, hydrate, (OC-6-11)- Hydrate d'acide (OC-6-11)-hexachloroplatinique
27636-21-1 1,6-Hexanediamine, polymer with (chloromethyl)oxirane Hexane-1,6-diamine polymérisée avec le (chlorométhyl)oxirane
30980-84-8 Iridium oxide (IrO2), hydrate Hydrate d'oxyde d'iridium (IrO2)
32740-79-7 Ruthenium oxide (RuO2), hydrate Hydrate d'oxyde de ruthénium (RuO2)
32916-07-7 Nitric acid, palladium(2+), dihydrate Dihydrate de nitrate de palladium (2+)
35541-81-2 1,4-Cyclohexanedimethanol, dibenzoate Dibenzoate de cyclohexane-1,4-diméthanol
36550-26-2 Palladate(2-), hexachloro-, dihydrogen, (OC-6-11)- Hexachloropalladate(2-) de dihydrogène
36732-58-8 Rhodate(2-), hexachloro-, dihydrogen, (OC-6-11)- Hexachlororhodate(2-) de dihydrogène (OC-6-11)
36861-47-9 Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]- (±)-1,7,7-Triméthyl-3-[(4méthylphényl)méthylène]bicyclo[2.2.1]heptan-2-one
39373-27-8 Rhodium oxide (Rh2O3), pentahydrate Pentahydrate d'oxyde de rhodium (Rh2O3)
44470-26-0 Ruthenate(2-), hexachloro-, dihydrogen, (OC-6-11)- Hexachlororuthénate(2-) de dihydrogène (OC-6-11)
52734-36-8 2-Propenoic acid, 2-methyl-, 2-(3-oxazolidinyl)ethyl ester, homopolymer Méthacrylate de 2-(oxazolidin-3-yl)éthyle homopolymérisé
52785-06-5 Platinum oxide (PtO2), hydrate Hydrate d'oxyde de platine (PtO2),
54968-01-3 Iridium hydroxide (Ir(OH)3) Hydroxyde d'iridium [Ir(OH)3]
55127-80-5 Oxirane, 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, homopolymer, di-2-propenoate 2,2′-[Isopropylidènebis(p-phénylèneoxyméthylène)]dioxirane homopolymérisé, diacrylate
57214-10-5 Formaldehyde, polymer with 1,3-benzenedimethanamine and phenol Formaldéhyde polymérisé avec le benzène-1,3-diméthanamine et le phénol
57876-28-5 Iridate(2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)- Hexahydrate d'acide (OC-6-11)-hexachloroiridique
61827-62-1 1,2-Benzenedicarboxylic acid, hexyl octyl ester Phtalate d'hexyle et d'octyle
64109-12-2 Palladium oxide (PdO), hydrate Hydrate d'oxyde de palladium (PdO)
64741-73-7 Distillates (petroleum), alkylate Distillats (pétrole), alkylation
67703-99-5 Hexanedioic acid, polymer with N¹-(2-aminoethyl)-1,2-ethanediamine and 1,2-dichloroethane Polymère de l'acide hexanedioïque avec la N¹-(2-aminoéthyl)éthane-1,2-diamine et le 1,2-dichloroéthane
67859-71-6 Phosphoric acid, rhodium(3++) salt (1:1) Phosphate de rhodium
68071-36-3 Ethanol, 2,2′,2″-nitrilotris-, compds. with polyethylene glycol mono-C12-15-alkyl ethers phosphates 2,2′,2″-Nitrilotriéthanol, composés avec des phosphates d'éthers mono-C12-15-alkyliques du polyéthylèneglycol
68188-19-2 Paraffin waxes and Hydrocarbon waxes, chloro, chlorosulfonated Cires de paraffine et cires d'hydrocarbures, chloro, sulfochlorées
68228-02-4 Neodecanoic acid, palladium(2++) salt Néodécanoate de palladium(2++)
68412-56-6 Platinum, chloro octanol complexes Platine, complexes chloro d'octanol
68425-21-8 Turpentine, oil, mixed with Venice turpentine, sulfurized, tetrachloropalladates Essence de térébenthine, mélangée avec la térébenthine de mélèze, sulfurisée, tétrachloropalladates
68425-76-3 Ethanol, 2,2′-iminobis-, polymer with α-tridecyl-ω-hydroxypoly(oxy-1,2-ethanediyl) phosphate 2,2′-Iminodiéthanol polymérisé avec le phosphate de l'α-tridécyl-ω-hydroxypoly(oxyéthylène)
68442-70-6 1,2-Benzenedicarboxylic acid, mixed cetyl and stearyl esters Phtalates mixtes de cétyle et de stéaryle
68478-92-2 Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes Platine complexé avec le 1,1,3,3-tétraméthyl-1,3-divinyldisiloxane
68515-41-3 1,2-Benzenedicarboxylic acid, di-C7-9-branched and linear alkyl esters Phtalates de dialkyles en C7-9, ramifiés et linéaires
68515-42-4 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters Phtalates de dialkyles en C7-11, ramifiés et linéaires
68515-44-6 1,2-Benzenedicarboxylic acid, diheptyl ester, branched and linear Phtalates de diheptyle ramifié et linéaire
68515-45-7 1,2-Benzenedicarboxylic acid, dinonyl ester, branched and linear Phtalates de dinonyle ramifié et linéaire
68585-32-0 Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane Hexachloroplatinate(2-) de dihydrogène (OC-6-11), produits de réaction avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinylcyclotétrasiloxane
68648-91-9 1,2-Benzenedicarboxylic acid, di-C7-11-alkyl esters Phtalates de dialkyles en C7-11
68916-29-0 Balsams, Douglas-fir, sulfurized, iridium salts Baumes de Douglas sulfurisés, sels d'iridium
68916-30-3 Balsams, Douglas-fir, sulfurized, rhodium salts Baumes de Douglas sulfurisés, sels de rhodium
68916-31-4 Balsams, Douglas-fir, sulfurized, ruthenium salts Baumes de Douglas sulfurisés, sels de ruthénium
68916-35-8 Balsams, copaiba, sulfurized, platinum salts Baumes de copahu sulfurisés, sels de platine
68917-69-1 Turpentine, Venice, sulfurized, hexachlororhodate Térébenthine de mélèze sulfurisée, hexachlororhodate
70321-75-4 Balsams, Douglas-fir, sulfurized, palladium salts Baumes de Douglas sulfurisés, sels de palladium
71033-08-4 Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyleneoxy[1-(butoxymethyl)-2,1-ethanediyl]oxymethylene]]bis- 2,2'-[(1-Méthyléthylidène)bis[4,1-phénylénoxy[1-(butoxyméthyl)éthylène]oxyméthylène]]bisoxirane
71832-62-7 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with N,N'-bis(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, [(dodecyloxy)methyl]oxirane, [(methylphenoxy)methyl]oxirane and [(tetradecyloxy)methyl]oxirane p,p′-Isopropylidènediphénol polymérisé avec la N,N′-bis(2-aminoéthyl)éthylènediamine, le (chlorométhyl)oxirane, le (dodécyloxy)méthyloxirane, le (méthylphénoxy)méthyloxirane et le (tétradécyloxy)méthyloxirane
72245-02-4 Amines, tallow alkyl, ethoxylated, 2-ethylhexanoates 2-Éthylhexanoates d'alkyl(de suif)amines éthoxylées
72854-22-9 Paraffin waxes and Hydrocarbon waxes, chloro, sulfonated, ammonium salts Sels d'ammonium de cires de paraffines et de cires d'hydrocarbures chlorées et sulfonées
73018-55-0 Platinum, dicarbonyldichloro-, reaction products with 2,4,6-triethenyl-2,4,6-trimethylcyclotrisiloxane Dicarbonyldichloroplatine(II), produits de réaction avec le 2,4,6-trivinyl-2,4,6-triméthylcyclotrisiloxane
73936-91-1 Phenol, 2-(2H-benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)- 2-(2H-Benzotriazol-2-yl)-6-(1-méthyl-1-phényléthyl)-4-(1,1,3,3-tétraméthylbutyl)phénol
85204-21-3 2-Butenoic acid, 4-[(2-ethylhexyl)amino]-4-oxo-, (Z)-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1) Acide 4-[(2-éthylhexyl)amino]-4-oxoisocrotonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1)
89415-87-2 2,4-Imidazolidinedione, 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 1,3-Dichloro-5-éthy1-5-méthylimidazolidine-2,4-dione
90193-94-5 1,2-Benzenedicarboxylic acid, mixed decyl and octyl diesters Acide phtalique, mélange de diesters de décyle et d'octyle
91082-67-6 Turpentine, Venice, sulfurized, reaction products with dihydrogen hexachloroiridate(2-) Térébenthine de mélèze sulfurisée, produits de réaction avec l'hexachloroiridate(2-) diacide
91082-70-1 Turpentine, Venice, sulfurized, reaction products with osmium chloride (OsCl3) Térébenthine de mélèze sulfurisée, produits de réaction avec le chlorure d'osmium (OsCl3)
94266-84-9 Amines, polyethylenepoly-, polymers with adipic acid, 1,2-dichloroethane and diethylenetriamine, hydrochlorides Polyéthylènepolyamines polymérisées avec l'acide adipique, le 1,2-dichloroéthane et la 3-azapentane-1,5-diamine, chlorhydrates
95193-73-0 1,2-Benzenedicarboxylic acid, di-C16-18 and C18-unsatd. alkyl esters Acide benzènedicarboxylique-1,2, esters de dialkyles en C16-18 et insaturés en C18
97375-25-2 Platinum, carbonyl chloro 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane complexes Platine, complexée avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinyltétrasiloxane, chlorés et carbonylés
97765-58-7 Balsams, Canada, sulfurized, iridium salts Baumes du Canada sulfurisés, sels d'iridium
97766-48-8 Turpentine, Venice, sulfurized, platinum salt Térébenthine de mélèze sulfurisée, sel de platine
100402-68-4 Palladium, isooctyl 3-mercaptopropanoate complexes Palladium, complexé avec le 3-mercaptopropionate d'isooctyle
100432-49-3 Bicyclo[3.1.1]heptane-3-thiol, 2,6,6-trimethyl-, rhodium(3++) salt 2,6,6-Triméthylbicyclo[3.1.1]heptane-3-thiolate de rhodium(3++)
100432-50-6 Bicyclo[3.1.1]heptane-2-thiol, 2,6,6-trimethyl-, rhodium(3++) salt 2,6,6-Triméthylbicyclo[3.1.1]heptane-2-thiolate de rhodium(3++)
109909-39-9 Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[2,4,6-tris(1-methylpropyl)phenoxy]-, sodium salt α-Sulfo-ω-(2,4,6-tri-sec-butylphénoxy)poly(oxyéthylène), sel de sodium
111381-90-9 1,2-Benzenedicarboxylic acid, heptyl undecyl ester, branched and linear Phtalate d'heptyle/undécyle, ramifiés et linéaires
111905-52-3 Alcohols, C9-11-branched and linear, butoxylated ethoxylated Alcools en C9-11 ramifiés ou linéaires, butoxylés, éthoxylés
118421-10-6 1,2-Cyclohexanediamine, reaction products with N-[4-oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)oxiranemethanamine Cyclohexane-1,2-diamine, produits de réaction avec la N-[4-(oxiranylméthoxy)phényl]-N-(oxiranylméthyl)oxiraneméthanamine
124232-16-2 Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(tridecyloxy)- α-(3-Carboxy-1-oxopropyl)-ω-(tridécyloxy)poly(oxyéthylène)
126019-82-7 Phenol, 2(or 4)-C9-10-branched alkyl derivs., phosphorothioates (3:1) Phosphorothioates (3:1) de (dérivés alkyliques 2(ou 4)-ramifiés en C9-10)phénol
126820-93-7 Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes and sulfur Sel d'or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d'isooctyle palladium et le soufre
126820-94-8 Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes, sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1++) salt Sel d'or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d'isooctyle palladium, le soufre et le sel d'argent(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol
129828-23-5 Fatty acids, tall-oil, reaction products with Bu phenylmethyl phthalate, 2-(dimethylamino)ethanol, morpholine and overbased calcium petroleum sulfonates Acides gras, produits de réaction du tallöl avec le phtalate de butylphénylméthyle, le 2-(diméthylamino)éthanol, la morpholine et des sulfonates de pétrole à proportion plus que stoechiométrique de calcium
131298-44-7 C9-11-branched alkyl benzoate Esters alkyliques en C9-11 ramifiés de l'acide benzoïque
134112-54-2 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 4-amino-α,α,4-trimethylcyclohexanemethanamine, 5-amino-1,3,3-trimethylcyclohexanmethanamine, (chloromethyl)oxirane, 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine 4,4′-(Isopropylidène)diphénol polymérisé avec la 4-amino-α,α-4-triméthylcyclohexaneméthanamine, la 5-amino-1,3,3-triméthylcyclohexaneméthanamine, le (chlorométhyl)oxirane, la 2,2,4-triméthylhexane-1,6-diamine et la 2,4,4-triméthylhexane-1,6-diamine
137397-37-6 Decanedioic acid, polymer with carbonic dichloride and 4,4′-(1-methylethylidene)bis(phenol), 4-(1-methyl-1-phenylethyl) phenyl ester (9CI) Acide décanedioïque polymérisé avec du dichlorure carbonique et du 4,4′-(propane-2,2-diyl)bis(phénol), ester 4-(2-phénylpropane-2-yl) phénylique (9CI)
146729-34-2 Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(pentadecyloxy)- α-(3-Carboxyoxoprop-1-yl)-ω-(pentadécyloxy)poly(oxyéthylène)
147170-44-3 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-(C8-18 and C18-unsatd. acyl) derivs., inner salts Dérivés N-(acyliques en C8-18 et en C18-insaturé) du 3-amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, sels internes
149778-23-4 Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, polymer with 2-ethylhexyl 2-propenoate and 2-propenamide Chlorure de N,N,N-triméthyl-2-[oxy(acryloyl)]éthanaminium polymérisé avec l'acrylate de 2-éthylhexyle et l'acrylamide
149879-98-1 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[[(13Z)-1-oxo-13-docosenyl]amino]-, inner salt N-(carboxyméthyl)-N,N-diméthyl-3-[[(13Z)-1-oxo-13-docosényl]amino]-1-propanaminium, sel interne
151574-14-0 Ammonium α-sulfo-ω-[2-(1-propenyl)-4-nonyl(branched)phenoxy]poly(1-30)(oxyethylene) α-Sulfo-ω-(4-nonyl-2-allylphénoxy)poly(oxyéthylène), ramifié, sels d'ammonium
154862-43-8 2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]- 3,9-Bis[2,4-bis(1-méthyl-1-phénéthyl)phénoxy]-2,4,8,10-tétraoxa-3,9-diphosphaspiro[5.5]undécane
162030-42-4 1,4-Benzenedicarboxylic acid, di-C11-14-isoalkyl esters, C13-rich Téréphtalates de diisoalkyle en C11-14, enrichis en C13
163149-26-6 Tall oil polymeric reaction products with maleic anhydride, rosin, zinc oxide and calcium hydroxide Tallöl, produits de réaction avec l'anhydride maléique, la colophane, l'oxyde de zinc et l'hydroxyde de calcium
165883-95-4 Siloxanes and Silicones, di-Me, 3-(ethylamino)-2-methylpropyl group-terminated Di-Me siloxanes et silicones terminés par le groupe 3-(éthylamino)-2-méthylpropyle 
180685-83-0 Tannins, polymers with N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]ethanaminium chloride, graft Tannins polymérisés avec le chlorure de N,N,N-triméthyl-2-[(1-oxo-2-propényl)oxy]éthanaminium, greffé
182371-64-8 Hexanedioic acid, polymer with N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine, N-(2-aminoethyl)-1,2-ethanediamine and (chloromethyl)oxirane, sulfate Acide adipique, polymérisé avec la N-(2-aminoéthyl)-N′-[2-[(2-aminoéthyl)amino]éthyl]-éthylènediamine, la N-(2-aminoéthyl)-éthylènediamine et le (chlorométhyl)oxirane, sulfate
185857-36-7 Alkanes, C10-C13-branched and linear Alcanes en C10-C13 linéaires et ramifiés
188627-10-3 Siloxanes and Silicones, di-Me, [[[3-[(2-aminoethyl)amino]-2-methylpropyl]methoxymethylsilyl]oxy]- and (C13-15-alkyloxy)-terminated Di-Me siloxanes et silicones terminés par les groupes [({3-[(2-aminoéthyl)amino]-2-méthylpropyl}méthoxyméthylsilyl)oxy] et (C13-15-alkyloxy) 
190085-41-7 Benzoic acid, 2-hydroxy-, 2-butyloctyl ester Salicylate de 2-butyloctyle
193098-40-7 1,6-Hexanediamine, N,N′-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymers with morpholine-2,4,6-trichloro-1,3,5-triazine reaction products, methylated 1,6-Hexanediamine, N,N′-bis(2,2,6,6-tétraméthyl-4-pipéridinyl)-, polymères formés avec des produits de réaction de la morpholine-2,4,6-trichloro-1,3,5-triazine, méthylés
207596-32-5 Nitric acid, palladium(2+) salt, hydrate (2:1:?) Hydrate de nitrate de palladium (2+) (?/2/1)
210920-40-4 Tin, Butyl, 1-dodecanethio, 2-mercaptoethanol thio complexes Complexes de Bu dodécane-1-thiol 2-mercaptoéthanol thioxo étain
220689-12-3 Phosphonium, tetrabutyl-, salt with 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonic acid (1:1) Perfluorobutane-1-sulfonate de tétrabutylphosphonium (1/1)
237753-63-8 Alcohols, C13-15, reaction products with N-[3-(dimethoxymethylsilyl)-2-methylpropyl]1,2-ethanediamine, glycidol, and hydroxy-terminated di-Me siloxanes Produits de réaction d'alcools C13-15 avec la N-[3-(diméthoxyméthylsilyl)-2-méthylpropyl]éthane-1,2-diamine, le glycidol et les di-Me siloxanes terminés par le groupe hydroxy  
671756-61-9 1-Tetradecanesulfonic acid, (dimethylphenyl)- Acide xylyltétradécane-1-sulfonique
676143-36-5 1-Hexadecanesulfonic acid, (dimethylphenyl)- Acide xylylhexadécane-1-sulfonique
848301-65-5 Naphtha (Fischer-Tropsch), light, C4-10-branched and linear Naphta (Fischer-Tropsch), léger, linéaire et ramifié en C4-10
848301-66-6 Kerosine (Fischer-Tropsch), full-range, C8-16-branched and linear Kérosène (Fischer-Tropsch), pleine gamme, linéaire et ramifié en C8-16
848301-67-7 Distillates (Fischer-Tropsch), C8-26- branched and linear Distillats (Fischer-Tropsch), linéaires et ramifiés en C8-26
848301-71-3 Residual oils (Fischer-Tropsch), base oil production, C40-70-branched, cyclic and linear aliphatic hydrocarbon fraction Huiles résiduelles (Fischer-Tropsch) de la production d'huile de base, fraction d'hydrocarbures aliphatiques linéaires, ramifiés et cycliques en C40-70
866259-61-2 N,N-dicoco-2-hydroxy-acetamide N,N-Di(alkyl de coco)-2-hydroxyacétamide
928771-01-1 Alkanes, C10-20 - branched and linear Alcanes en C10-20, ramifiés ou linéaires
944747-28-8 Fatty acids, C18-unsatd., dimers, polymers, with bisphenol A, diethylenetriamine, epichlorohydrin, N1, N1-1,2-ethanediylbis[1,3-propanediamine], tall-oil fatty acids and triethylenetetramine Dimères d'acides gras insaturés en C18, polymérisés avec du 4,4′-(propane-2,2-diyl)bisphénol, de la 3-azapentane-1,5-diamine, du 1-chloro-2,3-époxypropane, de la N,N-éthane-1,2-diylbis[propane-1,3-diamine], des acides gras de tallöl et de la 3,6 diazaoctane-1,8-diamine
1000817-22-0 Fatty acids, C8-18 and C18-unsatd, reaction products with diethanolamine and propylene oxide Acides gras en C8-18 et en C18 insaturés, produits de la réaction avec du 2,2′ aminobiséthanol et du 1,2-époxypropane
1001320-38-2 Carbamic acid, [(butylthio) thioxomethyl]-,butyl ester [(Butylthio) thioxométhyl]-carbamate de butyle
1013910-41-2 Oxirane, 2-ethyl-, polymer with oxirane, mono-C12-14-sec-alkyl ethers 2-Éthyloxirane polymérisé avec de l'oxirane, oxydes mono(sec-alkyl(C12-14)iques)
1022990-65-3 Oxirane, 2-ethyl-, polymer with oxirane, mono-C11-15-sec-alkyl ethers 2-éthyloxirane polymérisé avec de l'oxirane, oxydes mono-sec-alkyliques en C11-15
1174918-46-7 Alkanes, C14-16-branched and linear Alcanes en C14-16 linéaires et ramifiés
1224429-82-6 Phosphoric acid, mixed esters with polyethylene glycol and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanol, ammonium salts Acide phosphorique, esters mixtes avec du polyéthylèneglycol et du 3,3,4,4,5,5,6,6,7,7,8,8,8-tridécafluoro-1-octanol, sels ammoniacaux
1437280-84-6 Alkanes, C9-C13-branched and linear Alcanes en C9-C13 linéaires et ramifiés
1437280-85-7 Alkanes, C18-C24-branched and linear Alcanes en C18-C24 linéaires et ramifiés
1437281-01-0 Alkanes, C15-C19-branched and linear Alcanes en C15-C19 linéaires et ramifiés
1437281-03-2 Alkanes, C12-C15-branched and linear Alcanes en C12-C15 linéaires et ramifiés
1437281-04-3 Alkanes, C9-C12-branched and linear Alcanes en C9-C12 linéaires et ramifiés
1538409-50-5 Poly(oxy-1,2-ethanediyl), α-[2-[tetrahydro-1 (2H)-pyrimidinyl) ethyl]-ω-hydroxy-, N-tallow alkyl derivs., di-Me sulfate-quaternized α-[2-[tétrahydro-(2H)-pyrimidin-1-yl)ethyle]-ω-hydroxypoly(oxyéthane-1,2-diyle), dérivés N-(alkyle de suif), quaternarisés avec du sulfate de diméthyle
Part 1 masked substances
Confidential Accession Number (see footnote 17) Masked name Nom maquillé
13811-5 2-Propenoic acid, 2-methyl-, methyl ester, telomer with alkyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with 2,2′-thiobis[ethanol], lactates (salts) 2-Méthyl-2-propènoate de méthyle télomérisé avec le 2-propènoate d'alkyle, le tert-dodécanethiol, l'éthénylbenzène, le 2-méthyl-2-propènoate d'oxiranylméthyle et le mono(2-méthyl-2-propènoate) de propane-1,2-diol, produits de réaction avec le 2,2′-thiodiéthanol, lactates (sels)
13697-8 The reaction product of dihydro-undecyl-heteromonocycleethanamine, with oxirane, mono[(C12-14-alkyloxy)methyl] derivs. and 2-hydroxypropanoic acid Le produit de réaction de la dihydro-undécyl-hétéromonocycleéthanamine, avec les dérivés mono[(C12-14-alkyloxy)méthyliques d'oxirane et l'acide 2-hydroxypropanoïque
17963-8 Amines, alkyl, compounds with 2-mercapto-dialkyl-1,3,2-dioxaphosphorinane 2-oxide (1:1) Alcanamines, composés avec du 2-oxyde de 2 mercapto-dialkyl-1,3,2-dioxaphosphinane (1/1)
18735-6 1-substituted Propane, 3-(triethoxysilyl)-, reaction products with polyethylene glycol mono-(branched tridecyl) ether Propane substitué en position 1, 3-(triéthoxysilyl)-, produits de la réaction avec de l'éther tridécylique monoramifié de polyéthylèneglycol
13568-5 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 2(methylamino)ethanol, N-(1,3-dimethylbutylidene)-N′-[2-[(1,3-dimethylbutylidene)amino]ethyl]-1,2-ethanediamine and 2-hydroxypropanoic acid 4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, le 2-(méthylamino)éthanol, la N-(1,3-diméthylbutylidène)-N′-{2-[(1,3-diméthylbutylidène)amino]éthyl}éthane-1,2-diamine et l'acide 2-hydroxypropanoïque
13668-6 Polymer of 4,4′-(1-methylethylidene)bisphenol polymer with (chloromethyl)oxirane, 4,4′-(1-methylidene)bisphenol, alkylphenols, alkanolamines and alkylamines, lactic acid salt of Polymère du 4,4′-(1-méthyléthylidène)diphénol polymérisé avec le (chlorométhyl)oxirane, le 4,4′-(1-méthylidène)diphénol, des alkylphénols, des alcanolamines et des alkylamines, sel de l'acide lactique
13680-0 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with chloromethyloxirane, 4,4′-(1methylethylidene)bisphenol, hexahydro-1,3-isobenzofurandione, α,α′-[(1-methylethylidene)di4,1-phenylene]bis(ω-hydroxy)poly(oxy-1,2-ethanediyl), sulfamic acid, 2(methylamino)ethanol, N,N-dimethyl-1,3-alkanediamine and 2-aminoethanol 4,4′-(1-Méthyléthylidène)diphéhol polymérisé avec le chlo rométhyloxirane, le 4,4′-(1méthyléthylidène)diphénol, l'hexahydro-1,3-isobenzofurandione, l'α,α′-[(1-méthyléthylidène)di-4,1-phénylène]bis(ω-hydroxy)poly(oxyéthane-1,2-diyl), l'acide sulfamique, le 2-(méthylamino)éthanol, la N,N-diméthylalcane-1,3-diamine et le 2-aminoéthanol
13702-4 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 1,3-propanediamine, 2-methyl-N,N-dimethyl-1,5-pentanediamine, neodecanoic acid, hetermonocyclicmethyl ester, capped with 2,2′-iminobisethanol, salt with 2-hydroxypropanoic acid 4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, la propane-1,3-diamine, la 2-méthyl-N,N-diméthylpentane-1,5-diamine, le néodécanoate d'hétérmonocycliqueméthyle, terminé avec le 2,2′-iminobiséthanol, sel avec l'acide 2-hydroxypropanoïque
14236-7 (Chloromethyl)oxirane, polymer with 4,4′-(1-methylethylidene)bis[phenol] and N,N-dialkyl-1-octadecanamine, acetates (salts) (Chlorométhyl)oxirane polymérisé avec le 4,4′-(1-méthyléthylidène)diphénol et la N,N-dialkyloctadécan-1-amine, acétates (sels)
15099-6 Propanoic acid, 2-hydroxy-, (2S)-, compds. with bisphenol A-epichlorohydrin polymer dodecylphenol Ph ether-polyamine-N,N-dimethyl-1, 3-propanediamine-2-(methylamino) ethanol reaction products Acide lactique, (2S)-, composés avec un polymère de bisphénol A et d'épichlorhydrine, de l'oxyde de dodécylphénol et de phényle, une polyamine, de la N,N-diméthylpropane-1,3-diamine, produits de la réaction avec du 2-(méthylamino)éthanol
16285-4 Oxirane, alkyl-, homopolymer, 3-aminopropyl 4-dodecylphenyl ether Alkyloxirane, homopolymérisé, éther 4-dodécylphényl 3-aminopropylique
17772-6 Polymer of aliphatic amine, epichlorohydrin, oxalic acid and urea Polymère d'une amine aliphatique, l'épichlorhydrine, l'acide oxalique et l'urée
14857-7 1,3-Diisocyanatoalkylbenzene, polymer with α,α′-[(methylimino)di-2,1-ethanediyl]bis[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)], acetates (salts) 1,3-Diisocyanatoalkylbenzène polymérisé avec l'α,α′[(méthylimino)diéthane-1,2-diyl]bis[ω-hydroxypoly[oxy(méthyléthane-1,2-diyl)], acétates (sels)
14971-4 4,4′-(1-Methylethylidene)bisphenol, polymer with (chloromethyl)oxirane, and 2(dimethylamino)ethanol-blocked polyalkylenepolyphenylene isocyanate, lactates (salts) 4,4′-Isopropylidènebisphénol polymérisé avec du (chlorométhyl)oxirane et de l'isocyanate de polyalkylènepolyphénylène séquencé avec du 2 (diméthylamino)éthanol, lactates (sels)
18253-1 1-Alkanol, polyfluoro-, reaction products with phosphorus oxide (P2O5), ammonium salts polyfluoroalcan-1-ol, produits de réaction avec le pentoxyde de diphosphore (P2O5), sels d'ammonium,
15232-4 Poly[oxy(1,2-propanediyl)], α-(3-aminopropyl)-ω-hydroxy-, alkyl ethers α-(3-Aminopropyl)-ω-hydroxypoly[oxy(propane-1,2-diyl)], éthers alkyliques
18475-7 Alkanediol, reaction products with phosphorus oxide (P2O5), polyfluoro-1-alkanol,-ammonium salts Alcanediol, produits de la réaction avec de l'oxyde de phosphore (P2O5), polyfluoro 1-alcanol, sels ammoniacaux
Part 2
CAS RN Name of the substance Nom de la substance
95-31-8 2-Benzothiazolesulfenamide, N-(1,1-dimethylethyl)- N-tert-Butylbenzothiazole-2-sulfénamide
95-33-0 2-Benzothiazolesulfenamide, N-cyclohexyl- N-Cyclohexylbenzothiazole-2-sulfénamide
120-78-5 Benzothiazole, 2,2′-dithiobis- Disulfure de di(benzothiazol-2-yle)
149-30-4 2(3H)-Benzothiazolethione Benzothiazole-2-thiol
1321-69-3 Naphthalenesulfonic acid, sodium salt Naphtalènesulfonate de sodium
2492-26-4 2(3H)-Benzothiazolethione, sodium salt Sulfure de sodium et de benzothiazol-2-yle
3147-75-9 Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)- 2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3tétraméthylbutyl)phénol
3846-71-7 Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)- 2-Benzotriazol-2-yl-4,6-di-tert-butylphénol
3896-11-5 Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-6-(1,1-dimethylethyl)-4-methyl- Bumétrizole
4221-80-1 Benzoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2,4-bis(1,1-dimethylethyl)phenyl ester 3,5-Di-tert-butyl-4-hydroxybenzoate de 2,4-di-tert-butylphényle
4979-32-2 2-Benzothiazolesulfenamide, N,N-dicyclohexyl- N,N-Dicyclohexylbenzothiazole-2-sulfénamide
7726-95-6 Bromine Brome
21564-17-0 Thiocyanic acid, (2-benzothiazolylthio)methyl ester Thiocyanate de (benzothiazol-2-ylthio)méthyle
23128-74-7 Benzenepropanamide, N,N′-1,6-hexanediylbis[3,5-bis(1,1-dimethylethyl)-4-hydroxy- N,N′-Hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphénylpropionamide]
25167-32-2 Benzenesulfonic acid, oxybis[dodecyl-, disodium salt 2,2′(ou 3,3′)-Oxybis[5(ou 2)-dodécylbenzènesulfonate] de disodium
25322-17-2 Naphthalenesulfonic acid, dinonyl- Acide dinonylnaphtalènesulfonique
25619-56-1 Naphthalenesulfonic acid, dinonyl-, barium salt Bis(dinonylnaphtalènesulfonate) de baryum
25638-17-9 Naphthalenesulfonic acid, butyl-, sodium salt Butylnaphtalènesulfonate de sodium
29385-43-1 1H-Benzotriazole, 4(or 5)-methyl- Méthyl-1H-benzotriazole
36437-37-3 Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1-dimethylethyl)-6-(1-methylpropyl)- 2-(2H-Benzotriazol-2-yl)-4-(tert-butyl)-6-(secbutyl)phénol
36443-68-2 Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-5-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester Bis[3-(5-tert-butyl-4-hydroxy-m-tolyl)propionate] d'éthylènebis(oxyéthylène)
60223-95-2 Naphthalenedisulfonic acid, dinonyl- Acide dinonylnaphtalènedisulfonique
70321-86-7 Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)- 2-(2H-Benzotriazol-2-yl)-4,6-bis(1-méthyl-1-phényléthyl)phénol
80584-90-3 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-4-methyl- N,N-Bis(2-éthylhexyl)-4-méthyl-1H-benzotriazole-1-méthylamine
80595-74-0 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-5-methyl- N,N-Bis(2-éthylhexyl)-5-méthyl-1H-benzotriazole-1-méthylamine
94270-86-7 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-ar-methyl- N,N-Bis(2-éthylhexyl)-ar-méthyl-1H-benzotriazole-1-méthanamine
Part 3
CAS RN Name of the substance Nom de la substance
50-27-1 Estra-1,3,5(10)-triene-3,16,17-triol, (16α,17β)- Oestriol
50-28-2 Estra-1,3,5(10)-triene-3,17-diol (17β)- Estra-1,3,5(10)-triène-3,17-diol (17β)-
57-11-4 Octadecanoic acid Acide stéarique
57-88-5 Cholest-5-en-3-ol (3β)- Cholestérol
58-93-5 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide Hydrochlorothiazide
61-73-4 Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride Chlorure de méthylthioninium
67-20-9 2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]- Nitrofurantoïne
67-43-6 Glycine, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]- Acide N-carboxyméthyliminobis(éthylènenitrilo)tétraacétique
67-68-5 Methane, sulfinylbis- Diméthylsulfoxyde
68-12-2 Formamide, N,N-dimethyl- N,N-Diméthylformamide
74-93-1 Methanethiol Méthanethiol
75-08-1 Ethanethiol Éthanethiol
75-33-2 2-Propanethiol Propane-2-thiol
75-75-2 Methanesulfonic acid Acide méthanesulfonique
75-77-4 Silane, chlorotrimethyl- Chlorotriméthylsilane
75-79-6 Silane, trichloromethyl- Trichloro(méthyl)silane
77-58-7 Stannane, dibutylbis[(1-oxododecyl)oxy]- Dilaurate de dibutylstannane
77-90-7 1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, tributyl ester O-Acétylcitrate de tributyle
78-04-6 1,3,2-Dioxastannepin-4,7-dione, 2,2-dibutyl- Maléate de dibutylstannane
78-06-8 6H-1,3,2-Oxathiastannin-6-one, 2,2-dibutyldihydro- 2,2-Dibutyldihydro-6H-1,3,2-oxathiastannin-6-one
78-70-6 1,6-Octadien-3-ol, 3,7-dimethyl- Linalol
79-11-8 Acetic acid, chloro- Acide chloroacétique
79-14-1 Acetic acid, hydroxy- Acide glycolique
79-34-5 Ethane, 1,1,2,2-tetrachloro- 1,1,2,2-Tétrachloroéthane
79-36-7 Acetyl chloride, dichloro- Chlorure de dichloroacétyle
79-92-5 Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene- Camphène
80-07-9 Benzene, 1,1′-sulfonylbis[4-chloro- Bis(4-chlorophényl)sulfone
80-46-6 Phenol, 4-(1,1-dimethylpropyl)- p-(1,1-Diméthylpropyl)phénol
80-62-6 2-Propenoic acid, 2-methyl-, methyl ester Méthacrylate de méthyle
83-44-3 Cholan-24-oic acid, 3,12-dihydroxy-, (3α,5β,12α)- Acide 3α,12α-dihydroxy-5β-cholan-24-oïque
83-86-3 myo-Inositol, hexakis(dihydrogen phosphate) Acide phytique
84-65-1 9,10-Anthracenedione Anthraquinone
85-43-8 1,3-Isobenzofurandione, 3a,4,7,7a-tetrahydro- Anhydride 1,2,3,6-tétrahydrophtalique
87-29-6 2-Propen-1-ol, 3-phenyl-, 2-aminobenzoate Anthranilate de cinnamyle
87-69-4 Butanedioic acid, 2,3-dihydroxy- [R-(R,R)]- Acide (++)-tartrique
88-89-1 Phenol, 2,4,6-trinitro- Acide picrique
89-78-1 Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1α,2β,5α)- Menthol
89-82-7 Cyclohexanone, 5-methyl-2-(1-methylethylidene)-, (R)- p-Menth-4(8)-én-3-one
90-43-7 [1,1′-Biphenyl]-2-ol Biphényl-2-ol
91-17-8 Naphthalene, decahydro- Décahydronaphtalène
92-69-3 [1,1′-Biphenyl]-4-ol Biphényl-4-ol
92-84-2 10H-Phenothiazine Phénothiazine
92-88-6 [1,1′-Biphenyl]-4,4′-diol Biphényle-4,4′-diol
94-13-3 Benzoic acid, 4-hydroxy-, propyl ester 4-Hydroxybenzoate de propyle
94-18-8 Benzoic acid, 4-hydroxy-, phenylmethyl ester 4-Hydroxybenzoate de benzyle
94-26-8 Benzoic acid, 4-hydroxy-, butyl ester 4-Hydroxybenzoate de butyle
94-36-0 Peroxide, dibenzoyl Peroxyde de dibenzoyle
94-60-0 1,4-Cyclohexanedicarboxylic acid, dimethyl ester Cyclohexane-1,4-dicarboxylate de diméthyle
95-14-7 1H-Benzotriazole Benzotriazole
95-47-6 Benzene, 1,2-dimethyl- o-Xylène
95-49-8 Benzene, 1-chloro-2-methyl- 2-Chlorotoluène
95-63-6 Benzene, 1,2,4-trimethyl- 1,2,4-Triméthylbenzène
96-05-9 2-Propenoic acid, 2-methyl-, 2-propenyl ester Méthacrylate d'allyle
96-14-0 Pentane, 3-methyl- 3-Méthylpentane
96-26-4 2-Propanone, 1,3-dihydroxy- 1,3-Dihydroxyacétone
96-37-7 Cyclopentane, methyl- Méthylcyclopentane
96-48-0 2(3H)-Furanone, dihydro- γ-Butyrolactone
96-49-1 1,3-Dioxolan-2-one Carbonate d'éthylène
97-00-7 Benzene, 1-chloro-2,4-dinitro- 1-Chloro-2,4-dinitrobenzène
97-63-2 2-Propenoic acid, 2-methyl-, ethyl ester Méthacrylate d'éthyle
97-65-4 Butanedioic acid, methylene- Acide itaconique
97-77-8 Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetraethyl- Disulfirame
97-90-5 2-Propenoic acid, 2-methyl-, 1,2-ethanediyl ester Diméthacrylate d'éthylène
97-99-4 2-Furanmethanol, tetrahydro- Alcool tétrahydrofurfurylique
98-29-3 1,2-Benzenediol, 4-(1,1-dimethylethyl)- 4-tert-Butylpyrocatéchol
98-73-7 Benzoic acid, 4-(1,1-dimethylethyl)- Acide 4-tert-butylbenzoïque
98-83-9 Benzene, (1-methylethenyl)- 2-Phénylpropène
98-86-2 Ethanone, 1-phenyl- Acétophénone
99-08-1 Benzene, 1-methyl-3-nitro- 3-Nitrotoluène
99-62-7 Benzene, 1,3-bis(1-methylethyl)- 1,3-Diisopropylbenzène
99-97-8 Benzenamine, N,N,4-trimethyl- N,N-Diméthyl-p-toluidine
100-18-5 Benzene, 1,4-bis(1-methylethyl)- 1,4-Diisopropylbenzène
100-20-9 1,4-Benzenedicarbonyl dichloride Dichlorure de téréphtaloyle
100-21-0 1,4-Benzenedicarboxylic acid Acide téréphtalique
100-42-5 Benzene, ethenyl- Styrène
101-02-0 Phosphorous acid, triphenyl ester Phosphite de triphényle
101-72-4 1,4-Benzenediamine, N-(1-methylethyl)-N′-phenyl- N-Isopropyl-N′-phényl-p-phénylènediamine
102-06-7 Guanidine, N,N′-diphenyl- 1,3-Diphénylguanidine
102-77-2 Morpholine, 4-(2-benzothiazolylthio)- 2-(Morpholinothio)benzothiazole
103-09-3 Acetic acid, 2-ethylhexyl ester Acétate de 2-éthylhexyle
104-43-8 Phenol, 4-dodecyl- p-Dodécylphénol
104-93-8 Benzene, 1-methoxy-4-methyl- 4-Méthylanisole
105-08-8 1,4-Cyclohexanedimethanol Cyclohexane-1,4-diméthanol
105-11-3 2,5-Cyclohexadiene-1,4-dione, dioxime p-Benzoquinone-dioxime
105-59-9 Ethanol, 2,2′-(methylimino)bis- 2,2′-Méthyliminodiéthanol
105-76-0 2-Butenedioic acid (Z)-, dibutyl ester Maléate de dibutyle
105-83-9 1,3-Propanediamine, N-(3-aminopropyl)-N-methyl- N,N-Bis(3-aminopropyl)méthylamine
106-20-7 1-Hexanamine, 2-ethyl-N-(2-ethylhexyl)- Bis(2-éthylhexyl)amine
106-23-0 6-Octenal, 3,7-dimethyl- Citronellal
106-42-3 Benzene, 1,4-dimethyl- p-Xylène
106-50-3 1,4-Benzenediamine p-Phénylènediamine
106-91-2 2-Propenoic acid, 2-methyl-, oxiranylmethyl ester Méthacrylate de 2,3-époxypropyle
106-98-9 1-Butene But-1-ène
107-01-7 2-Butene But-2-ène
107-12-0 Propanenitrile Propiononitrile
107-19-7 2-Propyn-1-ol Prop-2-yn-1-ol
107-71-1 Ethaneperoxoic acid, 1,1-dimethylethyl ester Peracétate de tert-butyle
108-01-0 Ethanol, 2-(dimethylamino)- 2-Diméthylaminoéthanol
108-05-4 Acetic acid ethenyl ester Acétate de vinyle
108-30-5 2,5-Furandione, dihydro- Anhydride succinique
108-38-3 Benzene, 1,3-dimethyl- m-Xylène
108-77-0 1,3,5-Triazine, 2,4,6-trichloro- 2,4,6-Trichloro-1,3,5-triazine
108-87-2 Cyclohexane, methyl- Méthylcyclohexane
108-95-2 Phenol Phénol
108-98-5 Benzenethiol Benzènethiol
109-08-0 Pyrazine, methyl- 2-Méthylpyrazine
109-16-0 2-Propenoic acid, 2-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester Diméthacrylate de 2,2′-éthylènedioxydiéthyle
109-28-4 9-Octadecenamide, N-[3-(dimethylamino)propyl]-, (Z)- N-[3-(Diméthylamino)propyl]oléamide
109-55-7 1,3-Propanediamine, N,N-dimethyl- 3-Aminopropyldiméthylamine
109-65-9 Butane, 1-bromo- 1-Bromobutane
109-69-3 Butane, 1-chloro- 1-Chlorobutane
109-70-6 Propane, 1-bromo-3-chloro- 1-Bromo-3-chloropropane
109-74-0 Butanenitrile Butyronitrile
110-05-4 Peroxide, bis(1,1-dimethylethyl) Peroxyde de di-tert-butyle
110-86-1 Pyridine Pyridine
110-97-4 2-Propanol, 1,1′-iminobis- 1,1′-Iminodipropan-2-ol
111-66-0 1-Octene Oct-1-ène
112-18-5 1-Dodecanamine, N,N-dimethyl- Dodécyldiméthylamine
112-35-6 Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]- 2-[2-(2-Méthoxyéthoxy)éthoxy]éthanol
112-36-7 Ethane, 1,1′-oxybis[2-ethoxy- Oxyde de bis(2-éthoxyéthyle)
112-62-9 9-Octadecenoic acid (Z)-, methyl ester Oléate de méthyle
112-73-2 Butane, 1,1′-[oxybis(2,1-ethanediyloxy)]bis- Oxyde de bis(2-butoxyéthyle)
115-11-7 1-Propene, 2-methyl- 2-Méthylpropène
115-27-5 4,7-Methanoisobenzofuran-1,3-dione, 4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro- Anhydride 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ène-2,3-dicarboxylique
117-39-5 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy- 3,3′,4′,5,7-Pentahydroxyflavone
118-55-8 Benzoic acid, 2-hydroxy-, phenyl ester Salicylate de phényle
118-79-6 Phenol, 2,4,6-tribromo- 2,4,6-Tribromophénol
119-36-8 Benzoic acid, 2-hydroxy-, methyl ester Salicylate de méthyle
119-84-6 2H-1-Benzopyran-2-one, 3,4-dihydro- 3,4-Dihydrocoumarine
120-32-1 Phenol, 4-chloro-2-(phenylmethyl)- Clorofène
120-47-8 Benzoic acid, 4-hydroxy-, ethyl ester 4-Hydroxybenzoate d'éthyle
120-61-6 1,4-Benzenedicarboxylic acid, dimethyl ester Téréphtalate de diméthyle
121-54-0 Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride Chlorure de benzethonium
121-79-9 Benzoic acid, 3,4,5-trihydroxy-, propyl ester 3,4,5-Trihydroxybenzoate de propyle
122-32-7 9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester Trioléate de 1,2,3-propanetriyle
122-69-0 2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester Cinnamate de cinnamyle
122-99-6 Ethanol, 2-phenoxy- 2-Phénoxyéthanol
123-51-3 1-Butanol, 3-methyl- 3-Méthylbutan-1-ol
123-79-5 Hexanedioic acid, dioctyl ester Adipate de dioctyle
124-17-4 Ethanol, 2-(2-butoxyethoxy)-, acetate Acétate de 2-(2-butoxyéthoxy)éthyle
124-18-5 Decane Décane
124-22-1 1-Dodecanamine Dodécylamine
124-28-7 1-Octadecanamine, N,N-dimethyl- Dimantine
124-63-0 Methanesulfonyl chloride Chlorure de méthanesulfonyle
124-68-5 1-Propanol, 2-amino-2-methyl- 2-Amino-2-méthylpropanol
125-46-2 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl- 2,6-Diacétyl-1,2,3,9b-tétrahydro-7,9-dihydroxy-8,9b-diméthyldibenzofurane-1,3-dione
126-00-1 Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl- Acide 4,4-bis(4-hydroxyphényl)valérique
127-65-1 Benzenesulfonamide, N-chloro-4-methyl-, sodium salt Tosylchloramide sodique
127-91-3 Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene- Pin-2(10)-ène
128-04-1 Carbamodithioic acid, dimethyl-, sodium salt Diméthyldithiocarbamate de sodium
129-17-9 Ethanaminium, N-[4-[[4-(diethylamino)phenyl](2,4disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, hydroxide, inner salt, sodium salt Hydrogéno[4-[4-(diéthylamino)-2′,4′-disulfonatobenzhydrylidène]cyclohexa-2,5-dién-1-ylidène]diéthylammonium, sel de sodium
131-17-9 1,2-Benzenedicarboxylic acid, di-2-propenyl ester Phtalate de diallyle
131-53-3 Methanone, (2-hydroxy-4-methoxyphenyl)(2hydroxyphenyl)- Dioxybenzone
131-55-5 Methanone, bis(2,4-dihydroxyphenyl)- 2,2′,4,4′-Tétrahydroxybenzophénone
131-56-6 Methanone, (2,4-dihydroxyphenyl)phenyl- 2,4-Dihydroxybenzophénone
131-57-7 Methanone, (2-hydroxy-4-methoxyphenyl)phenyl- Oxybenzone
135-19-3 2-Naphthalenol 2-Naphtol
135-37-5 Glycine, N-(carboxymethyl)-N-(2-hydroxyethyl)-, disodium salt 2-Hydroxyéthyliminodi(acétate) de disodium
135-57-9 Benzamide, N,N′-(dithiodi-2,1-phenylene)bis- N,N′-Dithiodi-o-phénylènedibenzamide
136-30-1 Carbamodithioic acid, dibutyl-, sodium salt Dibutyldithiocarbamate de sodium
139-13-9 Glycine, N,N-bis(carboxymethyl)- Acide nitrilotriacétique
140-10-3 2-Propenoic acid, 3-phenyl-, (E)- Acide trans-cinnamique
140-67-0 Benzene, 1-methoxy-4-(2-propenyl)- 4-Allylanisole
142-16-5 2-Butenedioic acid (Z)-, bis(2-ethylhexyl) ester Maléate de bis(2-éthylhexyle)
142-83-6 2,4-Hexadienal, (E,E)- Hexa-2,4-diénal
143-28-2 9-Octadecen-1-ol, (Z)- (Z)-Octadéc-9-énol
149-44-0 Methanesulfinic acid, hydroxy-, monosodium salt Hydroxyméthanesulfinate de sodium
149-57-5 Hexanoic acid, 2-ethyl- Acide 2-éthylhexanoïque
287-92-3 Cyclopentane Cyclopentane
288-32-4 1H-Imidazole Imidazole
301-10-0 Hexanoic acid, 2-ethyl-, tin(2++) salt Bis(2-éthylhexanoate) d'étain
314-13-6 1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt 6,6′-[3,3′-Diméthyl-(1,1′-biphényl-4,4′diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphtalènedisulfonate) de tétrasodium
330-54-1 Urea, N′-(3,4-dichlorophenyl)-N,N-dimethyl- Diuron
396-01-0 2,4,7-Pteridinetriamine, 6-phenyl- Triamtérène
513-35-9 2-Butene, 2-methyl- 2-Méthylbut-2-ène
520-36-5 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- 5,7-dihydroxy-2-(hydroxy4-phényl)-4H-1-benzopyran-4-one
540-72-7 Thiocyanic acid, sodium salt Thiocyanate de sodium
546-80-5 Bicyclo[3.1.0]hexan-3-one, 4-methyl-1-(1-methylethyl)-, [1S-(1α,4α,5α)]- 1-Isopropyl-4-méthylbicyclo[3.1.0]hexan-3-one
552-89-6 Benzaldehyde, 2-nitro- 2-Nitrobenzaldéhyde
556-63-8 Formic acid, lithium salt Formiate de lithium
563-80-4 2-Butanone, 3-methyl- 3-Méthylbutanone
590-18-1 2-Butene, (Z)- (Z)-But-2-ène
593-56-6 Hydroxylamine, O-methyl-, hydrochloride Chlorure de méthoxyammonium
597-82-0 Phosphorothioic acid, O,O,O-triphenyl ester Thiophosphate de O,O,O-triphényle
616-45-5 2-Pyrrolidinone 2-Pyrrolidone
624-64-6 2-Butene, (E)- (E)-But-2-ène
624-92-0 Disulfide, dimethyl Disulfure de diméthyle
628-96-6 1,2-Ethanediol, dinitrate Dinitrate d'éthylène
629-59-4 Tetradecane Tétradécane
646-06-0 1,3-Dioxolane 1,3-Dioxolane
683-18-1 Stannane, dibutyldichloro- Dichlorure de dibutylstannane
753-73-1 Stannane, dichlorodimethyl- Dichlorure de diméthylstannane
756-79-6 Phosphonic acid, methyl-, dimethyl ester Méthylphosphonate de diméthyle
818-08-6 Stannane, dibutyloxo- Oxyde de dibutylstannane
822-06-0 Hexane, 1,6-diisocyanato- Diisocyanate d'hexaméthylène
868-77-9 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester Méthacrylate de 2-hydroxyéthyle
924-42-5 2-Propenamide, N-(hydroxymethyl)- N-(Hydroxyméthyl)acrylamide
931-36-2 1H-Imidazole, 2-ethyl-4-methyl- 2-Éthyl-4-méthylimidazole
947-04-6 Azacyclotridecan-2-one Dodécane-12-lactame
982-57-0 Butanedioic acid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester, monosodium salt Ester mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophényl)propylique] de l'acide butanedioïque, sel monosodique
989-38-8 Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, chloride Chlorure de 9-[2-(éthoxycarbonyl)phényl]3,6-bis(éthylamino)-2,7-diméthylxanthylium
993-16-8 Stannane, trichloromethyl- Trichlorométhylstannane
999-97-3 Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)- 1,1,1,3,3,3-Hexaméthyldisilazane
1064-48-8 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)-, disodium salt 4-Amino-5-hydroxy-3-(4-nitrophénylazo)-6-(phénylazo)naphtalène-2,7-disulfonate de sodium
1067-33-0 Stannane, bis(acetyloxy)dibutyl- Di(acétate) de dibutylstannane
1067-53-4 2,5,7,10-Tetraoxa-6-silaundecane, 6-ethenyl-6-(2-methoxyethoxy)- Tris(2-méthoxyéthoxy)vinylsilane
1072-63-5 1H-Imidazole, 1-ethenyl- 1-Vinylimidazole
1118-46-3 Stannane, butyltrichloro- Trichlorure de butylstannane
1185-55-3 Silane, trimethoxymethyl- Triméthoxy(méthyl)silane
1185-81-5 Stannane, dibutylbis(dodecylthio)- Dibutylbis(dodécylthio)stannane
1222-05-5 Cyclopenta[g]-2-benzopyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl- 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexaméthylindéno[5,6-c]pyrane
1241-94-7 Phosphoric acid, 2-ethylhexyl diphenyl ester Phosphate de 2-éthylhexyle et de diphényle
1304-28-5 Barium oxide (BaO) Oxyde de baryum, obtenu par calcination de la withérite
1306-38-3 Cerium oxide (CeO2) Dioxyde de cérium
1309-64-4 Antimony oxide (Sb2O3) Trioxyde de diantimoine
1311-10-0 Strontium hydroxide (Sr(OH)2), octahydrate Octahydrate d'hydroxyde de strontium (Sr(OH)2)
1317-35-7 Manganese oxide (Mn3O4) Tétraoxyde de trimanganèse
1330-20-7 Benzene, dimethyl- Xylène, mélange d'isomères, pur
1506-02-1 Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- 1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one
1562-00-1 Ethanesulfonic acid, 2-hydroxy-, monosodium salt 2-Hydroxyéthanesulfonate de sodium
1569-02-4 2-Propanol, 1-ethoxy- 1-Éthoxypropan-2-ol
1633-05-2 Carbonic acid, strontium salt (1:1) Carbonate de strontium
1634-04-4 Propane, 2-methoxy-2-methyl- Oxyde de tert-butyle et de méthyle
1638-22-8 Phenol, 4-butyl- 4-Butylphénol
1806-26-4 Phenol, 4-octyl- p-Octylphénol
1936-15-8 1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-(phenylazo)-, disodium salt 7-Hydroxy-8-phénylazonaphtalène-1,3-disulfonate de disodium
1962-75-0 1,4-Benzenedicarboxylic acid, 1,4-dibutyl ester téréphtalate de dibutyle,
1987-50-4 Phenol, 4-heptyl- 4-Heptylphénol
2173-57-1 Naphthalene, 2-(2-methylpropoxy)- Oxyde d'isobutyle et de 2-naphtyle
2216-51-5 Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1α,2β,5α)]- 2-Menthol
2315-67-5 Ethanol, 2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- 2-[4-(1,1,3,3-Tétraméthylbutyl)phénoxy]éthanol
2386-87-0 7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, 7-oxabicyclo[4.1.0]hept-3-ylmethyl ester 7-Oxabicyclo[4.1.0]heptane-3-carboxylate de 7-oxabicyclo[4.1.0]hept-3-ylméthyle
2432-99-7 Undecanoic acid, 11-amino- Acide 11-aminoundécanoïque
2440-22-4 Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl- 2-(2H-Benzotriazol-2-yl)-p-crésol
2463-53-8 2-Nonenal Non-2-énal
2530-83-8 Silane, trimethoxy[3-(oxiranylmethoxy)propyl]- [3-(2,3-Époxypropoxy)propyl]triméthoxysilane
2530-85-0 2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester Méthacrylate de 3-triméthoxysilylpropyle
2530-87-2 Silane, (3-chloropropyl)trimethoxy- 3-Chloropropyltriméthoxysilane
2610-05-1 1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt 1-naphtalénol, 2-méthyl-, 1-acétate
2650-18-2 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, diammonium salt Diammonio(éthyl)[4-({4-[éthyl(3-sulfonatobenzyl)amino]phényl}(2-sulfonatophényl)méthylène)cyclohexa-2,5-dién-1-ylidène](3-sulfonatobenzyl)ammonium
2680-03-7 2-Propenamide, N,N-dimethyl- N,N-Diméthylacrylamide
2768-02-7 Silane, ethenyltrimethoxy- Triméthoxyvinylsilane
2781-10-4 Stannane, dibutylbis[(2-ethyl-1-oxohexyl)oxy]- Bis(2-éthylhexanoate) de dibutylétain
2855-13-2 Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl- 3-Aminométhyl-3,5,5-triméthylcyclohexylamine
2935-90-2 Propanoic acid, 3-mercapto-, methyl ester 3-Mercaptopropionate de méthyle
2996-92-1 Silane, trimethoxyphenyl- Triméthoxyphénylsilane
3081-01-4 1,4-Benzenediamine, N-(1,4-dimethylpentyl)-N′-phenyl- N-(1,4-Diméthylpentyl)-N′-phénylbenzène-1,4-diamine
3164-85-0 Hexanoic acid, 2-ethyl-, potassium salt 2-Éthylhexanoate de potassium
3248-91-7 Benzenamine, 4-[(4-amino-3-methylphenyl)(4-imino-3-methyl-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, monohydrochloride 4-[(4-Amino-m-tolyl)(4-imino-3-méthylcyclohexa-2,5-dién-1-ylidène)méthyl]-o-toluidine, monochlorhydrate
3268-49-3 Propanal, 3-(methylthio)- 3-(Méthylthio)propionaldéhyde
3302-10-1 Hexanoic acid, 3,5,5-trimethyl- Acide 3,5,5-triméthylhexanoïque
3322-93-8 Cyclohexane, 1,2-dibromo-4-(1,2-dibromoethyl)- 1,2-Dibromo-4-(1,2-dibromoéthyl)cyclohexane
3520-42-1 Xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, hydroxide, inner salt, sodium salt Hydrogéno-3,6-bis(diéthylamino)-9-(2,4-disulfonatophényl)xanthylium, sel de sodium
3648-18-8 Stannane, dioctylbis[(1-oxododecyl)oxy]- Dilaurate de dioctylétain
3669-02-1 Distannoxane, 1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]- 1,1,3,3,-Tétrabutyl-1,3-bis[(1-oxododécyl)oxy]distannoxane
3864-99-1 Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)- 2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phénol
3926-62-3 Acetic acid, chloro-, sodium salt Chloroacétate de sodium
3982-87-4 Phosphine sulfide, tris(2-methylpropyl)- Sulfure de triisobutylphosphine
4065-45-6 Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy- Sulisobenzone
4067-16-7 3,6,9,12-Tetraazatetradecane-1,14-diamine 3,6,9,12-Tétraazatétradécaméthylènediamine
4191-73-5 Benzoic acid, 4-hydroxy-, 1-methylethyl ester 4-Hydroxybenzoate d'isopropyle
4198-19-0 2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4,5-dihydroxy-, tetrasodium salt 3,3′-{[3,3′-Diméthoxy(1,1′-biphényl)-4,4′diyl]bis(azo)}bis(4,5-dihydroxynaphtalène-2,7-disulfonate) de tétrasodium
4247-02-3 Benzoic acid, 4-hydroxy-, 2-methylpropyl ester 4-Hydroxybenzoate d'isobutyle
4253-22-9 Stannane, dibutylthioxo- Dibutylthioxostannane
4403-90-1 Benzenesulfonic acid, 2,2′-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-methyl-, disodium salt 2,2′-(9,10-Dioxoanthracène-1,4-diyldiimino)bis(5-méthylsulfonate de disodium
4424-06-0 Bisbenzimidazo[2,1-b:2′,1′i]benzo[lmn][3,8]phenanthroline-8,17-dione Bisbenzimidazo[2,1-b:2′,1′-i]benzo[lmn][3,8]phénanthroline-8,17-dione
4712-55-4 Phosphonic acid, diphenyl ester Phosphonate de diphényle
4719-04-4 1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol 2,2′,2″-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triéthanol
5026-74-4 Oxiranemethanamine, N-[4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)- p-(2,3-Époxypropoxy)-N,N-bis(2,3-époxypropyl)aniline
5039-78-1 Ethanaminium, N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, chloride Chlorure de [2(méthacryloyloxy)éthyl]triméthylammonium
5124-30-1 Cyclohexane, 1,1′-methylenebis[4-isocyanato- Diisocyanate de 4,4′-méthylènedicyclohexyle
5141-20-8 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, disodium salt Dihydrogéno(éthyl)(4-{p-[éthyl(msulfonatobenzyl)amino]-p′sulfonatobenzhydrylène}cyclohexa-2,5-dién-1ylidène)(m-sulfonatobenzyl)ammonium, sel de disodium
5146-66-7 2,6-Octadienenitrile, 3,7-dimethyl- 3,7-Diméthylocta-2,6-diènenitrile
5153-25-3 Benzoic acid, 4-hydroxy-, 2-ethylhexyl ester 4-Hydroxybenzoate de 2-éthylhexyle
5165-97-9 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propenyl)amino]-, monosodium salt 2-Méthyl-2-[(1-oxoallyl)amino]propanesulfonate de sodium
5392-40-5 2,6-Octadienal, 3,7-dimethyl- Citral
5435-64-3 Hexanal, 3,5,5-trimethyl- 3,5,5-Triméthylhexanal
5466-77-3 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester 4-Méthoxycinnamate de 2-éthylhexyle
5847-55-2 Stannane, dibutylbis[(1-oxooctadecyl)oxy]- Dibutylbis(stéaroyloxy)stannane
5989-27-5 Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (R)- (R)-p-Mentha-1,8-diène
6104-30-9 Urea, N,N″-(2-methylpropylidene)bis- N,N″-(Isobutylidène)diurée
6197-30-4 2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester Octocrylène
6259-76-3 Benzoic acid, 2-hydroxy-, hexyl ester Salicylate d'hexyle
6362-79-4 1,3-Benzenedicarboxylic acid, 5-sulfo-, monosodium salt Hydrogéno-5-sulfoisophtalate de sodium
6373-74-6 Benzenesulfonic acid, 5-[(2,4-dinitrophenyl)amino]-2-(phenylamino)-, monosodium salt 2-Anilino-5-(2,4-dinitroanilino)benzènesulfonate de sodium
6419-19-8 Phosphonic acid, [nitrilotris(methylene)]tris- Acide nitrilotriméthylènetriphosphonique
6422-86-2 1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester Téréphtalate de bis(2-éthylhexyle)
6528-34-3 Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]N-(2-methoxyphenyl)-3-oxo- 2-[(4-Méthoxy-2-nitrophényl)azo]-N-(2-méthoxyphényl)-3-oxobutyramide
6728-26-3 2-Hexenal, (E)- trans-Hex-2-énal
6731-36-8 Peroxide, (3,3,5-trimethylcyclohexylidene)bis[(1,1dimethylethyl) Diperoxyde de di-tert-butyle et de 3,3,5-triméthylcyclohexylidène
6739-62-4 Benzoic acid, 2-[[2-amino-6-[[4′-[(3-carboxy-4-hydroxyphenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt 2-[[2-Amino-6-[[4′-[(3-carboxylato-4hydroxyphényl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]-5-hydroxy-7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium
6834-92-0 Silicic acid (H2SiO3), disodium salt Métasilicate de disodium
6842-15-5 1-Propene, tetramer Prop-1-ène tétramérisé
6864-37-5 Cyclohexanamine, 4,4′-methylenebis[2-methyl- 2,2′-Diméthyl-4,4′-méthylènebis(cyclohexylamine)
7381-01-3 Dodecanoic acid, 2-sulfoethyl ester, sodium salt Laurate de sodium et de 2-sulfonatoéthyle
7398-69-8 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride Chlorure de diallyldiméthylammonium
7488-55-3 Sulfuric acid, tin(2++) salt (1:1) Sulfate d'étain
7492-66-2 2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl- 1,1-Diéthoxy-3,7-diméthylocta-2,6-diène
7563-33-9 Butanoic acid, 3-methyl-, ammonium salt Isovalérate d'ammonium
7601-89-0 Perchloric acid, sodium salt Perchlorate de sodium
7631-95-0 Molybdate (MoO42-), disodium, (ß-4)- Molybdate de disodium
7637-07-2 Borane, trifluoro- Trifluorure de bore
7646-78-8 Stannane, tetrachloro- Tétrachlorure d'étain
7647-15-6 Sodium bromide (NaBr) Bromure de sodium
7699-43-6 Zirconium, dichlorooxo- Oxydichlorure de zirconium
7719-09-7 Thionyl chloride Dichlorure de thionyle
7722-64-7 Permanganic acid (HMnO4), potassium salt Permanganate de potassium
7757-74-6 Disulfurous acid, disodium salt Anhydrosulfite disodique
7757-86-0 Phosphoric acid, magnesium salt (1:1) Hydrogénoorthophosphate de magnésium
7758-02-3 Potassium bromide (KBr) Bromure de potassium
7758-09-0 Nitrous acid, potassium salt Nitrite de potassium
7758-19-2 Chlorous acid, sodium salt Chlorite de sodium
7773-01-5 Manganese chloride (MnCl2) Dichlorure de manganèse
7775-14-6 Dithionous acid, disodium salt Dithionite de sodium
7775-27-1 Peroxydisulfuric acid ([(HO)S(O)2]2O2), disodium salt Peroxodisulfate de disodium
7783-47-3 Tin fluoride (SnF2) Difluorure d'étain
7785-87-7 Sulfuric acid, manganese(2++) salt (1:1) Sulfate de manganèse
7789-23-3 Potassium fluoride (KF) Fluorure de potassium
7791-07-3 Sodium perchlorate, monohydrate Monohydrate de perchlorate de sodium
7791-25-5 Sulfuryl chloride Dichlorure de sulfuryle
7803-51-2 Phosphine Phosphine
8012-00-8 C.I. Pigment Yellow 41 Pyrochlore, jaune d'antimoine et de plomb
8068-05-1 Lignin, alkali Thiolignine
9003-36-5 Formaldehyde, polymer with (chloromethyl)oxirane and phenol Formaldéhyde polymérisé avec le (chlorométhyl)oxirane et le phénol
9006-27-3 Poly(oxy-1,2-ethanediyl), α-(1-oxododecyl)-ω-methoxy- α-Lauroyl-ω-méthoxypoly(oxyéthylène)
9017-01-0 Benzene, 1,3-diisocyanatomethyl-, homopolymer Diisocyanate de m-tolylidène, homopolymérisé
9046-10-0 Poly[oxy(methyl-1,2-ethanediyl)], α-(2-aminomethylethyl)-ω-(2-aminomethylethoxy)- α-[2-(Aminométhyl)éthyl]-ω-[2(aminométhyl)éthoxy]poly[oxy(méthyléthylène)]
10025-70-4 Strontium chloride (SrCl2), hexahydrate chlorure de strontium, 6-hydrate
10026-06-9 Stannane, tetrachloro-, hydrate (1:5) Hydrate de tétrachlorostannane (5/1)
10042-84-9 Glycine, N,N-bis(carboxymethyl)-, sodium salt 2,2′,2″-Nitrilotriacétate de sodium
10102-40-6 Molybdate (MoO42-), sodium, hydrate (1:2:2), (T-4)- Dihydrate de (T 4) molybdate(MoO42-) de disodium
10117-38-1 Sulfurous acid, dipotassium salt Sulfite de potassium
10213-10-2 Tungstate (WO42-), disodium, dihydrate, (T-4)- Dihydrate de (T-4)-tungstate (WO42-) de disodium
10377-60-3 Nitric acid, magnesium salt Nitrate de magnésium
10476-85-4 Strontium chloride (SrCl2) Chlorure de strontium
10584-98-2 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 4,4-dibutyl-10-ethyl-7-oxo-, 2-ethylhexyl ester 4,4-Dibutyl-10-éthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle
11070-44-3 1,3-Isobenzofurandione, tetrahydromethyl- Anhydride tétrahydrométhylphtalique
12040-43-6 Silicic acid, aluminum magnesium sodium salt Acide silicique, sel d'aluminium, de magnésium et de sodium
12058-66-1 Stannate (SnO32-), disodium Trioxyde d'étain et de disodium
12070-12-1 Tungsten carbide (WC) Carbure de tungstène
12125-03-0 Stannate (SnO32-), dipotassium, trihydrate Trihydrate de stannate (SnO32-) de dipotassium
12142-33-5 Stannate (SnO32-), dipotassium Trioxyde d'étain et de dipotassium
12222-00-3 Cuprate(4-), [µ-[[4,4′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[3-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium [µ-[[4,4′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[3-hydroxynaphtalène-2,7disulfonato]](8-)]]dicuprate(4-) de tétrasodium
13311-84-7 Propanamide, 2-methyl-N-[4-nitro-3(trifluoromethyl)phenyl]- 2-méthyl-N-[4-nitro-3(trifluorométhyl)phényl]propanamide
13323-62-1 Stannane, dibutylbis[(1-oxo-9-octadecenyl)oxy]-, (Z,Z)- Dibutylbis(octadéc-9(Z)-énoyloxy)stannane
13446-34-9 Manganese chloride (MnCl2), tetrahydrate; Tétrahydrate de chlorure de manganèse (MnCl2)
13455-21-5 Potassium fluoride dihydrate Dihydrate de fluorure de potassium
13466-08-5 Sodium bromide dihydrate Dihydrate de bromure de sodium
13472-45-2 Tungstate (WO42-), disodium, (ß-4)- Tungstate de disodium
13473-26-2 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-4,5,6,7-tetrachloro-3′,6′-dihydroxy- 2′,4′,5′,7′-Tétrabromo-4,5,6,7-tétrachloro-3′,6′-dihydroxyspiro[isobenzofurane-1(3H),9′[9H]xanthène]-3-one
13475-82-6 Heptane, 2,2,4,6,6-pentamethyl- 2,2,4,6,6-Pentaméthylheptane
13520-92-8 Zirconium, dichlorooxo-, octahydrate Octahydrate d'oxyde de dichlorozirconium
13752-51-7 Morpholine, 4-[(4-morpholinylthio)thioxomethyl]- 4-[(Morpholinothio)thioxométhyl]morpholine
13775-53-6 Aluminate(3-), hexafluoro-, trisodium, (OC-6-11)- Hexafluoroaluminate de trisodium
14025-21-9 Zincate(2-), [[N,N′-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N′,O,O′,ON,ON′]-, disodium, (OC-6-21)- ({N,N′-Éthylènediylbis[N(carboxylatométhyl)glycinato(4-)]}N,N′,O,O′,ON,ON′)zincate(2-) de disodium
14254-22-9 Stannane, butoxydibutylchloro- Butoxydibutylchlorostannane
14901-07-6 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- 4-(2,6,6-Triméthylcyclohex-1-én-1-yl)-but-3-én-2-one
15546-11-9 2,7,9-Trioxa-8-stannatrideca-4,11-dien-13-oic acid, 8,8-dibutyl-3,6,10-trioxo-, methyl ester, (Z,Z)- (Z,Z)-8,8-Dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatridéca-4,11-dién-13-oate de méthyle
15546-12-0 5,7,12-Trioxa-6-stannaoctadeca-2,9-dienoic acid, 6,6-dibutyl-14-ethyl-4,8,11-trioxo-, 2-ethylhexyl ester 6,6-Dibutyl-14-éthyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadéca-2,9-diénoate de 2-éthylhexyle
15546-16-4 5,7,12-Trioxa-6-stannahexadeca-2,9-dienoic acid, 6,6-dibutyl-4,8,11-trioxo-, butyl ester, (Z,Z)- (Z,Z)-6,6-Dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannahexadéca-2,9-diénoate de butyle
15571-58-1 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dioctyl-7-oxo-, 2-ethylhexyl ester 10-Éthyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle
15625-89-5 2-Propenoic acid, 2-ethyl-2-[[(1-oxo-2propenyl)oxy]methyl]-1,3-propanediyl ester Diacrylate de 2-éthyl-2-[[(1oxoallyl)oxy]méthyl]propane-1,3-diyle
15630-89-4 Carbonic acid disodium salt, compd. with hydrogen peroxide (H2O2) (2:3) Carbonate de disodium, composé avec le peroxyde d'hydrogène(2:3)
16056-95-4 Strontium chloride (SrCl2), dihydrate; Dihydrate de chlorure de strontium (SrCl2)
16091-18-2 1,3,2-Dioxastannepin-4,7-dione, 2,2-dioctyl- Maléate de dioctylstannane
16409-43-1 2H-Pyran, tetrahydro-4-methyl-2-(2-methyl-1-propenyl)- Tétrahydro-4-méthyl-2-(2-méthylprop-1-ényl)pyrane
16423-68-0 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-, disodium salt 2-(2,4,5,7-Tétraiodo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium
16470-24-9 Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt 4,4′-Bis[[4-[bis(2-hydroxyéthyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]stilbène-2,2′-disulfonate] de tétrasodium
16731-55-8 Disulfurous acid, dipotassium salt Bisulfite de dipotassium
17372-87-1 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy-, disodium salt 2-(2,4,5,7-Tétrabromo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium
17589-24-1 1,3-Diazetidine-2,4-dione, 1,3-bis[4-[(4-isocyanatophenyl)methyl]phenyl]- Diisocyanate de 2,4-dioxo-1,3-diazétidine-1,3-diylbis[p-phénylèneméthylène-p-phénylène]
17796-82-6 1H-Isoindole-1,3(2H)-dione, 2-(cyclohexylthio)- N-(Cyclohexylthio)phtalimide
18127-01-0 Benzenepropanal, 4-(1,1-dimethylethyl)- 3-(4-tert-Butylphényl)propionaldéhyde
18172-67-3 Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1S)- (-)-Pin-2(10)-ène
18282-10-5 Tin oxide (SnO2) Dioxyde d'étain
18480-07-4 Strontium hydroxide (Sr(OH)2) Hydroxyde de strontium
19438-60-9 1,3-Isobenzofurandione, hexahydro-5-methyl- Anhydride hexahydro-4-méthylphtalique
19766-89-3 Hexanoic acid, 2-ethyl-, sodium salt 2-Éthylhexanoate de sodium
20325-40-0 [1,1′-Biphenyl]-4,4′-diamine, 3,3′-dimethoxy-, dihydrochloride Dichlorure de 3,3′-diméthoxybiphényl-4,4′-ylènediammonium
20603-88-7 Manganese chloride (MnCl2), dihydrate Dihydrate de chlorure de manganèse (MnCl2)
21145-77-7 Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- 1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one
22205-30-7 Stannane, bis(dodecylthio)dioctyl- Bis(dodécylthio)dioctylstannane
22373-78-0 Monensin, monosodium salt Monensin, sel monosodique
22464-99-9 Hexanoic acid, 2-ethyl-, zirconium salt Acide 2-éthylhexanoïque, sel de zirconium
22673-19-4 Tin, dibutylbis(2,4-pentanedionato-O,O′)-, (OC-6-11)- Dibutylbis(pentane-2,4-dionato-O,O′)stannane
25155-25-3 Peroxide, [1,3(or 1,4)-phenylenebis(1-methylethylidene)]bis[(1,1-dimethylethyl) Peroxyde de [1,3(ou et de 1,4)-phénylènebis(1-méthyléthylidène)]bis[tert-butyle]
25167-67-3 Butene Butène
25167-70-8 Pentene, 2,4,4-trimethyl- 2,4,4-Triméthylpentène
25168-21-2 2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis[4-oxo-, diisooctyl ester, (Z,Z)- 4,4′-[(Dibutylstannylène)bis(oxy)]bis[4-oxoisocrotonate] de diisooctyle
25168-22-3 Stannane, dibutylbis[(1-oxoneodecyl)oxy]- Dibutylbis[(1-oxonéodécyl)oxy]stannane
25168-24-5 Acetic acid, 2,2′-[(dibutylstannylene)bis(thio)]bis-, diisooctyl ester 2,2′-[(Dibutylstannylène)bis(thio)]diacétate de diisooctyle
25214-63-5 1,2-Ethanediamine, polymer with methyloxirane Éthane-1,2-diamine polymérisée avec le méthyloxirane
25214-70-4 Formaldehyde, polymer with benzenamine Formaldéhyde polymérisé avec l'aniline
25321-09-9 Benzene, bis(1-methylethyl)- Diisopropylbenzène
25340-17-4 Benzene, diethyl- Diéthylbenzène
25584-83-2 2-Propenoic acid, monoester with 1,2-propanediol Acide acrylique, monoester avec le propane-1,2-diol
25686-28-6 Benzene, 1,1′-methylenebis[4-isocyanato-, homopolymer Diisocyanate de 4,4′-méthylènediphényle homopolymérisé
25723-16-4 Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (3:1) avec le propylidynetriméthanol
26401-86-5 Acetic acid, 2,2′,2″-[(octylstannylidyne)tris(thio)]tris-, triisooctyl ester 2,2′,2″-[(Octylstannylidyne)tris(thio)]triacétate de triisooctyle
26401-97-8 Acetic acid, 2,2′-[(dioctylstannylene)bis(thio)]bis-, diisooctyl ester 2,2′-[(Dioctylstannylène)bis(thio)]diacétate de diisooctyle
26472-00-4 4,7-Methano-1H-indene, 3a,4,7,7a-tetrahydrodimethyl- Méthylcyclopentadiène
26658-42-4 1,2-Ethanediamine, N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-, polymer with (chloromethyl)oxirane 3,6,9-Triazaundécane-1,11-diamine polymérisée avec le (chlorométhyl)oxirane
26761-45-5 Neodecanoic acid, oxiranylmethyl ester Néodécanoate de 2,3-époxypropyle
27029-41-0 1,3-Propanediamine, N,N-dimethyl-, polymer with (chloromethyl)oxirane N,N-Diméthylpropane-1,3-diamine polymérisée avec le (chlorométhyl)oxirane
27107-89-7 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-, 2-ethylhexyl ester 10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle
27247-96-7 Nitric acid, 2-ethylhexyl ester Nitrate de 2-éthylhexyle
27344-41-8 Benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt 2,2′-([1,1′-Biphényl]-4,4′diyldivinylène)bis(benzènesulfonate) de disodium
27813-02-1 2-Propenoic acid, 2-methyl-, monoester with 1,2-propanediol Acide méthacrylique, monoester avec le propane-1,2-diol
28407-37-6 Cuprate(4-), [µ-[[3,3′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium [µ-[[3,3′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[5-amino-4-hydroxynaphtalène-2,7-disulfonato]](8-)]]dicuprate(4-) de tétrasodium
28472-97-1 Nonanedioic acid, diisodecyl ester Azélate de diisodécyle
28883-73-0 Poly(oxy-1,2-ethanediyl), α,α′[(octadecylimino)di-2,1-ethanediyl]bis[ω-hydroxy-, hydrochloride α,α′-{[(Octadécyl)imino]diéthylène}bis[ω-hydroxypoly(oxyéthylène)], chlorhydrate
28961-43-5 Poly(oxy-1,2-ethanediyl), α-hydro-ω-[(1-oxo-2-propenyl)oxy]-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) α-Hydro-ω-(acryloyloxy)poly(oxyéthylène), éther (3:1) avec le propylidynetriméthanol
30499-70-8 1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with (chloromethyl)oxirane 2-Éthyl-2-(hydroxyméthyl)propane-1,3-diol polymérisé avec le (chlorométhyl)oxirane
31107-36-5 1,3-Diazetidin-2-one, 1,3-bis[4-[(4isocyanatophenyl)methyl]phenyl]-4-[[4-[(4-isocyanatophenyl)methyl]phenyl]imino]- Diisocyanate de 4-[[p-(pisocyanatobenzyl)phényl]imino]-2-oxo-1,3-diazétidine-1,3-diylbis(p-phénylèneméthylène-p-phénylène)
31394-54-4 Isoheptane Isoheptane
32388-55-9 Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-, [3R-(3α,3aβ,7β,8aα)]- [3R-(3α,3aβ,7β,8aα)]-1-(2,3,4,7,8,8a-Hexahydro-3,6,8,8-tétraméthyl-1H-3a,7-méthanoazulén-5-yl)éthan-1-one
32492-61-8 Poly(oxy-1,2-ethanediyl), α,α′-[(1-methylethylidene)di4,1-phenylene]bis[ω-hydroxy- α,α′-(Isopropylidènedi-p-phénylène)bis[ωhydroxypoly(oxyéthylène)]
33145-10-7 Phenol, 2,2′-(2-methylpropylidene)bis[4,6-dimethyl- 2,2′-(2-Méthylpropylidène)bis[4,6-xylénol]
34041-09-3 Hexanoic acid, 2-ethyl-, molybdenum salt Acide 2-éthylhexanoïque, sel de molybdène
35176-06-8 Ethanol, 2,2′-iminobis-, polymer with methyloxirane 2,2′-Iminodiéthanol polymérisé avec le méthyloxirane
36631-30-8 1,2,4-Benzenetricarboxylic acid, 1,2,4-triisodecyl ester Benzène-1,2,4-tricarboxylate de triisodécyle
37353-75-6 Poly[oxy(methyl-1,2-ethanediyl)], α,α′-[(1-methylethylidene)di-4,1-phenylene]bis[ω-hydroxy- α,α′-(Isopropylidènedi-p-phénylène)bis{ωhydroxypoly[oxy(méthyléthylène)]}
37640-57-6 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, compd. with 1,3,5-triazine-2,4,6-triamine (1:1) 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, composé avec la 1,3,5-triazine-2,4,6-triamine (1:1)
37853-59-1 Benzene, 1,1′-[1,2ethanediylbis(oxy)]bis[2,4,6-tribromo- 1,1′-(Éthane-1,2-diylbisoxy)bis(2,4,6-tribromobenzène)
37971-36-1 1,2,4-Butanetricarboxylic acid, 2-phosphono- Acide 2-phosphonobutane-1,2,4-tricarboxylique
40530-60-7 Carbonic acid, 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]ethyl ethyl ester Carbonate d'éthyle et de 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]éthyle
41272-40-6 Methanaminium, N-[4-[[4-(dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate Acétate de [4-[α-[4(diméthylamino)phényl]benzylidène]cyclohexa-2,5-dién-1-ylidène]diméthylammonium
42978-66-5 2-Propenoic acid, (1-methyl-1,2ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] ester Diacrylate de (1-méthyléthane-1,2diyl)bis[oxy(méthyléthylène)]
44992-01-0 Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2propenyl)oxy]-, chloride Chlorure de [2-(acryloyloxy)éthyl]triméthylammonium
50586-59-9 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) α-Hydro-ω-hydroxypoly(oxyéthylène), éther (3:1) avec le 2-éthyl-2-(hydroxyméthyl)propane-1,3-diol
52408-84-1 Poly[oxy(methyl-1,2-ethanediyl)], α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxo-2-propenyl)oxy]- α,α′,α″-Propane-1,2,3-triyltris{ω(acryloyloxy)poly[oxy(méthyléthylène)]}
52625-13-5 Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with D-glucitol (6:1) α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (6:1) avec le D-glucitol
53148-32-6 Hexanoic acid, 2-ethyl-, 1,4-cyclohexanediylbis(methylene) ester Bis(2-éthylhexanoate) de cyclohexane-1,4-diylbisméthylène
53306-54-0 1,2-Benzenedicarboxylic acid, bis(2-propylheptyl) ester Phtalate de bis(2-propylheptyle)
53988-10-6 2H-Benzimidazole-2-thione, 1,3-dihydro-4(or 5)-methyl- 1,3-Dihydro-4(ou-5)-méthyl-2H-benzimidazole-2-thione
54076-97-0 Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, homopolymer Chlorure de [2-(acryloyl)oxy]triméthylammonium homopolymérisé
54423-67-5 Neononanoic acid, ethenyl ester Néononanoate de vinyle
54464-57-2 Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- 1-(1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one
54464-59-4 Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthalenyl)- 1-(1,2,3,4,5,6,7,8-Octahydro-2,3,5,5-tétraméthyl-2-naphtyl)éthan-1-one
54849-38-6 Acetic acid, 2,2′,2″-[(methylstannylidyne)tris(thio)]tris-, triisooctyl ester 2,2′,2″-[(Méthylstannylidyne)tris(thio)]triacétate de triisooctyle
57018-52-7 2-Propanol, 1-(1,1-dimethylethoxy)- 1-tert-Butoxypropan-2-ol
57219-64-4 Zirconium, [µ-[carbonato(2-)-O:O′]]dihydroxydioxodi- [µ-[Carbonéato(2-)-O:O′]]dihydroxydioxodizirconium
57583-34-3 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-, 2-ethylhexyl ester 10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-méthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle
57583-35-4 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dimethyl-7-oxo-, 2-ethylhexyl ester 10-Éthyl-4,4-diméthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle
61791-39-7 1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs. 4,5-Dihydro-1H-imidazole-1-éthanol, dérivés de 2-nortallöl alkyles
63500-71-0 2H-Pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl)- 2-Isobutyl-4-méthyltétrahydro-2H-pyran-4-ol
64742-10-5 Extracts (petroleum), residual oil solvent Extraits au solvant (pétrole), huile résiduelle
65997-17-3 Glass, oxide, chemicals Verre aux oxydes, produits chimiques
66418-17-5 Cuprate(3-), [µ-[4-[[4′-[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3′-dihydroxy[1,1′-biphenyl]-4yl]azo]-3-hydroxy-2,7-naphthalenedisulfonato(7-)]]di-, trisodium [µ-[4-[[4′-[(6-Amino-1-hydroxy-3-sulfo-2-naphtyl)azo]3,3′-dihydroxy[1,1′-biphényl]-4-yl]azo]-3-hydroxynaphtalène-2,7-disulfonato(7-)]]dicuprate(3-) de trisodium
67762-79-2 2,5-Furandione, dihydro-, monopolybutenyl derivs. Anhydride succinique, dérivés mono[poly(butényliques)]
67800-94-6 1,3-Benzenediamine, ar-methyl-, polymer with methyloxirane and oxirane Benzène-1,3-diamine, ar-méthylée, polymérisée avec le méthyloxirane et l'oxirane
67989-23-5 1,2,4-Benzenetricarboxylic acid, decyl octyl ester Acide benzène-1,2,4-tricarboxylique, ester de décyle et d'octyle
68092-47-7 Benzoic acid, 3-methyl-, barium salt m-Toluate de baryum
68131-73-7 Amines, polyethylenepoly- Amines, polyéthylènepoly-
68155-66-8 Ethanone, 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- 1-(1,2,3,5,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one
68155-67-9 Ethanone, 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- 1-(1,2,3,4,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one
68186-85-6 C.I. Pigment Green 50 Spinelle vert de titanite de cobalt
68186-90-3 C.I. Pigment Brown 24 Rutile couleur chamois de chrome, d'antimoine et de titane
68187-10-0 C.I. Pigment Brown 34 Spinelle brun de ferrite de nickel
68299-15-0 Stannane, dioctylbis[(1-oxoneodecyl)oxy]- Bis(néodécanoyloxy)dioctylstannane
68412-21-5 Neodecanoic acid, rare earth salts Acide néodécanoïque, sels de terres rares
68439-70-3 Amines, C12-16-alkyldimethyl Amines, alkyle en C12-16 diméthyles
68479-98-1 Benzenediamine, ar,ar-diethyl-ar-methyl- Diéthylméthylbenzènediamine
68514-09-0 Sulfite liquors and Cooking liquors, spent, oxidized Lessives de sulfite et lessives de cuisson usées, oxydées
68515-50-4 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear Phtalates de dihexyle ramifié et linéaire
68515-51-5 1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters Phtalates de dialkyles en C6-10
68515-73-1 D-Glucopyranose, oligomeric, decyl octyl glycosides Éthers décyliques et octyliques du D-glucose, oligomères
68526-83-0 Alcohols, C7-9-iso-, C8-rich Alcools en C7-9, iso-, riches en C8
68609-97-2 Oxirane, mono[(C12-14-alkyloxy)methyl] derivs. Oxirane, dérivés mono[(alcoolates en C12-14)méthyle]
68855-45-8 Phenol, dodecyl-, sulfurized, calcium salts Phénol, dodécyl-, sulfurisé, sels de calcium
68891-38-3 Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C12-14-alkyl ethers, sodium salts α-Sulfo-ω-hydroxypoly(oxyéthylène), éthers C12-14-alkyliques, sels de sodium
68928-76-7 Stannane, dimethylbis[(1-oxoneodecyl)oxy]- Diméthylbis[(1-oxonéodécyl)oxy]stannane
68938-03-4 Octene, hydroformylation products, low-boiling Octène, produits d'hydroformylation, fraction à bas point d'ébullition
68990-67-0 Quillaja saponaria, ext. Extrait de Quillaja saponaria
70210-32-1 Benzenesulfonic acid, 3-(benzoylamino)-4-hydroxy-5-[[1-[[[4′-[[2-[[2-hydroxy-5(methylsulfonyl)phenyl]azo]-1,3-dioxobutyl]amino]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]amino]carbonyl]-2-oxopropyl]azo]-, monosodium salt 3-Benzamido-4-hydroxy-5-[[1-[[4′-[[2-[[2-hydroxy-5-(méthylsulfonyl)phényl]azo]-1,3-dioxobutyl]amino]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]carbamoyl]-2-oxopropyl]azo]benzènesulfonate de sodium
70714-66-8 Phosphonic acid, [[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-, ammonium salt Acide [[(phosphonométhyl)imino]bis[éthylènenitrilobis(méthylène)]]tétraphosphonique, sel d'ammonium
71566-41-1 Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt 2-[[2-Amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfonato-1-naphtyl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium
71617-10-2 2-Propenoic acid, 3-(4-methoxyphenyl)-, 3-methylbutyl ester p-Méthoxycinnamate d'isopentyle
71631-15-7 C.I. Pigment Black 30 Spinelle noir de chromite de fer et de nickel
71868-10-5 1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]2-(4-morpholinyl)- 2-Méthyl-1-[4-(méthylthio)phényl]-2-(morpholin-4-yl)propan-1-one
71873-63-7 Cuprate(4-), [µ-[7-[[3,3′-dihydroxy-4′-[(4-hydroxy-2-sulfobenzo[a]phenazin-3-yl)azo][1,1′-biphenyl]-4-yl]azo]-8-hydroxy-1,3,6-naphthalenetrisulfonato(8-)]]di-, tetrasodium [µ-[7-[[3,3′-Dihydroxy-4′-[(4-hydroxy-2sulfobenzo[a]phénazin-3-yl)azo][1,1′-biphényl]-4yl]azo]-8-hydroxynaphtalène-1,3,6trisulfonato(8-)]]dicuprate(4-) de tétrasodium
72903-27-6 1,4-Cyclohexanedicarboxylic acid, 1,4-diethyl ester Ester 1,4-diéthylique de l'acide cyclohexane-1,4-dicarboxylique
73913-06-1 Manganese chloride (MnCl2), hydrate Hydrate de chlorure de manganèse (MnCl2)
75782-86-4 Alcohols, C12-13 Alcools en C12-13
75782-87-5 Alcohols, C14-15 Alcools en C14-15
75880-28-3 Propanol, [(1-methyl-1,2-ethanediyl)bis(oxy)]bis-, polymer with 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene and 1,1′-methylenebis[4-isocyanatobenzene] (Propylènedioxy)dipropanol polymérisé avec le diisocyanate de 2,4′-méthylènediphényle et le diisocyanate de 4,4′-méthylènediphényle
75980-60-8 Phosphine oxide, diphenyl(2,4,6-trimethylbenzoyl)- Oxyde de diphényl(2,4,6-triméthylbenzoyl)phosphine
84896-44-6 Propanoic acid, 3,3′-[(dibutylstannylene)bis(thio)]bis-, diisotridecyl ester 3,3′-[(Dibutylstanylène)bis(thio)]dipropionate de diisotridécyle
84989-41-3 2-Oxetanone, 3-C12-16-alkyl-4-C13-17-alkylidene derivs. Oxétan-2-one, dérivés 3-C12-16-alkyl-4-C13-17-alkylidéniques
85017-91-0 Strontium chloride (SrCl2), hydrate Hydrate de chlorure de strontium (SrCl2)
85117-41-5 Benzene, mono-C10-14-alkyl derivs., fractionation bottoms Benzène, dérivés mono-C10-14-alkyliques, produits de queue de fractionnement
87735-26-0 3,5,7,9-Tetraoxa-4,8-disila-6-stannaundecane, 6,6-dibutyl-4,4,8,8-tetraethoxy- 6,6-Dibutyl-4,4,8,8-tétraéthoxy-3,5,7,9-tétraoxa-4,8-disila-6-stannaundécane
94279-36-4 1,2,4-Benzenetricarboxylic acid, tri-C9-11 alkyl esters Mélange de benzène-1,2,4-tricarboxylates de trialkyle en C9-11
97488-98-7 Oils, fish, oxidized, bisulfited, sodium salts Huiles de poisson oxydées, bisulfitées, sels de sodium
101200-51-5 Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, disodium salt Sel disodique de l'acide 2-{2-amino-5-hydroxy-6-[4′-(2-hydroxy-6-sulfo-1-naphtylazo)-3,3′-diméthoxybiphényl-4-ylazo]-7-sulfo-1-naphtylazo}-5-nitrobenzoïque
111850-24-9 Phenol, 2,6-bis(1-methylpropyl)-4-[(4-nitrophenyl)azo]- 2,6-Bis(1-méthylpropyl)-4-[(4-nitrophényl)azo]phénol
117527-94-3 Amines, C12_14-tert-alkyl, compds. with 1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenol 1-[[2-hydroxy-4(or 5)-nitrophenyl]azo]-2-naphthalenol chromium complexes tert-Alkylamines en C12-14, composés avec des complexes de chrome du 1-[(2-hydroxy-3-nitro-5-tert-pentylphényl)azo]-2-naphtol et du 1-[(2-hydroxy-4(ou 5)-nitrophényl)azo]-2-naphtol
118832-72-7 Acetic acid, [[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]-, C10-14-isoalkyl esters Esters C10-14-alkyliques de l'acide ({[3,5-bis(tert-butyl)-4-hydroxyphényl]méthyl}thio)acétique
119313-12-1 1-Butanone, 2-(dimethylamino)-1-[4-(4-morpholinyl)phenyl]-2-(phenylmethyl)- 2-(Diméthylamino)-1-[4-(morpholin-4-yl)phényl]-2-(phénylmethyl)butan-1-one
121246-28-4 1,3,5-Triazine-2,4,6-triamine, N,N′,N″-tris[4-[(1,4-dimethylpentyl)amino]phenyl]- N,N′,N″-Tris[4-[(1,4diméthylpentyl)amino]phényl]mélamine
125997-21-9 Phosphoryl chloride, polymer with 1,3-benzenediol, phenyl ester Chlorure de phosphoryle polymérisé avec le résorcinol, éther phénylique
206770-18-5 1,2,4-Benzenetricarboxylic acid, mixed 2-ethylhexyl and stearyl triesters Triesters mixtes 2-éthylhexyliques et stéaryliques de l'acide benzène-1,2,4-tricarboxylique
207683-20-3 Sodium perchlorate hydrate Hydrate de perchlorate de sodium
474919-59-0 1,2-Cyclohexanedicarboxylic acid, 1,2-dinonyl ester, branched and linear Cyclohexane-1,2-dicarboxylates de dinonyle (ramifiés ou linéaires)
866625-93-6 Benzotriazole, 1(or 2)-[1-(cyclohexyloxy)heptyl]methyl- 1(ou 2)-[1-(Cyclohexyloxy)heptyl]méthylbenzotriazole
1163775-81-2 1,2,4-Benzenetricarboxylic acid, mixed lauryl and octyl triesters Mélange de triesters dodécyliques et/ou octyliques de l'acide benzène-1,2,4-tricarboxylique
Part 3 masked substances
Confidential Accession Number Masked name Nom maquillé
13827-3 Phosphonic acid, dibutyl ester, reaction products with alkyl substituted ethanol Phosphonate de dibutyle, produits de réaction avec de l'éthanol substitué avec un alkyle
Part 4 — Substances from the In-Commerce List (ICL)
CAS RN Substance name Nom de la substance
52-01-7 Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, γ-lactone, (7α,17α)- Spironolactone
53-43-0 Androst-5-en-17-one, 3-hydroxy-, (3β)- Prastérone
57-85-2 Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17β)- Propionate de testostérone
60-13-9 Benzeneethanamine, α-methyl-, sulfate (2:1) sulfate d'amphétamine
60-31-1 Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride Chlorure d'acétylcholine
66-40-0 Ethanaminium, N,N,N-triethyl- tétraéthylammonium
68-05-3 Ethanaminium, N,N,N-triethyl-, iodide Iodure de tétraéthylammonium
73-31-4 Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- N-(2-(5-méthoxyindole-3-yl)éthyl)acetamide
79-17-4 Hydrazinecarboximidamide aminoguanidine
83-43-2 Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6α,11β)- Méthylprednisolone
85-19-8 Methanone, (5-chloro-2-hydroxyphenyl)phenyl- 5-chloro-2-hydroxybenzophénone
85-70-1 1,2-Benzenedicarboxylic acid, 2-butoxy-2-oxoethyl butyl ester Phtalate de butoxycarbonylméthyle et de butyle
87-18-3 Benzoic acid, 2-hydroxy-, 4-(1,1-dimethylethyl)phenyl ester Salicylate de 4-tert-butylphényle
91-68-9 Phenol, 3-(diethylamino)- 3-Diéthylaminophénol
94-43-9 Mercury, (benzoato-O)phenyl- benzoate de phénylmercure
94-51-9 1-Propanol, 3,3′-oxybis-, 1,1′-dibenzoate dibenzoate de 3,3′-oxydipropyle
95-84-1 Phenol, 2-amino-4-methyl- 2-Amino-p-crésol
97-18-7 Phenol, 2,2′-thiobis[4,6-dichloro- Bithionol
99-57-0 Phenol, 2-amino-4-nitro- 2-Amino-4-nitrophénol
102-29-4 1,3-Benzenediol, monoacetate Acétate de 3-hydroxyphényle
102-98-7 Mercurate(2-), [orthoborato(3-)-κO]phenyl-, hydrogen (1:2) [orthoborato(3-)-O]phénylmercurate(2-) de dihydrogéno
104-98-3 2-Propenoic acid, 3-(1H-imidazol-4-yl)- Acide 3-imidazol-4-ylacrylique
116-38-1 Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1) chlorure de d'édrophonium
122-11-2 Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)- sulfadiméthoxine
123-78-4 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- 2-aminooctadec-4-ène-1,3-diol
130-95-0 Cinchonan-9-ol, 6′-methoxy-, (8α,9R)- Quinine
132-69-4 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, hydrochloride (1:1) 3-[[1-benzyl-1H-indazole-3-yl]oxy]-N,N-diméthylpropylamine, monochlorhydrate
137-88-2 Pyridinium, 1-[(4-amino-2-propyl-5- pyrimidinyl)methyl]-2-methyl-, chloride, hydrochloride (1:1:1) Pyridinium, 1-[(4-amino-2-propyl-5-pyrimidinyl)méthyl]-2-méthyl-, chlorure, chlorhydrate (1:1:1)
141-02-6 2-Butenedioic acid (E)-, bis(2-ethylhexyl) ester Fumarate de bis(2-éthylhexyle)
141-86-6 2,6-Pyridinediamine Pyridine-2,6-diyldiamine
141-94-6 5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl- Héxétidine
142-55-2 2-hydroxypropyl laurate laurate de 2-hydroxypropyle
145-13-1 Pregn-5-en-20-one, 3-hydroxy-, (3β)- prégnenolone
148-01-6 Benzamide, 2-methyl-3,5-dinitro- dinitolmide
148-79-8 1H-Benzimidazole, 2-(4-thiazolyl)- Thiabendazole
153-61-7 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)- céfalotine
293-51-6 Cyclotetrasiloxane Cyclotétrasiloxane
303-98-0 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)- Coenzyme Q-10
306-94-5 Naphthalene, octadecafluorodecahydro- Perflunafène
317-34-0 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1) Aminophylline
330-95-0 Urea, N,N′-bis(4-nitrophenyl)-, compd. with 4,6-dimethyl-2(1H)-pyrimidinone (1:1) 1,3-Bis(4-nitrophényl)urée--4,6-diméthylpyrimidin-2-ol (1:1)
362-74-3 Adenosine, N-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate bucladesine
404-86-4 6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)- Capsaïcine
500-38-9 1,2-Benzenediol, 4,4′-(2,3-dimethyl-1,4-butanediyl)bis- 4,4′-(2,3-diméthyltétraméthylene)dipyrocatéchol
501-30-4 4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)- 5-hydroxy-2-hydroxyméthyl-4-pyrone
508-02-1 Olean-12-en-28-oic acid, 3-hydroxy-, (3β)- Acide 3β-hydroxyoléan-12-én-28-oïque
518-40-1 Benzoic acid, 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthen-9-yl)- Acide 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthén-9-yl)benzoïque
522-48-5 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, monohydrochloride Tétryzoline, chlorhydrate
522-51-0 Quinolinium, 1,1′-(1,10-decanediyl)bis[4-amino-2-methyl-, dichloride cotarmine de déqualinium
530-43-8 Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester palmitate de chloramphénicol
538-02-3 Cyclopentaneethanamine, N,α-dimethyl-, hydrochloride cyclopentamine, chlorhydrate
546-46-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3) Dicitrate de trizinc
556-38-7 Pentanoic acid, zinc salt Divalérate de zinc
557-61-9 1-Octacosanol Octacosan-1-ol
576-55-6 Phenol, 2,3,4,5-tetrabromo-6-methyl- 3,4,5,6-Tétrabromo-o-crésol
594-45-6 Ethanesulfonic acid Acide éthanesulfonique
603-85-0 Phenol, 2-amino-3-nitro- 2-amino-3-nitrophénol
611-75-6 Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride  bromhexine, chlorhydrate
660-27-5 Acetic acid, dichloro-, compd. with N-(1-methylethyl)-2-propanamine (1:1) Dichloroacétate de diisopropylammonium
719-59-5 Methanone, (2-amino-5-chlorophenyl)phenyl- 2-Amino-5-chlorobenzophénone
820-66-6 1-Octadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, hydroxide, inner salt (Carboxylatométhyl)diméthyl(octadécyl)ammonium
832-01-9 2-Propenoic acid, 3-(4-methoxyphenyl)-, methyl ester p-méthoxycinnamate de méthyle
865-44-1 Iodine chloride (ICl3) Trichlorure d'iode
866-82-0 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2++) salt (1:2) Citrate de dicuivre
1093-16-9 Spiro[naphthalene-2(1H),2′-oxirane]-1-propanol, α-ethenyloctahydro-α,5,5,8a-tetramethyl- α-Vinyloctahydro-α,5,5,8a-tétraméthyl-spiro[naphtalène-2(1H),2′-oxirane]propan-1-ol
1109-11-1 2,4,6,8,10,12,14,16-Heptadecaoctaenoic acid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethyl ester, (2E,4E,6E,8E,10E,12E,14E,16E)- 8′-apo-.bêta.-carotène-8′-oate d'éthyle
1112-38-5 Phosphorothioic acid, O,O-dimethyl ester Phosphorothioate d'O,O-diméthyle
1314-84-7 Zinc phosphide (Zn3P2) Diphosphure de trizinc
1315-04-4 Antimony sulfide (Sb2S5) Pentasulfure de diantimoine
1317-26-6 Aluminum magnesium hydroxide (AlMg2(OH)7), monohydrate magaldrate
1319-53-5 Malachite (Cu2(CO3)(OH)2) malachite
1322-14-1 10-Undecenoic acid, calcium salt Diundéc-10-énoate de calcium
1335-26-8 Magnesium peroxide Peroxyde de magnésium
1337-20-8 Chlorophyllins, copper potassium sodium chlorophyllines, cuivre, potassium et sodium
1399-80-0 Benzenedimethanaminium, ar-dodecyl-ar,N,N,N,N′,N′,N′-heptamethyl-, dichloride, mixt. with ar-dodecyl-ar,N,N,N-tetramethylbenzenemethanaminium chloride Benzènediméthanaminium, ar-dodécyl-ar,N,N,N,N′,N′,N′-heptaméthyl-, dichlorure, mélange avec le chlorure d'ar-dodécyl-ar,N,N,N-tétraméthylbenzèneméthanaminium
1405-89-6 Bacitracin zinc Bacitracine zincique
1463-95-2 Pyridinium, 2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1) iodure de 2-[2-[(5-bromo-2-pyridyl)amino]vinyl]-1-éthyl-6-méthylpyridinium
1553-41-9 5,8,11,14,17-Eicosapentaenoic acid acide 5Z,8Z,11Z,14Z,17Z-eicosapentaénoïque
1570-64-5 Phenol, 4-chloro-2-methyl- 4-Chloro-o-crésol
1641-17-4 Methanone, (2-hydroxy-4-methoxyphenyl)(4-methylphenyl)- mexénone
1778-02-5 Pregn-5-en-20-one, 3-(acetyloxy)-, (3β)- acétate de prégnenolone
1929-30-2 2-Propenoic acid, 3-(4-methoxyphenyl)-, ethyl ester p-méthoxycinnamate d'éthyle
1976-28-9 3-Pyridinecarboxylic acid, aluminum salt (3:1) trinicotinate d'aluminium
2016-45-7 1-Hexadecanamine, N,N-dimethyl-, hydrochloride (1:1) chlorure de hexadécyldiméthylammonium
2040-10-0 Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]- 4′-tert-Butyl-2′,6′-diméthylacétophénone
2136-71-2 Ethanol, 2-(hexadecyloxy)- 2-(hexadécyloxy)éthanol
2180-18-9 Acetic acid, manganese salt Acide acétique, sel de manganèse
2197-63-9 1-Hexadecanol, hydrogen phosphate Hydrogénophosphate de dihexadécyle
2224-49-9 Dodecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) Acide laurique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)
2315-66-4 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- 3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]-
2370-64-1 Dodecanoic acid, 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl ester laurate de 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yle
2380-86-1 1H-Indol-6-ol 6-hydroxyindole
2420-29-3 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol
2487-40-3 6H-Purin-6-one, 1,2,3,7-tetrahydro-2-thioxo- 1,2,3,7-Tétrahydro-2-thioxo-6H-purin-6-one
2565-36-8 Ethanol, 2,2′-[methylenebis(oxy)]bis- 2,2′-[méthylènebis(oxy)]biséthanol
2568-33-4 1, 3-Butanediol, 3-methyl 1,3-butanediol, 3-méthyl-
2638-43-9 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- 3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]-
2748-88-1 Pyridinium, 4-methyl-1-tetradecyl-, chloride Chlorure de 4-méthyl-1-tétradécylpyridinium
2784-94-3 Ethanol, 2,2′-[[4-(methylamino)-3nitrophenyl]imino]bis- 2,2′-[[4-(Méthylamino)-3-nitrophényl]imino]diéthanol
2835-98-5 Phenol, 2-amino-5-methyl- 6-amino-m-cresol
2835-99-6 Phenol, 4-amino-3-methyl- 4-Amino-m-crésol
2919-66-6 Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-16-methylene- acétate de mélengestrol
2944-65-2 Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, iron(2+) salt (1:1) [R-(R*,R*)]-tartrate de fer
3069-40-7 Silane, trimethoxyoctyl- Triméthoxyoctylsilane
3184-65-4 Phenol, 4-chloro-2-(phenylmethyl)-, sodium salt 2-Benzyl-4-chlorophénolate de sodium
3251-56-7 Phenol, 2-methoxy-4-nitro- 2-Méthoxy-4-nitrophénol
3305-68-8 9-Octadecen-1-ol, phosphate (3:1), (9Z,9′Z,9″Z)- phosphate de trioléyle
3374-30-9 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl(phenylmethyl)amino]phenyl](5-hydroxy-2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-, hydroxide, inner salt, calcium salt (2:1) Bis[hydrogéno(benzyl)[4-[[4-(benzyléthylamino)phényl](5-hydroxy-2,4-disulfonatophényl)méthylène]cyclohexa-2,5-dién-1-ylidène](éthyl)ammonium], sel de calcium
3397-16-8 L-Glutamic acid, N-(1-oxooctadecyl)- acide N-(1-oxooctadécyl)-L-glutamique
3520-90-9 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(4-octylphenoxy)- 3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-(4-octylphénoxy)-
3521-84-4 D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3′-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoate] (2:1) (salt) adipiodone, sel de dimeglumine
3564-09-8 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(2,4,5-trimethylphenyl)diazenyl]-, sodium salt (1:2) 3-hydroxy-4-[(2,4,5-triméthylphényl)azo]naphtalène-2,7-disulfonate de disodium
3599-32-4 1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-, hydroxide, inner salt, sodium salt 2-{7-[1,3-Dihydro-1,1-diméthyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidène]hepta-1,3,5-triényl}-1,1-diméthyl-3-(4-sulfobutyl)-1H-benz[e]indolium, hydroxyde, sel interne, sel de sodium
3697-42-5 2,4,11,13-Tetraazatetradecanediimidamide, N,N″-bis(4-chlorophenyl)-3,12-diimino-, hydrochloride (1:2) chlorhexidine, dichlorhydrate
4316-73-8 Glycine, N-methyl-, monosodium salt Sarcosinate de sodium
4372-02-5 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 4′,5′-dibromo-3′,6′-dihydroxy-, sodium salt (1:2) 2-(4,5-dibromo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium
4478-97-1 3,6,9,12,15-Pentaoxahentriacontan-1-ol 3,6,9,12,15-pentaoxahentriacontan-1-ol
4618-23-9 Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, disodium salt Acide 2,3,4,5-tétrachloro-6-(2,4,5,7-tétrabromo-6-hydroxy-3-oxo-3H-xanthén-9-yl)benzoïque, sel disodique
4861-19-2 Urea, phosphate (1:1) Phosphate d'urée
4991-65-5 1,3-Benzoxathiol-2-one, 6-hydroxy- tioxolone
5353-26-4 3,6,9,12-Tetraoxatriacont-21-en-1-ol, (Z)- 3,6,9,12-tétraoxatriacont-21-én-1-ol, (Z)-
5697-02-9 1-naphthalenol, 2-methyl-, acetate 1-naphtalénol, 2-méthyl-, 1-acétate
5725-96-2 Methanamine, N-hydroxy-N-methyl- N-Hydroxydiméthylamine
5836-69-1 Phosphinic amide, P,P-dibutyl-N,N-dipropyl- Amide phosphinique, P,P-dibutyl-N,N-dipropyl-
5858-61-7 2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-, disodium salt 3-[[4-(acétylamino)phényl]azo]-4-hydroxynaphtalène-2,7-disulfonate de disodium
5863-51-4 Benzenemethanaminium, N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt Hydrogéno[4-[(2-chlorophényl)[4-[éthyl(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium
5905-52-2 Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1) dilactate de fer
6159-41-7 10-Undecenoic acid, potassium salt (1:1) Acide 10-undécénoïque, sel de potassium (1:1)
6182-11-2 Octadecanoic acid, 1-methyl-1,2-ethanediyl ester Distéarate de propylène
6219-67-6 1,3-Benzenediamine, 4-methoxy-, sulfate Sulfate de 4-méthoxybenzène-1,3-diamine
6219-69-8 1,3-Benzenediamine, 4-ethoxy-, sulfate 1,3-benzènediamine, 4-éthoxy-, sulfate
6273-99-0 Mercury, [.mu.-[orthoborato(2-)-κO:κO′]]diphenyldi- [.mu.-[orthoborato(2-)-O:O′]]diphényldimercure
6358-53-8 2-Naphthalenol, 1-[(2,5-dimethoxyphenyl)azo]- 1-[(2,5-Diméthoxyphényl)azo]napht-2-ol
6371-76-2 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(phenylazo)-, calcium salt (2:1) Bis[3-hydroxy-4-(phénylazo)-2-naphtoate] de calcium
6371-96-6 Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]-N-(2-methylphenyl)-3-oxo- 2-[(4-Méthoxy-2-nitrophényl)azo]-3-oxo-N-(o-tolyl)butyramide
6505-30-2 Benzenemethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt Hydrogéno[4-[[4-(diéthylamino)phényl][4-[éthyl[(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium
6548-12-5 Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, barium salt (1:1) dihydrogéno(éthyl)[4-[[4-[éthyl(3-sulfonatobenzyl)amino]phényl](2-sulfonatophényl)methylène]cyclohexa-2,5-diène-1-ylidène](3-sulfonatobenzyl)ammonium, sel de baryum
6640-03-5 1-Tetradecanol, hydrogen phosphate Hydrogénophosphate de ditétradécyle
6966-09-2 Cyclohexanone, 2-(1-piperidinylmethyl)-, hydrochloride (1:1) Cyclohexanone, 2-(1-pipéridinylméthyl)-, chlorhydrate (1:1)
7091-57-8 8-Quinolinol, benzoate (salt) acide benzoïque, composé avec quinoléine-8-ol (1:1)
7147-34-4 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-ethylhexyl)ester 2-hydroxypropane-1,2,3-tricarboxylate de tris(2-éthylhexyle)
7211-53-2 Docosanoic acid, potassium salt (1:1) Sel de potassium de l'acide docosanoïque (1:1) 
7230-93-5 Dodecanoic acid, aluminum salt (3:1) trilaurate d'aluminium
7360-38-5 Hexanoic acid, 2-ethyl-, 1,2,3-propanetriyl ester 2-ethylhexanoate de propane-1,2,3-triyle
7446-27-7 Phosphoric acid, lead(2++) salt (2:3) Bis(orthophosphate) de triplomb
7492-68-4 Carbonic acid, copper salt acide carbonique, sel de cuivre
7651-99-2 Phosphonic acid, [1,2-ethanediylbis[nitrilobis (methylene)]]tetrakis-, pentasodium salt [Éthylènebis(nitrilobisméthylène)]tétrakisphosphonate pentasodique
7704-67-8 Erythromycin, thiocyanate (salt) thiocyanate d'érythromycine
7773-03-7 Sulfurous acid, monopotassium salt Hydrogénosulfite de potassium
7789-46-0 Iron bromide (FeBr2) Dibromure de fer
7790-44-5 Stibine, triiodo- Triiodure d'antimoine
8007-56-5 Aqua regia Acide nitrochlorhydrique
9022-75-7 Poly[oxy[hydroxymethyl)-1,2-ethanediyl]], α-dodecyl-ω-hydroxy- Poly[oxy[hydroxyméthyl)-1,2-éthanediyl]], α-dodécyl-oméga-hydroxy-
9050-93-5 β-D-Glucan, (1→3)-, carboxymethyl ether, sodium salt β-D-glucane, (1→3)-, éther carboxyméthylique, sel sodique
9065-63-8 Oxirane, methyl-, polymer with oxirane, butyl ether Oxirane, méthyl-, polymérisé avec l'oxirane, éther butylique
10031-23-9 Radium bromide (RaBr2) bromure de radium
10031-59-1 Sulfuric acid, thallium salt Sulfate de thallium
10101-63-0 Lead iodide (PbI2) Diiodure de plomb
10124-48-8 Mercury amide chloride (Hg(NH2)Cl) Chlorure d'aminomercure
10124-49-9 Sulfuric acid, iron salt Acide sulfurique, sel de fer
10139-47-6 Zinc iodide (ZnI2) Iodure de zinc
10161-34-9 Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17β)- 17-acétate de 17.bêta.-hydroxyestra-4,9,11-triène-3-one
10192-46-8 Boric acid (H3BO3), zinc salt (2:3) Acide borique (H3BO3), sel de zinc (2:3)
10233-14-4 9-Octadecenoic acid (Z)-, 2-[2-(2-hydroxyethoxy)ethoxy]ethyl ester Oléate de 2-[2-(2-hydroxyéthoxy)éthoxy]éthyle
10279-59-1 Phosphoric acid, aluminum sodium salt (8:2:3) Acide phosphorique, sel d'aluminium et de sodium (8:2:3)
10294-31-2 Gold iodide (AuI) Monoiodure d'or
10294-70-9 Tin iodide (SnI2) Diiodure d'étain
10305-76-7 Phosphoric acid, aluminum sodium salt (8:3:1), tetrahydrate Acide phosphorique, sel d'aluminium et de sodium (8:3:1), tétrahydrate
10326-21-3 Chloric acid, magnesium salt Chlorate de magnésium
10361-76-9 Peroxymonosulfuric acid, potassium salt (1:2) Acide peroxymonosulfurique, sel de potassium (1:2)
10476-84-3 Octadecanoic acid, manganese salt (1:?) Acide octadécanoïque, sel de manganèse (1:?)
10476-86-5 Strontium iodide (SrI2) Iodure de strontium
11092-32-3 Aluminum oxide (AlO2) oxyde d'aluminium
11108-73-9 Uranium alloy, base, U,Nb,Zr (Mulberry) Alliage d'uranium, base, U, Nb, Zr (Mulberry)
12018-01-8 Chromium oxide (CrO2) Dioxyde de chrome
12122-15-5 Nickel carbonate hydroxide (Ni5(CO3)2(OH)6) Hydroxyde de carbonate de nickel (Ni5(CO3)2(OH)6)
12217-41-3 C.I. Basic Blue 22 Basic Blue 22 du C.I.
12217-43-5 9,10-Anthracenedione, 1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]- 1-amino-4-[[4-[(diméthylamino)méthyl]phényl]amino]anthraquinone
12221-52-2 C.I. Basic Red 22 C.I. rouge basique 22
12222-04-7 C.I. Direct Blue 199 Direct Blue 199 du C.I.
12640-40-3 Bismuth oxide oxyde de bismuth
12651-23-9 Titanium hydroxide hydroxyde de titane
12684-19-4 Lead iodide Iodure de plomb
13103-75-8 Benzenamine, N,N-dimethyl-4-(2-pyridinylazo)- N,N-Diméthyl-4-(2-pyridylazo)aniline
13408-62-3 Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)- Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)-
13429-07-7 2-Propanol, 1-(2-methoxypropoxy)- 1-(2-méthoxypropoxy)propane-2-ol
13557-75-0 Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) laurate de sodium et de 2-(1-carboxylatoéthoxy)-1-méthyl-2-oxoéthyle
13682-92-3 Aluminum, (glycinato-N,O)dihydroxy-, (ß-4)- Glycinate de dihydroxyaluminium
13779-98-1 Plumbane, tetraiodo- Plumbane, tétraiodo-
14452-57-4 Magnesium peroxide (Mg(O2)) Dioxyde de magnésium
14465-68-0 9,12,15-Octadecatrienoic acid, 1,1′,1″-(1,2,3-propanetriyl) ester, (9Z,9′Z,9″Z,12Z,12′Z,12″Z,15Z,15′Z,15″Z)- tris[(9Z,12Z,15Z)-octadéca-9,12,15-triénoate] de propane-1,2,3-triyle
14639-25-9 2-Pyridinecarboxylic acid, chromium(3+) salt (3:1) Acide 2-pyridinecarboxylique, sel de chrome (3+) (3:1)
15454-75-8 Zinc, bis(5-oxo-L-prolinato-κN1,κO2)-, (T-4)- bis(5-oxo-L-prolinato-N1,O2)zinc
15763-02-7 Butanedioic acid, 2-hydroxy-, 1,4-dioctyl ester 2-hydroxybutanedioate de 1,4-dioctyle
15792-51-5 Benzenesulfonic acid, 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylamino)sulfonyl]phenyl]azo]-1H-pyrazol-1-yl]-, monosodium salt 4-[4-[[3-(anilinosulfonyl)phényl]azo]-4,5-dihydro-3-méthyl-5-oxo-1H-pyrazole-1-yl]-2,5-dichlorobenzènesulfonate de sodium
15876-39-8 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one,2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy, aluminum salt (3:2) tris[2-(2,4,5,7-tétrabromo-6-oxydo-3-oxoxanthène-9-yl)benzoate] de dialuminium
15905-86-9 Nitric acid, uranium salt Acide nitrique, sel d'uranium
16040-38-3 Phosphoric acid, lead salt Acide phosphorique, sel de plomb
16057-43-5 Ethanol,2{2-(octadecyloxy)ethoxy}- Éthanol, 2{2-(octadécyloxy)éthoxy}-
16508-79-5 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, barium salt (2:1) Acide 3-hydroxy-4-(2-phényldiazényl)-2-naphtalènecarboxylique, sel de baryum (2:1)
16508-80-8 Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, aluminum salt (1:?) acide 2-(2,4,5,7-tétrabromo-3,6-dihydroxyxanthène-9-yl)benzoïque, sel d'aluminium
16561-29-8 Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester Tétradécanoate de (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acétyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-décahydro-4a,7b-dihydroxy-3-(hydroxyméthyl)-1,1,6,8-tétraméthyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulén-9-yle
16693-53-1 Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) N-Méthyl-N-(1-oxododécyl)glycine, composé avec le 2,2′,2″-nitrilotri(éthanol) (1:1)
16824-78-5 Phenol, 2,4,6-trinitro-, calcium salt Phénol, 2,4,6-trinitro-, sel de calcium
17026-85-6 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:?) 1-hexadécanol, 1-(dihydrogen phosphate), potassium salt (1:?)
17121-12-9 1,3,5,7,2,4,6,8-Tetroxatetraphosphocane, 2,4,6,8-tetrahydroxy-,2,4,6,8-tetraoxide,ion(4-) 1,3,5,7,2,4,6,8-tétroxatétraphosphocane, 2,4,6,8-tétrahydroxy-,2,4,6,8-tétraoxyde, ionique (-4)
17375-37-0 Carbonic acid, manganese salt acide carbonique, sel de manganèse
17619-86-2 Ethanol, 2-amino-, sulfite (salt) Éthanol, 2-amino-, sulfite (sel)
17672-22-9 Phenol, 2-amino-6-methyl- Phénol, 2-amino-6-méthyl-
17879-97-9 Benzenepropanoic acid, 3-amino-α-ethyl-2,4,6-triiodo-, (R)- Acide (R)-3-amino-α-éthyl-2,4,6-triiodobenzènepropanoïque
17949-65-4 Zinc, bis(2-pyridinecarboxylato-κN1,κO2-, (T-4)- picolinate de zinc
18089-54-8 Silanol, methyl- Silanol, méthyl-
18358-13-9 2-Propenoic acid, 2-methyl-, ion(1-) Acide 2-méthyl-2-propénoïque ionique (1-)
18507-89-6 3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester 6-décyloxy-7-éthoxy-4-hydroxy-3-quinoleinate d'éthyle
18917-91-4 Aluminum, tris(2-hydroxypropanoato-O1,O2)- Trilactate d'aluminium
20636-48-0 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)- 3,6,9,12-tétraoxatétradécan-1-ol, 14-(4-nonylphénoxy)-
20858-25-7 3,6,9,12-Tetraoxatetracosanoic acid Acide 3,6,9,12-tétraoxatétracosanoïque
20882-75-1 9H-Xanthen-9-one, 1,2,8-trihydroxy-6-methoxy- 9H-xanthén-9-one, 1,2,8-trihydroxy-6-méthoxy-
21034-17-3 Oxazolium, 3,4-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide iodure de 3,4-dimethyl-2-[2-(phénylamino)vinyl]oxazolium
21109-95-5 Barium sulfide (BaS) Sulfure de baryum
21127-45-7 3,6,9,12,15-Pentaoxaheptacosanoic acid Acide 3,6,9,12,15-pentaoxaheptacosanoïque
21245-01-2 Benzoic acid, 4-(dimethylamino)-, 3-methylbutyl ester Padimate
21542-96-1 1-Docosanamine, N,N-dimethyl- N,N-diméthyldocosylamine
22204-24-6 2-naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine (1:1) acide 4,4′-méthylènebis[3-hydroxy-2-naphtoïque], composé avec (E)-1,4,5,6-tétrahydro-1-méthyl-2-[2-(2-thiényl)vinyl]pyrimidine (1:1)
22366-99-0 9,10-Anthracenedione, 1-[(3-aminopropyl)amino]-4-(methylamino)- 1-[(3-aminopropyl)amino]-4-(méthylamino)anthraquinone
22801-45-2 9-Octadecenoic acid (9Z)-, 2-octyldodecyl ester oléate de 2-octyldodécyle
23059-38-3 Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, cis- cis-1,4-Diméthylcyclohexanecarboxylate de méthyle
23250-42-2 Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester (trans) trans-1,4-Diméthylcyclohexanecarboxylate de méthyle
24292-52-2 2-Propen-1-one, 1-[4-[[6-O-(6-deoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (E)- 1-[4-[[6-O-(6-Désoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-méthoxyphényl]-3-(3-hydroxy-4-méthoxyphényl)prop-2-én-1-one
24545-86-6 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-dinitro- 3′,6′-dihydroxy-4′,5′-dinitrospiro[isobenzofuranne-1(3H),9′-[9H]xanthène]-3-one
24905-87-1 Ethanol, 2-[(4-amino-3-nitrophenyl)amino]- 2-(4-amino-3-nitroanilino)éthanol
25136-75-8 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride, polymer with 2-propenamide and 2-propenoic acid Chlorure de diallyldiméthylammonium polymérisé avec l'acrylamide et l'acide acrylique
25482-78-4 Peroxymonosulfuric acid, potassium salt Acide peroxymonosulfurique, sel de potassium
25709-83-5 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy- Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy-
25709-84-6 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy- Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy-
25852-45-3 Poly(oxy-1,2-ethanediyl), α-phosphono-ω-(dodecyloxy)- α-Phosphono-ω-(dodécyloxy)poly(oxyéthylène)
25999-20-6 Benzoic acid, 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt acide benzoïque, [[éthyl-5 (éthyl-5 tétrahydrohydroxy-5 méthyl-6 2H-pyrannyl-2)-5 tétrahydrométhyl-3 furannyl-2]-7 hydroxy-4 diméthyl-3,5 oxononyl-6]-6 hydroxy-2 méthyl-3, sel monosodique, [2R-[2α[2S* (3R*,4S*,5S*,7R*),3S*,5S*],5α,6.bêta.]]-
26264-02-8 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)- 14-(nonylphénoxy)-3,6,9,12-tétraoxatétradécane-1-ol
26538-44-3 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, [3S-(3R,7S)]- Zéranol
26545-51-7 Benzamide, N,N-diethylmethyl- Benzamide, N,N-diéthylméthyl-
26658-83-3 2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate 2-méthyl-2-propénoate de butyle, polymérisé avec le 2-méthyl-2-propénoate de 2-(diméthylamino)éthyle
26915-12-8 Benzenamine, ar-methyl- Toluidine
26920-62-7 1-Docosanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt (carboxylatométhyl)docosyldiméthylammonium
27177-03-3 3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(nonylphenoxy)- 20-(nonylphénoxy)-3,6,9,12,15,18-hexaoxaicosane-1-ol
27177-07-7 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(octylphenoxy)- 3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-(octylphénoxy)-
27636-82-4 2,4-imidazolidinedione, (hydroxymethyl)-5,5-dimethyl- 2,4-imidazolidinedione, (hydroxyméthyl)-5,5-diméthyl-
27640-89-7 13-Docosenoic acid, (13Z)-13-docosen-1-yl ester, (13Z)- (Z)-docos-13-énoate de (Z)-docos-13-ényle
28212-44-4 Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-(4-nonylphenoxy)- α-(Carboxyméthyl)-ω-(p-nonylphénoxy)poly(oxyéthylène)
28261-54-3 Pyrrolidinone Pyrrolidinone
28602-69-9 Diphosphoric acid, ammonium manganese(2+) salt (2:2:3) Acide diphosphorique, sel d'ammonium et de manganèse(2+) (2:2:3)
28855-27-8 Benzenemethanaminium, ar-dodecyl-ar,N,N,N-tetramethyl-, chloride chlorure de (dodécylméthylbenzyl)triméthylammonium
30599-15-6 1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with oxirane 2,2-Bis(hydroxyméthyl)propane-1,3-diol polymérisé avec l'oxirane
31282-04-9 D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1.fwdarw.2-3)-O-β-D-talopyranosyl-(1.fwdarw.5)-2-deoxy-N3-methyl- hygromycine B
31512-74-0 Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)]
31692-79-2 Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy- Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy-
31846-06-7 Cyclohexanol, 3-(1,1-dimethylethyl)-, acetate Acétate de 3-tert-butylcyclohexanyle
32310-26-2 Androstene Androstène
33239-19-9 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo-, sodium salt (1:2) 2-(4,5-diiodo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium
33907-46-9 Octadecanoic acid, hydroxy-, 2-hydroxyethyl ester Hydroxyoctadécanoate de 2-hydroxyéthyle
33907-47-0 Octadecanoic acid, hydroxy-, monoester with 1,2-propanediol acide hydroxyoctadécanoïque, monoester avec propane-1,2-diol
34452-51-2 Acetic acid, mercapto-, monopotassium salt Mercaptoacétate de potassium
34464-38-5 Isodecane isodécane
34769-44-3 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt (1:1) 2,6-diacétyl-7,9-dihydroxy-8,9b-diméthyldibenzofuranne-1,3(2H,9bH)-dione, sel de monosodium
34965-01-0 Pyrrolidine, 1-[2-(dodecyloxy)ethyl]-, hydrochloride Pyrrolidine, 1-[2-(dodécyloxy)éthyl]-, chlorhydrate
35602-69-8 Cholest-5-en-3-ol (3β)-, 3-octadecanoate sterate de cholest-5-ène-3-β-yle
36284-86-3 Octadecanamide, N-(2-hydroxy-1,1-dimethylethyl)- Octadécanamide, N-(2-hydroxy-1,1-diméthyléthyl)-
37220-90-9 Silicic acid, lithium magnesium salt Acide silicique, sel de lithium et de magnésium
37222-66-5 Potassium peroxymonosulfate sulfate (K5(HSO5)2(HSO4)(SO4)) Sulfate de peroxymonosulfate de potassium (K5(HSO5)2(HSO4)(SO4))
37286-92-3 Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt Acide éthénylbenzènesulfonique, homopolymère, sel de calcium
38480-64-7 1-Dodecanesulfonic acid, ion(1-) Acide 1-dodécanesulfonique, ionique (1-)
38577-97-8 Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo- 3′,6′-Dihydroxy-4′,5′-diiodospiro[isobenzofurane-1(3H),9′-[9H]xanthène]-3-one
38621-51-1 Octadecanoic acid, 12-hydroxy-, monoester with 1,2-propanediol Acide hydroxyoctadécanoïque, monoester avec le propane-1,2-diol
38866-20-5 Morpholinium, 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)amino]propyl]-4-methyl-, methyl sulfate (1:1) sulfate de 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxoanthryl)amino]propyl]-4-méthylmorpholinium et de méthyle
38886-21-4 Phenol, 2-methoxynitro- Phénol, 2-méthoxynitro-
38975-03-0 3,6,9,12,15-Pentaoxaheptacosanoic acid, sodium salt Acide 3,6,9,12,15-pentaoxaheptacosanoïque, sel sodique
39322-04-8 Chromium potassium oxide Oxyde de chrome et de potassium
39456-59-2 Phosphoric acid, mixt. with sodium fluoride (NaF) Acide phosphorique, mélange avec le fluorure de sodium (NaF)
40160-92-7 Poly(oxy-1,2-ethanediyl), α-(3-pentadecylphenyl)-ω-hydroxy- α-(3-Pentadécylphényl)-ω-hydroxypoly(oxyéthane-1,2-diyl)
40188-41-8 Octanenitrile, 3,7-dimethyl- 3,7-Diméthyloctanonitrile
40738-57-6 2-Propenoic acid, ethenylidene ester, homopolymer 2-propénoate d'éthénylidène, homopolymère
40754-59-4 Butanedioic acid, 2-sulfo-, 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] ester, sodium salt (1:2) 2-sulfonatosuccinate de disodium et de 4-[2-[2-[2-(dodécyloxy)éthoxy]éthoxy]éthyle
41080-66-4 Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxooctadecyl)oxy]- Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-[(1-oxooctadécyl)oxy]-
41669-40-3 Tetradecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) Myristate de tris(2-hydroxyéthyl)ammonium
41927-88-2 Sodium iodide (Na123I) Iodure de sodium (Na123I)
42131-25-9 Isononanoic acid, isononyl ester Isononanoate d'isononyle
42766-91-6 Poly (oxy-1, 2-ethanediyl), α-[(3b, 5a)-cholestan-3-yl]-ω-hydroxy- Poly(oxy-1, 2-éthanediyle), α-[(3b, 5a)-cholestan-3-yl]-oméga-hydroxy-
45267-19-4 Tetradecanamide, N-[3-(dimethylamino)propyl]- N-[3-(Diméthylamino)propyl]myristamide
49625-21-0 Butanoic acid, 4-[[4-[[[(4-methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]-2-oxo- Acide 4-[[4-[[[(4-méthoxy-2-nitrophényl)amino]carbonyl]amino]benzoyl]amino]-2-oxobutanoïque
50545-60-3 Phenol, methyl-, tetrabromo deriv. Phénol, méthyl-, dérivés tétrabromés
50610-28-1 Ethanol, 2-[(4-amino-2-chloro-5-nitrophenyl)amino]- 2-[(4-amino-2-chloro-5-nitrophényl)amino]éthanol
50643-20-4 Poly (oxy-1,2-ethanediyl), α-hexadecyl-ω-hydroxy-, phosphate Poly(oxy-1,2-éthanediyle), α-hexadécyl-oméga-hydroxy-, phosphate
50800-85-6 Indium chloride (111InCl3) Chlorure d'indium (111InCl3)
50982-74-6 Ethanol, 2-(4-amino-3-nitrophenoxy)- Éthanol, 2-(4-amino-3-nitrophénoxy)-
50994-40-6 1,4-Benzenediamine, sulfate (1:?) 1,4-benzènediamine, sulfate (1:?)
51023-21-3 1H-Imidazolol, ethyldihydro[(9Z)-9-octadecen-1-yl]- 1H-imidazolol, éthyldihydro[(9Z)-9-octadécèn-1-yl]-
51192-09-7 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,2,3-propanetriol mono-9-octadecenoate (2:1), (Z)- α-Hydro-ω-hydroxypoly(oxyéthylène), éther (2:1) avec le monooléate du glycérol
51311-89-8 Antimony iodide Iodure d'antimoine
51365-71-0 1,2-Benzenedicarboxamide, N,N′-dioctadecyl- 1,2-benzènedicarboxamide, N,N′-dioctadécyl-
51513-58-7 6,10-Dodecadienal, 3,7,11-trimethyl-, (6E)- 6,10-Dodécadiénal, 3,7,11-triméthyl-, (6E)-
51781-21-6 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1) 5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone, monochlorhydrate
51810-70-9 Zinc phosphide phosphure de zinc
51852-65-4 Poly(oxy-1,2-ethanediyl), α-[2-hydroxy-3-[(1-oxooctadecyl)oxy]propyl]-ω-hydroxy- Poly(oxy-1,2-éthanediyle), α-[2-hydroxy-3-[(1-oxooctadécyl)oxy]propyl]-oméga-hydroxy-
52467-63-7 1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride Chlorure de N,N-dihexadécyl-N-méthyl-1-hexadécanaminium
52557-98-9 Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl- Acide 3,3-diméthylbicyclo[2.2.1]heptane-2-carboxylique
52793-97-2 N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]benzenaminim, methyl sulfate de méthyle et de N,N,N-triméthyl-4-[(4,7,7-triméthyl-3-oxobicyclo[2.2.1]hept-2-ylidène)méthyl]anilinium
52845-07-5 Isoeicosane Isoeicosane
53171-04-3 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride 1-propanaminium, 2-hydroxy-N,N,N-triméthyl-3-[(1-oxododécyl)oxy]-, chlorure
54182-58-0 Aluminum, hexadeca-.mu.-hydroxytetracosahydroxy[.mu.8-[[1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl α-D-glucopyranoside tetrakis(sulfato-κO′)](8-)]]hexadeca- sucralfate
54422-45-6 N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-9-octadecenamide 9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)-
54590-52-2 Benzenesulfonic acid, 4-dodecyl-, compd. with 1-amino-2-propanol (1:1) Acide p-dodécylbenzènesulfonique, composé avec le 1-aminopropan-2-ol (1:1)
55134-13-9 Salinomycin, 4-methyl-, (4S)- narasine
55297-96-6 Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (1:1) (salt) acide acétique, [[(diéthylamino)-2 éthyl]thio]-, ester d'éthényldécahydro-6 hydroxy-5 tétraméthyl-4,6,9,10 oxo-1 propano-3a,9 3aH-cyclopentacyclo-octényl-8, [3aS-(3aα,4.bêta.,5α,6α,8.bêta.,9α,9a.bêta.,10S*)]-, (E)-butènedioate-2 (1:1) (sel)
55837-20-2 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, rel- 4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, rel-
55840-13-6 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate acide propanetricarboxylique-1,2,3, hydroxy-2, ester avec le mono-octadécanoate de propanetriol-1,2,3
55852-15-8 Propanoic acid, 2-hydroxy-, compd. with N-[3-(dimethylamino)propyl]-16-methylheptadecanamide (1:1) Acide lactique, composé (1:1) préparé avec le N-[3-(diméthylamino)propyl]-16-méthylheptadécanamide
55852-84-1 Bacitracin, methylenebis[2-hydroxybenzoate] Méthylènedisalicylate de la bacitracine
55901-20-7 D2-Proline, 5-oxo-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) 5-Oxo-D2-proline, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)
55940-73-3 Benzoic acid, 2-hydroxy-, oxybis(methyl-2,1-ethanediyl) ester disalicylate d'oxydipropylène
56038-13-2 α-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 4-chloro-4-deoxy- 4-chloro-4-désoxy-α-D-galactose de 1,6-dichloro-1,6-didésoxy-.bêta.-D-fructofurannosyle
56235-92-8 Butanedioic acid, hydroxy-, bis(2-ethylhexyl) ester malate de bis(2-éthylhexyle)
56554-41-7 9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester 9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)-
56639-51-1 Aluminum, hydroxybis(tetradecanoato-κO)- hydroxybis(myristato-O)aluminium
56827-95-3 1-Hexadecanol, phosphate (3:1) Phosphate de trihexadécyle
57072-40-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium(3+) salt (1:?) acide citrique, sel de chrome
57524-53-5 Ethanol, 2-[(4-methoxy-2-nitrophenyl)amino]- Éthanol, 2-[(4-méthoxy-2-nitrophényl)amino]-
57834-50-1 Benzoic acid, 4-[[[[4-(ethoxycarbonyl)phenyl]amino]methylene]amino]-, ethyl ester p-({[p-(Éthoxycarbonyl)anilino]méthylène}amino)benzoate d'éthyle
57934-97-1 2-Cyclohexene-1-carboxylic acid, 2-ethyl-6,6-dimethyl-, ethyl ester 2-Éthyl-6,6-diméthylcyclohex-2-ène-1-carboxylate d'éthyle
57963-76-5 4a(2H)-Naphthalenol, octahydro-4,4,8a-trimethyl-,trans- 4a(2H)-naphtalénol, octahydro-4,4,8a-triméthyl-, trans-
57963-77-6 cis-1,1,10-Trimethyl-9-decahydronaphthol cis-1,1,10-triméthyl-9-décahydronaphtol
58855-36-0 Ethanol, 2,2′-iminobis-, compd. with α-sulfo-ω-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1) Éthanol, 2,2′-iminobis-, composé avec l'α-sulfo-oméga-(dodécyloxy)poly(oxy-1,2-éthanediyle) (1:1)
59056-93-8 Ethanone, 1-[(2R,3S)-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl]-, rel- rel-1-[(2R,3S)-1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthylnaphtalén-2-yl]éthanone
59070-56-3 Poly(oxy-1,2-ethanediyl), α,α′.,α″-1,2,3-propanetriyltris[ω-hydroxy-, monododecanoate Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-hydroxy]-, monododécanoate
59219-71-5 Hexanoic acid, 3,5,5-trimethyl-, 3,5,5-trimethylhexyl ester 3,5,5-Triméthylhexanoate de 3,5,5-triméthylhexyle
59587-08-5 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, sodium salt (1:1) 5-éthyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoléine-7-carboxylate de sodium
59599-53-0 Benzoic acid, 2-hydroxy-, 2-(2-hydroxy-1-methylethoxy)-1-methylethyl ester 2-hydroxybenzoate de 2-(2-hydroxy-1-méthyléthoxy)-1-méthyléthyle
59599-58-5 Benzenesulfonic acid, 4-tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) Acide 4-tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1)
59792-81-3 Aluminum, tris(5-oxo-L-prolinato-κN1,κO2)- tris(5-oxo-L-prolinato-N1,O2)aluminium
59820-63-2 2-[3-(methylamino)-4-nitrophenoxy]ethanol 2-[3-(méthylamino)-4-nitrophénoxy]éthanol
59970-10-4 3,6,9,12-Tetraoxatriacontan-1-ol 3,6,9,12-tétraoxatriacontan-1-ol
60031-93-8 Cyclohexanemethanol, 4-ethenyl-α,α,4-trimethyl-3-(1-methylethenyl)-, acetate, [1R-(1α,3α,4β)]- Acétate de [1R-(1α,3α,4β)]-3-isopropyl-α,α,4-triméthyl-4-vinylcyclohexaneméthanol
60270-33-9 Docosanamide, N-[3-(dimethylamino)propyl]- N-[3-(diméthylamino)propyl]docosanamide
60684-33-5 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiène-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaén-1-yl)-5,6-diméthoxy-3-méthyl-
60778-99-6 Sulfuric acid, aluminum magnesium salt Sulfates mixtes d'aluminium et de magnésium
60908-77-2 Isohexadecane Isohexadécane
61692-77-1 2-Butenoic acid, 2-methyl-, 2-methylbutyl ester, (2Z)- 2-méthylisocrotonate de 2-méthylbutyle
61693-08-1 Heptadecane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadecamethyl- Heptadécane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadécaméthyl-
61702-44-1 1,4-Benzenediamine, 2-chloro-, sulfate (1:1) sulfate de 2-chloro-p-phénylénédiamine
61790-62-3 Fatty acids, coco, reaction products with N,N-dimethyl-1,3-propanediamine Acides gras de coco, produits de réaction avec la N,N-diméthylpropane-1,3-diamine
61886-59-7 Benzenesulfonic acid, tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) Acide tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)
62152-14-1 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, ammonium salt (1:1), homopolymer Acide 2-méthyl-2-[(1-oxo-2-propén-1-yl)amino]-1-propanesulfonique, sel d'ammonium (1:1), homopolymère
62406-73-9 6,10-Dioxaspiro[4.5]decane, 8,8-dimethyl-7-(1-methylethyl)- 6,10-dioxaspiro[4.5]décane,8,8-diméthyl-7-(-1-méthyléthyl)-
62625-14-3 Phenol, 2-amino-6-chloro-4-nitro-, monohydrochloride 2-Amino-6-chloro-4-nitrophénol , monochlorhydrate
63084-98-0 Phenol, 4-amino-, sulfate (2:1) (salt) Sulfate de bis[(4-hydroxyphényl)ammonium]
63089-86-1 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with D-glucitol (6:1), tetra-9-octadecenoate, (all-Z)- α-Hydro-ω-hydroxypoly(oxyéthylène), éther (6:1) avec le D-glucitol, tétraoléate
64924-67-0 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel- 4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, monobromhydrate, rel-
65235-31-6 4-[(2-hydroxyethyl)amino]-3-nitrophenol 4-[(2-hydroxyéthyl)amino]-3-nitrophénol
65389-08-4 Indium-111In, tris(8-quinolinolato-κN1,κO8)- Indium-111In, tris(8-quinolinolato-κN1,κO8)-
65405-96-1 Nickel, [.mu.-[carbonato(2-)-κO:κO′]]dihydroxydi- [.mu.-[carbonato(2-)-O:O′]]dihydroxydinickel
65710-07-8 D-Streptamine, o-4-amino-4-deoxy-α-D-glucopyranosyl-(1→8)-o-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-α-D-allo-octadialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy-, sulfate (salt) sulfate d'apramycine
66095-81-6 Ethanol, 2-[(2-methoxy-4-nitrophenyl)amino]- 2-[(2-méthoxy-4-nitrophényl)amino]éthanol
66575-29-9 1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, [3R-(3-α,4a-β,5-β,6-β,6a-α,10-α,10a-β,10b-α)]- colforsine
66671-82-7 1,4-Benzenediamine, 2-methoxy-, sulfate (1:1) Sulfate de 2-méthoxybenzène-1,4-diammonium
67783-98-6 Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol] and 2-methylphenol Formaldéhyde polymérisé avec le 4,4′-isopropylidènediphénol et l'o-crésol
67784-88-7 Glycerides, palm-oil mono- and di-, hydrogenated, ethoxylated Mono- et diglycérides d'huile de palme, hydrogénées, éthoxylées
67846-16-6 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate Sulfate d'éthyldiméthyl[3-[(1-oxooctadécyl)amino]propyl]ammonium et d'éthyle
67874-65-1 Propanoic acid, 3-mercapto-, 2,3-dihydroxypropyl ester 3-Mercaptopropionate de 2,3-dihydroxypropyle
67914-69-6 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- 4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d'éthyle, rel-
68015-98-5 1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1) Sulfate de 4-éthoxybenzène-1,3-diammonium
68187-29-1 2-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1) Acide 2-glutamique, dérivés N-acyles de coco, composés avec la triéthanolamine (1:1)
68239-79-2 Phenol, 3-(ethylamino)-4-methyl-, sulfate (2:1) (salt) Sulfate de bis[éthyl(4-hydroxy-o-tolyl)ammonium]
68239-83-8 1,4-Benzenediamine, 2-nitro-, sulfate (1:1) Sulfate de 2-nitrobenzène-1,4-diammonium
68239-84-9 Phenol, 3-(diethylamino)-, sulfate (2:1) (salt) Sulfate de bis[(diéthylhydroxyphényl)ammonium]
68391-32-2 2-Naphthalenaminium, 8-[(4-amino-3-nitrophenyl)azo]-7-hydroxy-N,N,N-trimethyl-, chloride Chlorure de [8-[(4-amino-3-nitrophényl)azo]-7-hydroxy-2-naphtyl]triméthylammonium
68413-33-2 Quaternary ammonium compounds, bis(2-hydroxy-C>10-alkyl)dimethyl, chlorides Chlorures de bis(2-hydroxy-C>G10-alkyl)diméthylammonium quaternaire
68475-50-3 Aluminum, tris[5-amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonato(2-)]di- Tris[5-amino-4-hydroxy-3-(phénylazo)naphtalène-2,7-disulfonato(2-)]dialuminium
68479-64-1 Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) 2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle]
68552-95-4 Fatty acids, vegetable-oil, ethoxylated Acides gras d'huile végétale, éthoxylés
68607-24-9 Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides Composés de l'ion ammonium quaternaire, alkyle en C20-22 triméthyles, chlorures
68797-65-9 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate Sulfate de N-éthyl-3-docosanamido-N,N-diméthylpropan-1-aminium et d'éthyle
68814-13-1 1-Hexadecanol, phosphate Hexadécan-1-ol, phosphate
68889-49-6 9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, polymer with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) Trioléate de propane-1,2,3-triyle polymérisé avec l'α-hydro-ω-hydroxypoly(oxyéthylène)
68890-92-6 Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxosulfopropyl)-ω-hydroxy-, ethers with lanolin alcs., disodium salts α-(3-Carboxysulfopropionyl)-ω-hydroxypoly(oxyéthylène), éthers avec des alcools de lanoline, sels disodiques
68910-56-5 Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides Composés de l'ion ammonium quaternaire, dialkyle en C12-15 diméthyles, chlorures
68915-25-3 Keratins, lauroyl Kératines, dérivés lauroyliques
68929-04-4 1H-Imidazolium, 1-[2-(2-carboxyethoxy)ethyl]-1-(2-carboxyethyl)-4,5-dihydro-2-undecyl-, hydroxide, disodium salt Hydroxyde de disodium et de 1-[2-(2-carboxyéthoxy)éthyl]-1-(2-carboxyéthyl)-4,5-dihydro-2-undécyl-1H-imidazolium
68935-40-0 1H-Indene-2-propanoic acid, 2,3-dihydro-1-oxo-5,6-bis(phenylmethoxy)-2-propyl- Acide 2,3-dihydro-1-oxo-5,6-bis(phénylméthoxy)-2-propyl-1H-indène-2-propanoïque
68953-59-3 Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N′-bis(hydrogenated tallow acyl) derivs., Me sulfates (salts) Bis(2-aminoéthyl)(2-hydroxyéthyl)méthylammonium, dérivés N,N′-diacylés de suif hydrogéné, sulfates mixtes de méthyle (sels)
68953-68-4 Aluminum, chloro propylene glycol complexes Aluminium, complexes chloro de propylèneglycol
69537-38-8 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxodocosyl)oxy]-, chloride (1:1) chlorure de 2-hydroxy-3-[(1-oxodocosyl)oxy]propyltriméthylammonium
70131-69-0 Silsesquioxanes, Phenyl Phénylsilsesquioxanes
70729-68-9 Heptanoic acid, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester Diheptanoate d'oxybis(éthane-2,1-diyloxyéthane-2,1-diyle)
70729-87-2 Isooctadecanoic acid, compd. with N,N-dimethyl-1-dodecanamine (1:1) Acide isooctadécanoïque, composé avec le N,N-diméthyldodécylamine (1:1)
70914-02-2 Glycerides, C14-18 and C16-18-unsatd. mono- and di-, ethoxylated Mono- et diglycérides en C14-18 et en C16-18 insaturés, éthoxylés
71060-72-5 Quaternary ammonium compounds, tri-C14-18-alkylmethyl, chlorides Chlorures de tri-C14-18-alkylméthylammonium quaternaire
71329-50-5 Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride Gomme de guar, éthers 2-hydroxypropylique et 2-hydroxy-3-(triméthylammonio)propylique, chlorure
71463-34-8 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, hydrogen sulfate (salt), monosodium salt 1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, hydrogénosulfate (sel), sel monosodique
71735-79-0 13-Oxabicyclo[10.1.0]trideca-4,8-diene, trimethyl- Triméthyl-13-oxabicyclo[10.1.0]tridéca-4,8-diène
71812-38-9 Sorbitan, isooctadecanoate (2:3) Sorbitane, isooctadécanoate (2:3)
71850-81-2 1-Propanaminium, N-(carboxymethyl)-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]-N,N-dimethyl-, hydroxide, inner salt, [R-(Z)]- [R-(Z)]-N-(Carboxyméthyl)-3-[(12-hydroxy-1-oxooctadéc-9-ényl)amino]-N,N-diméthylpropan-1-aminium, hydroxyde, sel interne
71957-08-9 Cobalt, bis(D-gluconato-κO1,κO2)-,(T-4)- bis(D-gluconato-O1,O2)cobalt
72175-39-4 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), octadecanoate (2:3) Octadécanoate (2:3) d'α-hydro-ω-hydroxypoly(oxyéthane-1,2-diyl) éther avec le méthyl-D-glucopyranoside (4:1)
72230-86-5 Terpenes and Terpenoids, cedarwood-oil, Texan, hydroxy, acetates Esters de l'acide acétique avec les alcools terpéniques tirés de l'essence du bois de cèdre du Texas
72484-69-6 Oxirane, methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether Oxirane, méthyl-, polymérisé avec l'oxirane, éther mono(2-décyltétradécylique)
73231-34-2 Acetamide, 2,2-dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]- Acétamide, 2,2-dichloro-N-[(1S,2R)-1-(fluorométhyl)-2-hydroxy-2-[4-(méthylsulfonyl)phényl]éthyl]-
73296-86-3 Isooctadecanoic acid, ester with oxybis[propanediol] Acide isooctadécanoïque, ester avec l'oxybis[propanediol]
73772-45-9 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxodecyl)amino]-, hydroxide, inner salt Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxodécyl)amino]propylammonium
73772-46-0 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxooctyl)amino]-, hydroxide, inner salt Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxooctyl)amino]propylammonium
74610-55-2 Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) Tylosine, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (sel)
75018-70-1 Ethanesulfonic acid, 2-[[[[(3α,5β,7α,12α,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75Se]acetyl]amino]- Acide éthanesulfonique, 2-[[[[(3α,5bêta,7α,12α,20S)-3,7,12-trihydroxy-20-méthylprégnan-21-yl]séléno-75Se]acétyl]amino]-
75911-79-4 Bicyclo[3.2.1]octan-8-ol, 1,5-dimethyl-, acetate Acétate de 1,5-diméthylbicyclo[3.2.1]oct-8-yle
77851-07-1 2-Cyclohexene-1-carboxylic acid, 2,3,6,6-tetramethyl-, ethyl ester 2,3,6,6-Tétraméthylcyclohex-2-ène-1-carboxylate d'éthyle
77923-28-5 Cyclododecane, (2-methoxyethoxy)- (2-Méthoxyéthoxy)cyclododécane
78509-74-7 1-(hexadecyloxy)octadecan-2-ol) 1-(hexadécyloxy)octadécan-2-ol)
78616-98-5 Dodecanoic acid, 2-aminoethyl ester Dodécanoate de 2-aminoéthyle
79120-33-5 Litharge (PbO) Litharge (PbO)
79702-63-9 Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) 2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle]
80435-42-3 Iron alloy, base, Fe 63-74,Cr 12.0-15.0,Ni 12.0-15.0, W 1.50-3.00,Mn 0-1.00,Si 0.30-0.80,C 0.35-0.50, Mo 0.20-0.50,P 0-0.045,S 0-0.030 (UNS S66009) Alliage de fer, base, Fe 63-74, Cr 12,0-15,0, Ni 12,0-15,0, W 1,50-3,00, Mn 0-1,00, Si 0,30-0,80, C 0,35-0,50, Mo 0,20-0 50, P 0-0,045, S 0-0,030 (UNS S66009)
81783-01-9 6,8-Nonadien-3-one,2,4,4,7-tetramethyl-,oxime 2,4,4,7-Tétraméthylnona-6,8-dièn-3-one-oxime
81818-54-4 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- 2-méthyl-3-(3,7,11,15-tétraméthylhexadec-2-ényl)-1,4-naphtoquinone
81907-73-5 3-Cyclopentene-1-acetic acid, 2,2,3-trimethyl-, ethyl ester 2,2,3-Triméthylcyclopent-3-ène-1-acétate d'éthyle
83120-95-0 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenoic acid Méthacrylate de dodécyle polymérisé avec la 1-vinylpyrrolidin-2-one et l'acide acrylique
83615-24-1 Cholest-5-en-3-ol (3β)-, 3-isooctadecanoate Cholest-5-én-3-ol (3bêta)-, 3-isooctadécanoate
83763-47-7 Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]- 2-[(3-amino-4-méthoxyphényl)amino]éthanol
83763-48-8 Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-, sulfate (1:1) sulfate de (3-ammonio-4-méthoxyphényl)(2-hydroxyéthyl)ammonium
84041-77-0 Ethanol, 2,2′-[(2-nitro-1,4-phenylene)diimino]bis- 2,2′-[(2-nitro-1,4-phénylène)diimino]biséthanol
84366-81-4 Riboflavin 5′-(trihydrogen diphosphate), 5′→5′-ester with adenosine, disodium salt 5′-(trihydrogénodiphosphate) de riboflavine, 5′→5′-ester avec adénosine, sel de disodium
84563-62-2 Chitosan, hexanedioate (salt) Chitosane, hexanedioate (sel)
84605-12-9 13-Docosenoic acid, 13-docosenyl ester docos-13-enoate de docos-13-ényle
84608-82-2 2-hydroxy-3-(oleoyloxy) propyl 5-oxo-L-prolinate 5-oxo-L-prolinate de 2-hydroxy-3-(oléoyloxy)propyle
84642-57-9 Cyclopentanone, 2-[(3,3,5-trimethylcyclohexyl)acetyl]- 2-[(3,3,5-triméthylcyclohexyl)acétyl]cyclopentane-1-one
84643-53-8 1-Hexadecanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1) chlorure de (2-hydroxyéthyl)(2-hydroxyhexadécyl)diméthylammonium
84753-08-2 1, 3-bis(2-ethylhexyl)cyclohexane 1,3-bis(2-éthylhexyl)cyclohexane
84878-33-1 Isononanoic acid, hexadecyl ester isononanoate d′hexadécyle
84878-34-2 Isononanoic acid, octadecyl ester isononanoate d'octadécyle
84878-61-5 2H-Pyran-2-acetic acid, 6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,2′R,3′S,5R,5′R)-3′-[(2,6-dideoxy-3,4-di-O-methyl-β-L-arabino-hexopyranosyl)oxy]octahydro-2-methyl-5′-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl][2,2′-bifuran]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]tetrahydro-2-hydroxy-4,5-dimethoxy-3-methyl-, ammonium salt (1:1), (2R,3S,4S,5R,6S)- sel d'ammonium de la maduramicine
85058-43-1 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- 4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d'éthyle, rel-
85066-57-5 Poly(oxy-1,2-ethanediyl), α-(1-oxooctadecyl)-ω-(octadecyloxy)- Poly(oxy-1,2-éthanediyle), α-(1-oxooctadécyl)-oméga-(octadécyloxy)-
85252-25-1 Benzoic acid, 2-hydroxy-, isodecyl ester salicylate d'isodécyle
85264-33-1 1H-Pyrazole-1-methanol, 3,5-dimethyl- 3,5-diméthyl-1H-pyrazole-1-méthanol
85563-48-0 1-Hexadecanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, phosphate (1:1) (salt) dihydrogénophosphate d'hexadécyl(2-hydroxyéthyl)diméthylammonium
85586-07-8 Sulfuric acid, mono-C12-14-alkyl esters, sodium salts acide sulfurique, esters de mono-alkyles en C12-14, sels de sodium
85765-48-6 Ethanol, 2-[4-[(2-aminoethyl)amino]-3-nitrophenoxy]- Éthanol, 2-[4-[(2-aminoéthyl)amino]-3-nitrophénoxy]-
86050-77-3 D-glucitol, 1-deoxy-1-(methylamino)-, [N,N-bis[2-[bis[(carboxy-κO)methyl]amino-κN]glycinato(5-)-κN,κO]gadolinate(2-) (2:1) gadopentétate de diméglumine
86419-69-4 1,2-Ethanediamine, N1-(5-methoxy-2-nitrophenyl)-, hydrochloride (1:1) 1,2-éthanediamine, N1-(5-méthoxy-2-nitrophényl)-, chlorhydrate (1:1)
86481-08-5 Poly(oxy-1,2-ethanediyl), α, α′.-(1-methyl-1,2-ethanediyl)bis[ω-[[(9Z)-1-oxo-9-octadecenyl]oxy]- Poly(oxy-1,2-éthanediyle), α, α′-(1-méthyl-1,2-éthanediyl)bis[oméga-[[(9Z)-1-oxo-9-octadécényl]oxy]-
88103-59-7 13-Docosenoic acid, 2-octyldodecyl ester, (13Z)- 13-docosénoate de 2-octyldodécyle, (13Z)-
90274-24-1 benzenemethanol, 4-hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride Benzèneméthanol, 4-hydroxy-a-[[[3-(4-hydroxyphényl)-1-méthylpropyl]amino]méthyl]-, chlorhydrate (1:1)
90283-04-8 1-Dodecanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-, chloride 1-dodécanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-, chlorure
90411-68-0 Hexanoic acid, 2-ethyl-, C16-18-alkyl esters acide hexanoïque, éthyl-2, esters d'alkyles en C16-18
90457-82-2 Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique
90529-57-0 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates propanaminium-1, amino-3 N-éthyl N,N-diméthyl-, dérivés N-acyles de soja, sulfates d''éthyle
90604-80-1 Zirconium, chloro glycine hydroxy aluminum complexes zirconium, complexes de glycine chloro et d'aluminium hydroxy
90817-34-8 2,3-Pyridinediamine, 6-methoxy-N2-methyl- 2,3-pyridinediamine, 6-méthoxy-N2-méthyl-
91032-11-0 Fatty acids, C12-20, reaction products with triethanolamine, di-Me sulfate-quaternized Acides gras en C12-20, produits de la réaction avec du 2,2′,2″-nitrilotriséthanol, quaternarisé avec du sulfate de diméthyle
91995-81-2 Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized acides gras en C10-20 et insaturés en C16-18, produits de réaction avec la triéthanolamine, quaternisés par le sulfate de diméthyle
92045-76-6 Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated cires de paraffine et cires d'hydrocarbures microcristallines, hydrotraitées
92045-77-7 Petrolatum (petroleum), hydrotreated pétrolatum (pétrole), hydrotraité
92201-88-2 Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates composés de l'ion imidazolium, (alkyl en C9-19, saturé et insaturé)-2 [(amido en C10-20, saturé et insaturé)éthyl]-1 dihydro-4,5 méthyl-1, sulfates de méthyle
92348-62-4 Octanoic acid, hydroxy- Acide hydroxyoctanoïque
92761-26-7 Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique
92952-81-3 Phenol, 4-[(3-hydroxypropyl)amino]-3-nitro- Phénol, 4-[(3-hydroxypropyl)amino]-3-nitro-
93106-60-6 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- Acide 1-cyclopropyl-7-(4-éthyl-1-pipérazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylique
93166-05-3 1-Propanaminium, N-(2-aminoethyl)-N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-3-(phosphonooxy)-, N-C6-18 acyl derivs ., hydroxides, inner salts, disodium salts N-(2-Aminoéthyl)-N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-3-(phosphonooxy)propan-1-aminium, dérivés acyles en N-C6-18, hydroxydes, sels internes, sels disodiques
93385-03-6 3,6,9,12-Tetraoxaoctacosan-1-ol, 11-methyl-, acetate 3,6,9,12-tétraoxaoctacosan-1-ol, 11-méthyl-, acétate
93385-13-8 Ethanol, 2-[2-[2-[2-(isohexadecyloxy)propoxy]ethoxy]ethoxy]-, acetate Éthanol, 2-[2-[2-[2-(isohexadécyloxy)propoxy]éthoxy]éthoxy]-, acétate
93385-14-9 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triisohexadecyl ester 2-hydroxy-1,2,3-propanetricarboxylate de 1,2,3-triisohexadécyle
93507-51-8 1-Propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-trimethyl-, chloride (1:1) 1-propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-triméthyl-, chlorure (1:1)
93841-25-9 Benzeneethanol, 2,5-diamino-, sulfate (1:1) sulfate de 3-(2-hydroxyéthyl)-p-phénylènediammonium
94158-13-1 Ethanol, 2,2′-[(4-amino-3-nitrophenyl)imino]bis-, monohydrochloride 2,2′-[(4-amino-3-nitrophényl)imino]biséthanol, chlorhydrate
94158-14-2 Ethanol, 2-(1,3-benzodioxol-5-ylamino)-, hydrochloride (1:1) 2-(1,3-benzodioxole-5-ylamino)éthanol, chlorhydrate
94201-62-4 Docosanoic acid, 2-hydroxy-1,3-propanediyl ester didocosanoate de 2-hydroxypropane-1,3-diyle
94247-26-4 Tetradecyl isooctadecanoate isooctadécanoate de tétradécyle
94277-32-4 1,2-Hexadecanediol, 1,1′-(hydrogen phosphate), monosodium salt phosphate de sodium et de bis(2-hydroxyhexadécyle)
94333-50-3 1-Cyclohexene-1-carboxylic acid, 2-ethyl-3,6,6-trimethyl-, ethyl ester 2-Éthyl-3,6,6-triméthylcyclohexènecarboxylate d'éthyle
94333-51-4 Cyclohexanecarboxylic acid, 6-ethylidene-2,2,5-trimethyl-, ethyl ester 6-Éthylidène-2,2,5-triméthylcyclohexanecarboxylate d'éthyle
94400-98-3 Naphth[2,3-b]oxirene, 1a,2,3,4,5,6,7,7a-octahydro-1a,3,3,4,6,6-hexamethyl-, (1aα,4α,7aα)- (1aα,4α,7aα)-1a,3,3,4,6,6-Hexaméthyl-1a,2,3,4,5,6,7,7a-octahydronapht[2,3-b]oxirène
94891-31-3 Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite composés de l'ion ammonium quaternaire, dialkyl en C16-18 diméthyles, sels avec l'hectorite
95193-70-7 Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate amines, N-(alkyl en C8-18 et insaturé en C18)triméthylènedi-, produits de réaction avec le chloro-2 éthanol et le chloracétate de sodium
95193-83-2 1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts 2-(quinolin-2-yl)-1H-indène-1,3(2H)-dione, sulfonée, sels de sodium
95371-16-7 Sulfonic acids, C14-16-1-alkene, sodium salts acides sulfoniques, alcène-1 en C14-16, sels de sodium
95576-89-9 1,2-Propanediol, 3-[(4-amino-2-chloro-5-nitrophenyl)amino]- 1,2-propanediol, 3-[(4-amino-2-chloro-5-nitrophényl)amino]-
95576-92-4 1,2-Propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phenylene)diimino]bis- 1,2-propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phénylène)diimino]bis-
96081-39-9 Alkyl(C16-18)polyethyleneglycol tetra decylene glycolether Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18
97375-39-8 C.I. Food Yellow 4:2 zirconium, complexes de dihydro-4,5 oxo-5 (sulfo-4 phényl)-1 [(sulfo-4 phényl)azo]-4 1H-pyrazole carboxylate-3
97862-59-4 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., hydroxides, inner salts propanaminium-1, amino-3 N-(carboxyméthyl) N,N-diméthyl-, dérivés N-acyles en C8-18, hydroxydes, sels internes
97862-76-5 Foots oil (petroleum), carbon-treated huile de ressuage (pétrole), traitée au charbon
97862-89-0 Paraffin waxes (petroleum), carbon-treated cires paraffiniques (pétrole), traitées au charbon
97862-97-0 Petrolatum (petroleum), carbon-treated pétrolatum (pétrole), traité au charbon
97952-68-6 Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite composés de l'ion ammonium quaternaire, benzyl bis(alkyl de suif hydrogéné)méthyles, sels avec la montmorillonite
99542-23-1 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[[(9Z,12Z)-1-oxo-9,12-octadecadienyl]amino]-, ethyl sulfate 1-propanaminium, N-éthyl-N,N-diméthyl-3-[[(9Z,12Z)-1-oxo-9,12-octadécadiényl]amino]-, sulfate d'éthyle
99610-72-7 Phenol, 2-[(2-hydroxyethyl)amino]-4,6-dinitro- Phénol, 2-[(2-hydroxyéthyl)amino]-4,6-dinitro-
99948-86-4 2-[(dihydroxymethylsilyl)oxy]propionic acid acide 2-[(dihydroxyméthylsilyl)oxy]propionique
100418-33-5 Ethanol, 2-[(4-methyl-2-nitrophenyl)amino]- Éthanol, 2-[(4-méthyl-2-nitrophényl)amino]-
100684-33-1 Petrolatum (petroleum), clay-treated pétrolatum (pétrole), traité à la terre
100684-38-6 Residual oils (petroleum), clay-treated solvent-dewaxed huiles résiduelles (pétrole), déparaffinées au solvant et traitées à la terre
100684-49-9 Slack wax (petroleum), carbon-treated gatsch (pétrole), traité au charbon
101831-37-2 Benzeneacetonitrile, 2,6-dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)- diclazuril
102868-96-2 Zinc, bis[N-(acetyl-κO)-L-methioninato-κO]-, (T-4)- Zinc, bis[N-(acétyl-κO)-L-méthioninato-κO]-, (T-4)-
103055-07-8 Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro- lufénuron
103622-85-1 3,6,9,12-Tetraoxatriacont-21-en-1-ol 3,6,9,12-tétraoxatriacont-21-én-1-ol
103810-94-2 Methanone, diphenyl-, dihydroxy deriv. Méthanone, diphényl-, dérivés dihydroxy
104226-19-9 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 3-((4-(bis(2-hydroxyéthyl)amino)-2-nitrophényl)amino)-1-propanol
104333-00-8 1,2-Propanediol, 3-[[2-nitro-4-(trifluoromethyl)phenyl]amino]- 1,2-propanediol, 3-[[2-nitro-4-(trifluorométhyl)phényl]amino]-
104365-75-5 2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol Acide 2-propénoïque, homopolymère, ester avec le 1,2,3-propanetriol
105859-93-6 Propanoic acid, 2,2-dimethyl-, tridecyl ester 2,2-diméthylpropanoate de tridécyle
105883-51-0 Copper, bis[N-(acetyl-κO)-L-methioninato-κO]- Cuivre, bis[N-(acétyl-κO)-L-méthioninato-κO]-
105883-52-1 Cobalt, bis[N-(acetyl-κO)-L-methioninato-κO]- Cobalt, bis[N-(acétyl-κO)-L-méthioninato-κO]-
106233-09-4 Poly(oxy-1,2-ethanediyl),α-hydro-ω-hydroxy-,mono-C16-18-alkyl ethers, phosphates Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éthers monoalkyliques en C16-18, phosphates
106392-12-5 Oxirane, 2-methyl-, polymer with oxirane, block Oxirane, 2-méthyl-, polymérisé avec l'oxirane, séquencé
106631-38-3 1-Naphthalenepropanol, α-ethenyldecahydro-α,5,5,8a-tetramethyl-2-methylene- α-Vinyldécahydro-α,5,5,8a-tétraméthyl-2-méthylènenaphtalène-1-propanol
108050-54-0 Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]- Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-α-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]-
108347-90-6 Poly[oxy(methyl-1-,2-ethanediyl)], α-benzoyl-ω-(octadecyloxy)- α-Benzoyl-ω-(octadécyloxy)poly(oxypropylène)
109423-22-5 Benzoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester salicylate de menthyle
109485-61-2 Nonane, 2,2,4,4,6,6,8-heptamethyl- 2,2,4,4,6,6,8-heptaméthylnonane
110332-91-7 Oxirane, methyl-, polymer with oxirane, monoacetate, isohexadecyl ether, block Oxirane, méthyl-, polymérisé avec l'oxirane, monoacétate, éther isohexadécylique, séquencé
113010-52-9 Benzoic acid, 4-amino-, ethyl ester, polymer with oxirane 4-aminobenzoate d'éthyle, polymérisé avec l'oxirane
113089-59-1 Collagens, hydrolyzates, reaction products with 3-chloro-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride Collagènes, hydrolysats, produits de réaction avec le chlorure de 3-chloro-2-hydroxy-N,N,N-triméthyl-1-propanaminium
113221-73-1 2-Naphthalenecarboxaldehyde, 5,6,7,8-tetrahydro-5,5,7,8,8-pentamethyl- 5,5,7,8,8-Pentaméthyl-5,6,7,8-tétrahydronaphtalène-2-carbaldéhyde
113431-54-2 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, triisooctadecyl ester 2-hydroxy-1,2,3-propanetricarboxylate de triisooctadécyle
113507-06-5 Milbemycin B, 5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)- Moxidectine
115340-78-8 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-apricot-oil acyl derivs., Et sulfates 1-propanaminium, 3-amino-N-éthyl-N,N-diméthyl-, dérivés N-acylés d'huile d'abricot, sulfates d'éthyle
117704-25-3 Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)- Doramectine
119691-49-5 1-Eicosanol, 2-tetradecyl- 2-Tétradécylicosan-1-ol
119831-19-5 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), dioctadecanoate Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), dioctadécanoate
120066-54-8 Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]- Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tétraazacyclododécane-1,4,7-triacétato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-
121546-77-8 Alcohols, C12-15 ethoxylate, sulfonate, sodium salt Alcools, éthoxylate en C12-15, sulfonate, sel sodique
121684-92-2 α-D-Glucopyranoside, β-D-fructofuranosyl, acetate dioctadecanoate α-D-glucopyranoside, bêta-D-fructofuranosyl-, acétate, dioctadécanoate
121734-19-8 1,3-Benzenediamine, 4-methoxy-, sulfate 1,3-benzènediamine, 4-méthoxy-, sulfate
121888-66-2 Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, benzoate lauryl sulfate, salts with bentonite Composés d'ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, benzoate sulfate de lauryle, sels avec le bentonite
121888-67-3 Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite Composés d'ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, sel de bis(alkyle de suif hydrogéné)diméthylammonium avec l'hectorite
121888-68-4 Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, stearates, salts with bentonite Composés d'ammonium quaternaires, benzyl(alkyle de suif hydrogéné) diméthyle, stéarates, sels avec le bentonite
123776-56-7 1-Propanaminium, 3-(acetylamino)-N,N,N-trimethyl-, chloride (1:1) 1-propanaminium, 3-(acétylamino)-N,N,N-triméthyl-, chlorure (1:1)
123997-26-2 Avermectin B1, 4"-(acetylamino)-4"-deoxy-, (4"R)- Eprinomectine
124046-05-5 Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., chlorides Benzèneméthanaminium, N-(3-aminopropyl)-N,N-diméthyl-, dérivés N-acylés d'huile de babassu, chlorures
124046-40-8 Amides, wheat germ-oil, N-[3-(dimethylamino)propyl], lactates Amides, huile de germe de blé, N-[3-(diméthylamino)propyl]-, lactates
125109-85-5 Benzenepropanal, β-methyl-3-(1-methylethyl)- β-Méthyl-3-isopropylbenzènepropanal
125804-04-8 Docosanoic acid, compd. with N-[3-(dimethylamino)propyl]docosanamide (1:1) Acide docosanoïque, composé avec le N-[3-(diméthylamino)propyl]docosanamide (1:1)
125804-08-2 Docosanoic acid, 2-octyldodecyl ester Docosanoate de 2-octyldodécyle
125804-10-6 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1) Acide (9Z,12Z)-9,12-octadécadiénoïque, dimère, composé avec le (9Z,12Z)-N-[3-(diméthylamino)propyl]-9,12-octadécadiénamide (1:1)
126121-35-5 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(2-octyldodecyl) 3-(2-octyl-7-pentylheptyl) ester 2-hydroxy-1,2,3-propanetricarboxylate de 1,2-bis(2-octyldodécyle) et de 3-(2-octyl-7-pentylheptyle)
126506-93-2 1,3,2-Dioxastibolane-4,5-dicarboxylic acid, 2-hydroxy-, 2-oxide Acide 2-hydroxy-1,3,2-dioxastibolane-4,5-dicarboxylique, 2-oxyde
126595-07-1 Propanoic acid, 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bis-, homopolymer Acide 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bispropanoïque, homopolymère
127061-56-7 L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-YL hydrogen phosphate], potassium salt (1:1) Acide L-ascorbique, 2-[(2R)-3,4-dihydro-2,5,7,8-tétraméthyl-2-[(4R,8R)-4,8,12-triméthyltridécyl]-2H-1-benzopyran-6-ylhydrogénophosphate], sel de potassium (1:1)
127311-98-2 1-Propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecenyl]amino]-N,N,N-trimethyl-, chloride 1-propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadécènyl]amino]-N,N,N-triméthyl-, chlorure
128729-28-2 1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]-2-propanol, tetrahydrochloride 2-propanol, 1,3-bis[(4-aminophényl)(2-hydroxyéthyl)amino]-, chlorhydrate (1:4)
128973-71-7 Siloxanes and Silicones, a-D-mannopyranuronoyloxy Me, hydroxy-terminated Siloxanes et silicones, a-D-mannopyranuronoyloxyméthyl-, à terminaison hydroxy
128973-73-9 Siloxanes and Silicones, Me[1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy, hydroxy-terminated Siloxanes et silicones, méthyl[1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy-, à terminaison hydroxy
128973-74-0 Siloxanes and Silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy] Me, hydroxyl-terminated Siloxanes et silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy]méthyl-, à terminaison hydroxyle
129496-10-2 Milbemycin, oxime Milbemycin, oxime
129541-40-8 Tetradecanamide, N-[3-(dimethylamino)propyl]-, phosphate (1:1) Tétradécanamide, N-[3-(diméthylamino)propyl]-, phosphate (1:1)
129757-76-2 2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol Oxépan-2-one polymérisée avec le 1,6-diisocyanate d'hexane et le propylidynetriméthanol
130291-58-6 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, homopolymer, compd. with bromomethane 2-méthyl-2-propénoate de 2-(diméthylamino)éthyle, homopolymère, composé avec le bromométhane
130353-64-9 Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-ethers with cellulose 2-hydroxyethyl ether, chlorides Composés d'ammonium quaternaire, cocoalkyl(2,3-dihydroxypropyl)diméthyl, 3-éthers avec l'éther 2-hydroxyéthylique de cellulose, chlorures
130381-02-1 Protein hydrolyzates, soya, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides Hydrolysats de protéines, soja, [3-(dodécyldiméthylammonio)-2-hydroxypropyl]-, chlorures
130381-04-3 Protein hydrolyzates, wheat germ, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides Hydrolysats de protéines, germe de blé, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures
130381-05-4 Protein hydrolyzates, wheat germ, [3-(dimethyloctadecylammonio)-2-hydroxypropyl], chlorides Hydrolysats de protéines, germe de blé, [3-(diméthyloctadécylammonio)-2-hydroxypropyl], chlorures
131044-77-4 Copper, N-acetyl-L-tyrosine hydroxy-terminated (S)-[2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropoxy] Me siloxanes Cuivre, complexes de N-acétyl-L-tyrosine et de (S)-[2-(acétylamino)-3-(4-hydroxyphényl)-1-oxopropoxy]méthylsiloxanes à terminaison hydroxy
131044-78-5 Copper, hydroxy-terminated Me (S)-[[(5-oxo-2-pyrrolidinyl) carbonyl]oxy] siloxanes 5-oxo-L-proline complexes Cuivre, complexes de (S)-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]méthylsiloxanes et de 5-oxo-L-proline
131216-83-6 Siloxanes and Silicones, 2-(acetylamino)-4-(methylthio)-1-oxobutyoxy Me, hydroxy-terminated Siloxanes et silicones, 2-(acétylamino)-4-(méthylthio)-1-oxobutyoxyméthyl-, à terminaison hydroxy
131410-48-5 Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]- Gadodiamide
131812-48-1 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- 2,4-Diméthyl-2-(5,6,7,8-tétrahydro-3,5,5,6,8,8-hexaméthylnapht-2-yl)-1,3-dioxolane
131812-49-2 Naphthalene, 7-(diethoxymethyl)-1,2,3,4-tetrahydro-1,1,2,4,4-pentamethyl- 7-(Diéthoxyméthyl)-1,2,3,4-tétrahydro-1,1,2,4,4-pentaméthylnaphtalène
131812-51-6 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, cis- 1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis-
131812-52-7 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, trans- 1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis-
131812-67-4 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)- 2,4-Diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tetraméthyl-2-naphtyl)-1,3-dioxolane
131954-48-8 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 1-ethenyl-2-pyrrolidinone 1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec la 1-éthényl-2-pyrrolidinone
132467-76-6 1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride 1-Octadécanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-diméthyl-4-oxobutoxy]propyl]-N,N-diméthyl-, chlorure
133934-09-5 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts 1-propanaminium, 3-amino-N-(carboxyméthyl)-N,N-diméthyl-, dérivés N-acylés d'huile de blé, sels internes
134112-42-8 1-Propanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-,chloride 1-propanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-3-[(1-oxoisooctadécyl)amino]-, chlorure
134375-99-8 Aluminum Zirconium Trichlorohydrex Glycine Aluminum zirconium trichlorohydrex glycine
135326-54-4 Propanol, (tetradecyloxy)-, acetate Propanol, (tétradécyloxy)-, acétate
136207-49-3 3,6,9,12,15-Pentaoxaheptatriacontan-1-ol 3,6,9,12,15-pentaoxaheptatriacontan-1-ol
136504-87-5 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-,N-soya acyl derivs., inner salts 3-Amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, dérivés N-(acyl de soya), sels internes
136505-01-6 2-Propenenitrile, homopolymer, hydrolyzed, block, reaction products with N,N-dimethyl-1,3-propanediamine 2-propènenitrile, homopolymère, hydrolysé, séquencé, produits de réaction avec la N,N-diméthyl-1,3-propanediamine
136920-08-6 1-Propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-dimethyl-, N-coco acyl derivs., chlorides 1-propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-diméthyl-, dérivés N-cocoacylés, chlorures
137044-11-2 1-Propanaminium, 3-[2-(acetylamino)ethoxy]-N,N,N-trimethyl-, chloride 1-propanaminium, 3-[2-(acétylamino)éthoxy]-N,N,N-triméthyl-, chlorure
137330-13-3 Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-, phosphate (1:1) (salt) Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-a-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]-, phosphate (1:1) (sel)
139096-04-1 Indate(2-)-111In, [N,N-bis[2 [bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, disodium Indate(2-)-111In, [N,N-bis[2 [bis(carboxyméthyl)amino]éthyl]glycinato(5-)]-, disodique
139247-28-2 Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-hydroxy-, benzoate Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris(oméga-hydroxy)-, benzoate
142104-11-8 2-Butenedioic acid (2E)-, di-C12-15-alkyl esters (2E)-2-butènedioate de dialkyles en C12-15
142164-39-4 Nickel carbonate hydroxide Hydroxyde de carbonate de nickel
142657-60-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[[(3-coco amidopropyl)dimethylammonio]acetate], chlorides Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[[(3-cocoamidopropyl)diméthylammonio]acétate] de polyéthylèneglycol, chlorures
142891-20-1 2-Propenoic acid, 2-chloro-3-[2-chloro-5-(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-, ethyl ester, (2Z)- cinidon-éthyl
144377-73-1 4,6-Dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dien-1-aminium, 5-[3-[dimethyl[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tetramethyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]-, 5-oxide, chloride (1:3), (23Z,26Z)- 4,6-dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dién-1-aminium, 5-[3-[diméthyl[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tétraméthyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl]
144610-93-5 Propanoic acid, 2,2-dimethyl-, tetradecyl ester 2,2-diméthylpropanoate de tétradécyle
145269-34-7 Hydrolyzed wheat protein hydroxypropyltriammonium Hydroxypropyltriammonium de protéines de blé hydrolysées
146192-98-5 2-Butenedioic acid (2Z)-, monobutyl ester, polymer with ethenyl acetate and 1,7,7-trimethylphenylbicyclo[2.2.1]hept-2-yl 2-propenoate (2Z)-2-butènedioate de monobutyle, polymérisé avec l'acétate d'éthényle et le 2-propénoate de 1,7,7-triméthylphénylbicyclo[2.2.1]hept-2-yle
146632-08-8 Siloxanes and Silicones, di-Me, Bu group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate and iso-Bu methacrylate Siloxanes et silicones, diméthyl-, à terminaison butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec l'acrylate de 2-[[(heptadécafluorooctyl)sulfonyl]méthylamino]éthyl et le méthacrylate d'isobutyle
147398-77-4 Ethanaminium, N-(carboxymethyl)-N,N-dimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, inner salt, polymer with methyl 2-methyl-2-propenoate Éthanaminium, N-(carboxyméthyl)-N,N-diméthyl-2-[(2-méthyl-1-oxo-2-propén-1-yl)oxy]-, sel interne, polymérisé avec le 2-méthyl-2-propénoate de méthyle
147550-61-6 Copper carbonate hydroxide Hydroxyde de carbonate de cuivre
148506-50-7 Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)]
148812-63-9 Protein hydrolyzates, wheat, reaction products with palmitoyl chloride Hydrolysats de protéines, blé, produits de réaction avec le chlorure de palmitoyle
150599-70-5 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenyl-2-pyrrolidinone Méthylsulfate de 1-vinyl-3-méthyl-1H-imidazolium polymérisé avec la 1-vinylpyrrolid-2-one
155601-30-2 1H-Pyrazole-1-ethanol,4,5-diamino-, sulfate (1:1) 1H-Pyrazole-1-éthanol, 4,5-diamino-, sulfate (1:1)
155683-77-5 Oxirane, 2-methyl-, polymer with oxirane, monoisodecyl ether Oxirane, 2-méthyl-, polymérisé avec l'oxirane, éther monoisodécylique
155715-93-8 Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1 propanaminium chloride-quaternized Gélatines, polymérisées avec les hydrolysats de kératine et la L-lysine, chlorure d'hydroxy-N,N,N-triméthyl-1 propanaminium quaternisé
156028-14-7 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt, sodium salt (1:1) 1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, sel interne, sel sodique (1:1)
156679-41-3 N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammonium tosylate Tosylate de N-dodécyl-[3-(4-diméthylamino)benzamido)propyl]diméthylammonium
156715-43-4 Protein hydrolyzates, soya, [3-(cocoalklydimethylammonio)-2-hydroxypropyl], chlorides Hydrolysats de protéines, soja, [3-(cocoalklydiméthylammonio)-2-hydroxypropyl]-, chlorures
156798-09-3 Keratins, hydrolyzates, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides Kératines, hydrolysats, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures
156798-11-7 Protein hydrolyzates, wheat, [2-hydroxy-3-(trimethylammonio)propyl] chlorides Hydrolysats de protéines, blé, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures
157009-77-3 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester (9Z,12Z)-9,12-octadécadiénoate de diisoeicosyle, dimère
158483-23-9 Poly(oxy-1,2-ethanediyl),α,α′,α"-1,2,3-propanetriyltris[ω-hydroxy-,2-hydroxypropanoate Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris[oméga-hydroxy-,2-hydroxypropanoate
158765-79-8 Micrococcus luteus, lysate Micrococcus luteus, lysat
159317-32-5 Acetic acid, hydroxy-, isooctadecyl ester Hydroxyacétate d'isooctadécyle
162030-43-5 Mannopyranuronic acid, 1-O-[hydroxymethyl [[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy]silyl]- Acide mannopyranuronique, 1-O-[hydroxyméthyl [[(1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy]silyl]-
162353-59-5 Quaternary ammonium compounds, (C10-20 and C10-20-unsatd. alkyl) (3-chloro-2-ydroxypropyl) dimethyl, chlorides, reaction products with silk protein hydrolyzates Composés d'ammonium quaternaire, (alkyles en C10-20 et alkyles insaturés en C10-20) (3-chloro-2-hydroxypropyl)diméthyl, chlorures, produits de réaction avec des hydrolysats de protéines de soie
162888-05-3 Octadecanoic acid, 12-hydroxy-, 16-methylheptadecyl ester 12-hydroxy-octadécanoate de 16-méthylheptadécyle
164288-56-6 1-Propanaminium, 3-amino-N-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-N,N-dimethyl-, N-C12-18 acyl derivs., chlorides 1-propanaminium, 3-amino-N-[2-[(2-hydroxyéthyl)amino]-2-oxoéthyl]-N,N-diméthyl-, dérivés N-acylés en C12-18, chlorures
165745-27-7 Carbamic acid, N-butyl-, 3-iodo-2-propyn-1-yl ester, mixt. with N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxymethyl)urea N-butylcarbamate de 3-iodo-2-propyn-1-yle, mélange avec la N-[1,3-bis(hydroxyméthyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxyméthyl)urée
168677-75-6 Poly(oxy-1,2-ethanediyl), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadecadien-1-yliminio]di-2,1-ethanediyl]bis[ω-hydroxy-, chloride (1:1) Poly(oxy-1,2-éthanediyle), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadécadién-1-yliminio]di-2,1-éthanediyl]bis(oméga-hydroxy)-, chlorure (1:1)
169590-61-8 Protein hydrolyzates, silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides Hydrolysats de protéines, soie, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures
172376-82-8 6,10-Dodecadienal, 3,7,11-trimethyl-, (6Z)- 6,10-Dodécadiénal, 3,7,11-triméthyl-, (6Z)-
173010-79-2 Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts Sels de sodium, chlorures, 3-phosphates (esters) de composés coco alkyl(2,3-dihydroxypropyl)diméthyl ammonium quaternaire
173763-15-0 Aluminum Sesquichlorohydrate sesquichlorohydrate d'aluminium
174761-16-1 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone 1H-imidazolium, 1-éthényl-3-méthyl-, sulfate de méthyle (1:1), polymérisé avec la 1-éthénylhexahydro-2H-azépin-2-one et la 1-éthényl-2-pyrrolidinone
175357-18-3 L-Phenylalanine, N-(1-oxo-10-undecen-1-yl)- L-phénylalanine, N-(1-oxo-10-undécén-1-yl)-
175893-70-6 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, diesters with caroboxymethyl wheat protein hydrolyzates Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, diesters avec des hydrolysats de protéines de blé carbométhylés
175893-71-7 2-Propenamide, N-[3-(dimethylamino)propyl]-2-methyl-, polymer with 1-ethenyl-2-pyrrolidinone, sulfate N-[3-(diméthylamino)propyl]-2-méthylpropèn-2-amide, polymérisée avec la 1-vinyl-2-pyrrolidinone, sulfate
177080-35-2 Phenol, 4-[(3-hydroxypropyl)amino]-2-nitro- Phénol, 4-[(3-hydroxypropyl)amino]-2-nitro-
177190-98-6 1-Propanaminium, N,N,N-trimethyl-3-[(1-oxo-3-phenyl-2-propen-1-yl)amino]-,chloride (1:1) 1-propanaminium, N,N,N-triméthyl-3-[(1-oxo-3-phényl-2-propén-1-yl)amino]-, chlorure (1:1)
179005-04-0 Siloxanes and Silicones, 3-[4-[[[3-[(2,3-dihydroxypropyl)dimethylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl Me, di-Me, 3-[3-[[3-(C8-22-acylamino)propyl]dimethylammonio]-2-hydroxypropyl phosphates], chlorides, sodium salts Siloxanes et silicones, méthyl-3-[4-[[[3-[(2,3-dihydroxypropyl)diméthylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl, diméthyl-, 3-[3-[[3-(C8-22-acylamino)propyl]diméthylammonio]-2-hydroxypropyl phosphates], sels de chlorures et de sodium
182700-78-3 Siloxanes and Silicones, 3-[(3-aminopropyl)amino]propyl Me, di-Me, 3-hydroxypropyl Me, ethoxylated, [(hydroxydimethylsilyl)oxy]-terminated Siloxanes et silicones, 3-[(3-aminopropyl)amino]propylméthyl-, diméthyl, 3-hydroxypropylméthyl-, éthoxylés, à terminaison [(hydroxydiméthylsilyl)oxy]
183476-82-6 L-Ascorbic acid, 2,3,5,6-tetrakis(2-hexyldecanoate) Acide 2,3,5,6-tétrakis(2-hexyldécanoate)-L-ascorbique
185018-43-3 L-Ascorbic acid, 2-[(3β)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt Acide L-ascorbique, 2-[hydrogénophosphate de (3bêta)-cholest-5-én-3-yle], sel monosodique
185429-83-8 Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethyl-2-naphthalenyl)-, cis- Éthanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tétraméthyl-2-naphthalényl)-, cis-
187175-42-4 Silsesquioxanes, Me, hydroxy-terminated, alginate, compds. with caffeine Silsesquioxanes, méthylés, à terminaison hydroxy, alginate, composés avec la caféine
187991-39-5 L-ascorbic acid, 6-O-(dihydroxymethylsilyl)- Acide L-ascorbique, 6-O-(dihydroxyméthylsilyl)-
190270-74-7 L-Lysine dihydroxymethylsilyl ester L-lysinate de dihydroxyméthylsilyle
193888-44-7 1-Propanaminium, N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-3-(phosphonooxy)-, inner salt, monosodium salt 1-propanaminium, N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-N-[2-[(1-oxododécyl)amino]éthyl]-3-(phosphonooxy)-, sel interne, sel monosodique
193892-43-2 Poly[oxy(dimethylsilylene)], α-docosyl-ω-(docosyloxy)- Poly[oxy(diméthylsilylène)], α-docosyl-oméga-(docosyloxy)-
197969-51-0 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with methyl 2-propenoate and 2-propenoic acid 1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec le 2-propénoate de méthyle et l'acide 2-propénoïque
198404-98-7 Cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-yl)methyl]- 1-méthyl-2-[(1,2,2-triméthylbicyclo[3.1.0]hex-3-yl)méthyl]cyclopropaneméthanol
205537-77-5 Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy-, mixt. with dimethicone Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy-, mélange avec la diméthicone
208126-52-7 Resin acids and Rosin acids, mixed esters with dipentaerythritol and 12-hydroxyoctadecanoic acid and stearic acid Acides résiniques et colophaniques, esters mixtes avec le dipentaérythritol, l'acide 12-hydroxyoctadécanoïque et l'acide stéarique
208126-56-1 Octadecanoic acid, 12-hydroxy-, mixed esters with dipentaerythritol and isostearic acid Acide 12-hydroxyoctadécanoïque, esters mixtes avec le dipentaérythritol et l'acide isostéarique
213127-10-7 2-Propen-1-aminium,N,N-dimethyl-N-2propenyl-, chloride, polymer with 2-propenoic acid AND partially neutralized sodium salt 2-propèn-1-aminium, N,N-diméthyl-N-2-propényl-, chlorure, polymérisé avec l'acide 2-propénoïque, sel sodique
214047-00-4 L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl- L-sérine, N2-(1-oxohexadécyl)-L-lysyl-L-thréonyl-L-thréonyl-L-lysyl-
220119-17-5 Avermectin A1a, 25-cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)- Avermectine A1a, 25-cyclohexyl-4′-O-dé(2,6-didésoxy-3-O-méthyl-α-L-arabino-hexopyranosyl)-5-déméthoxy-25-dé(1-méthylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)-
220714-63-6 Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[3-(dimethyloctadecylammonio)-2-hydroxypropyl hydrogen phosphate], inner salts Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[3-(diméthyloctadécylammonio)-2hydroxypropylhydrogénophosphate] de polyéthylèneglycol, sels internes
220828-91-1 1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, chloride (1:1) 1-propanaminium, N-(2-hydroxyéthyl)-N,N-diméthyl-3-[(1-oxodocosyl)amino]-, chlorure (1:1)
222400-35-3 Protein hydrolyzates, wheat, isostearoyl, compds. with 2-amino-2-methyl-1-propanol Hydrolysats de protéines, blé, isostéaroyl-, composés avec le 2-amino-2-méthyl-1-propanol
223717-75-7 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), tri-(9Z)-9-octadecenoate Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), tri-(9Z)-9-octadécénoate
224948-78-1 Poly(oxy-1,2-ethanediyl),α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-,N,N′-di-C14-18 acyl derivs., Me sulfates (salts) Poly(oxy-1,2-éthanediyle), α-[2-[bis(2-aminoéthyl)méthylammonio]éthyl]-oméga-hydroxy-, dérivés N,N′-diacylés en C14-18, sulfates de méthyle (sels)
227200-22-8 L-Ascorbic acid, reaction products with methylsilanetriol and pectin Acide L-ascorbique, produits de réaction avec le méthylsilanetriol et la pectine
227605-22-3 Lithium magnesium sodium oxide silicate (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28) Silicate d'oxyde de lithium, de magnésium et de sodium (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28)
243133-67-7 Poly(oxy-1,2-ethanediyl), α-(2-hydroxytetradecyl)-ω-hydroxy-,ω-C16-18-alkyl ethers Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18
243137-53-3 Siloxanes and Silicones, di-Me, polymers with mono[(ethenyldimethylsilyl)oxy]-terminated di-Me siloxanes Siloxanes et silicones, diméthyl-, polymérisés avec des diméthylsiloxanes à terminaison mono[(éthényldiméthylsilyl)oxy]
245443-07-6 L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl 2-octyldodecyl esters Mélange de N-(1-oxododécyl)-L-glutamate de (3β)-cholest-5-én-3-yle et de 2-octyldodécyle
246864-39-1 Decanoic acid, 1,2,3-propanetriyl ester, reaction products with polyethylene glycol and 1,2,3-propanetriyl trioctanoate Décanoate de 1,2,3-propanetriyle, produits de réaction avec le polyéthylèneglycol et le trioctanoate de 1,2,3-propanetriyle
261713-82-0 Poly(oxy-1,2ethanedily),α(2-hydoxypropyl)-w-[1-methyl-2-[(1-oxododecyl)oxy]ethoxy]ethoxy-(9Cl) Poly(oxy-1,2-éthanediyle), alpha-(2-hydroxypropyl)-oméga-[1-méthyl-2-[1-méthyl-2-[(1-oxododécyl)oxy]éthoxy]éthoxy]-
288839-50-9 1-Octadecanaminium, N,N-dimethyl-N-octyl-, methyl sulfate (1:1) 1-octadécanaminium, N,N-diméthyl-N-octyl-, sulfate de méthyle (1:1)
305812-16-2 Poly(oxy-1,2-ethanediyl),α,α′., α".-1,2,3-propanetriyltris [ω-methoxy- Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris(oméga-méthoxy)-
308067-11-0 Glycerides, C8-10 mono-, di- and tri-, ethoxylated Glycérides, C8-10, mono-, di- et tri-, éthoxylés
308068-34-0 Glycerides, C16-18 mono-, ethoxylated Glycérides, C16-18, mono-, éthoxylés
308068-94-2 Imidazolium compounds, 2-C12-14-alkyl-1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-, inner salts Composés d′imidazolium, 2-alkyles en C12-14-1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-, sels internes
308068-97-5 Onium compounds, isoquinolinium, C12-18-alkyl, bromides Composés d'onium, isoquinolinium, alkyles en C12-18, bromures
308074-11-5 Protein hydrolyzates, compds. with (Z)-N-[3-(dimethylamino)propyl]-9-octadecenamide Hydrolysats de protéines, composés avec le (Z)-N-[3-(diméthylamino)propyl]-9-octadécénamide
321735-39-1 Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d'isobutyle
321735-42-6 Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate and 2,2,2-trifluoroethyl methacrylate Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d'isobutyle et le méthacrylate de 2,2,2-trifluoroéthyle
329925-33-9 Oxacyclopentadec-10-en-2-one, 13-methyl- 13-Méthyloxacyclopentadéc-10-èn-2-one
345648-01-3 1-Propanaminium N- (3-aminopropyl) -2,3-dihydroxy-N,N-dimethyl-,N-limnanthes alba seed-oil acyl derivs., chlorides Minéraux du groupe des micas
348120-88-7 Hexanoic acid, 3,5,5 -trimethyl-, octadecyl ester 3,5,5 –triméthylhexanoate d'octadécyle
350708-35-9 Aspartic acid, compd. with α-methylbenzeneethanamine (1:1) Acide aspartique, composé avec l'α-méthylbenzèneéthanamine (1:1)
350708-40-6 D-Glucaric acid, compd. with (αS)-α-methylbenzeneethanamine (1:2) Acide D-glucarique, composé avec l'(αS)-α-méthylbenzèneéthanamine (1:2)
361459-38-3 Glycerides, mixed decanoyl and octanoyl mono-, di- and tri-, ethoxylated Mélange de mono-, di- et tri- décanoyl et octanoylglycérides, éthoxylés
480995-77-5 2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate, hexadecyleicosyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate Acide 2-méthyl-2-propénoïque, polymérisé avec le 2-propénoate de butyle, le 2-méthyl-2-propénoate d'hexadécylicosyle et le 2-méthyl-2-propénoate de méthyle
642072-46-6 Ethanol, 2,2′-iminobis-,compd. with α-sulfo-ω-(tetradecyloxy)poly(oxy-1,2-ethanediyl) Éthanol, 2,2′-iminobis-, composé avec l'α-sulfo-oméga-(tétradécyloxy)poly(oxy-1,2-éthanediyle)
756819-45-1 Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated, polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate Polydiméthylsiloxanes à terminaisons mono[3-[(2-méthylprop-2-énoyl)oxy]propyles, polymérisés avec du méthacrylate de butyle, de l'acrylate de 2-éthylhexyle et du méthacrylate de méthyle
827596-80-5 Octadecanoic acid, 12-hydroxy-, polymer with oxirane, triblock Acide 12-hydroxyoctadécanoïque, polymérisé avec l'oxirane, à trois blocs
869734-19-0 acids, Cannabis sativa seed-oil, esters with polyethylene glycol ether with glycerol (3:1) Acides, huile de Cannabis sativa, esters avec l'éther de polyéthylèneglycol avec le glycérol (3:1)
915223-67-5 Siloxanes and Silicones, di-Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl, Me stearyl Siloxanes et silicones, diméthyl-, méthyl-3,3,4,4,5,5,6,6,6-nonafluorohexyl-, méthyl-stéaryl-
958873-87-5 ethanaminium, 2-amino-N-(2-aminoethyl)-N-[2-(2-hydroxyethoxy)ethyl]-N-methyl-, N,N′-di-limnanthes alba seed-oil acyl derivs., Me sulfates (salts) Éthanaminium, 2-amino-N-(2-aminoéthyl)-N-[2-(2-hydroxyéthoxy)éthyl]-N-méthyl-, dérivés N,N′-diacylés d'huile de graines de Limnanthes alba, sulfates de méthyle (sels)
1007304-55-3 Poly(oxy-1,2-ethanediyl), ω′-hydroxy-ω-[(1- oxoisooctadecyl)oxy]-ω″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]- α,α′,α″-1,2,3-propanediyltris- Poly(oxy-1,2-éthanediyle), oméga′-hydroxy-oméga-[(1-oxoisooctadécyl)oxy]-oméga″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]-α,α′,α″-1,2,3-propanediyltris-
1034015-50-3 Polysaccharides, sugarcane, 3-(dimethyloctadecylammonio)-2-hydroxypropyl ethers, chlorides Polysaccharides, canne à sucre, éthers 3-(diméthyloctadécylammonio)-2-hydroxypropyliques, chlorures
1072005-10-7 Decanoic acid, mixed diesters with octanoic acid and 1,3-propanediol Acide décanedioïque, diesters mixtes avec l'acide octanoïque et le 1,3-propanediol
1384982-80-2 Quaternary Ammonium Compounds, dimethylbis (mixed C12-15-alkyl and cetyl and stearyl), chlorides Composés d'ammonium quaternaire, diméthylbis(mélange d'alkyles en C12-15, de cétyle et de stéaryle), chlorures
1429320-75-1 Butanedioic acid, 2-sulfo-, 1(or 4)-C10-16-alkyl esters, disodium salts 2-sulfobutanedioate de 1(ou 4)-alkyles en C10-16, sels disodiques

SCHEDULE 2

Persons required to provide information

  1. This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice.
  2. This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 4 of Schedule 1 to this notice that is a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act or is intended to be a component in such products.
  3. This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice, whether the substance is
    • (a) alone;
    • (b) at a concentration equal to or above 0.1% by weight (w/w%) in a mixture or in a product; or
    • (c) listed in Part 3 of Schedule 1 and at a concentration equal to or above 0.1% by weight (w/w%) in a manufactured item that is
      • (i) intended to be used by or for children under the age of six years,
      • (ii) intended to come into contact with the mucosa of an individual, other than eyes,
      • (iii) cookware, or a cooking or serving utensil that is intended to come into direct contact with heated food within a residence, unless the component that comes into direct contact with heated food is made of glass, stainless steel or porcelain,
      • (iv) food packaging that is intended to come into direct contact with food, unless the component that comes into direct contact with food is made of glass, stainless steel or porcelain,
      • (v) a reusable food or beverage container, unless the component that comes into direct contact with food or beverage is made of glass, stainless steel or porcelain,
      • (vi) intended to release the substance during conditions of use such that the substance may be inhaled or come into dermal contact with an individual,
      • (vii) clothing or footwear,
      • (viii) bedding, a sleeping bag or a towel,
      • (ix) furniture, a mattress, a cushion or a pillow intended to be used in a residence, where the substance is contained in foam or leather or in a textile fibre, yarn or fabric, or
      • (x) carpet, vinyl or laminate flooring, or foam underlay for flooring, intended to be used in a residence.
  4. This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance, listed in Part 4 of Schedule 1 to this notice, that is, is contained in, or is intended to be a component in, a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act.
  5. Any person for whom the criteria set out in Schedule 2 have been met for both the 2014 and 2015 calendar years shall provide information prescribed in sections 6 to 10 of Schedule 3 to this notice for the 2015 calendar year only.
  6. This notice does not apply to a substance listed in Schedule 1, whether alone, in a mixture, in a product, or in a manufactured item, that
    • (a) is in transit through Canada;
    • (b) is Tin fluoride (CAS RN 7783-47-3) contained in dental care products or mixtures;
    • (c) is, or is contained in, a hazardous waste or hazardous recyclable material within the meaning of the Export and Import of Hazardous Waste and Hazardous Recyclable Material Regulations and was imported pursuant to a permit issued under these Regulations;
    • (d) is, or is contained in, a pest control product registered under the Pest Control Products Act;
    • (e) is, or is contained in, a fertilizer or supplement registered under the Fertilizers Act;
    • (f) is, or is contained in, a feed registered under the Feeds Act; or
    • (g) is mixed with, or attached to, a seed registered under the Seeds Act.
  7. If a person provided information under the New Substances Notification Regulations, for a substance listed in Part 4 of Schedule 1, a response from that person is not required under this notice for that substance.
  8. Any person to whom this notice applies who
    • (a) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 1 or Part 3, shall provide the information requested in sections 4, 5, 6, 7, and 8 of Schedule 3;
    • (b) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 2, shall provide the information requested in sections 4, 5, 6, 7, 8 and 9 of Schedule 3;
    • (c) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 4, shall provide the information requested in sections 4, 5, 7, and 8 of Schedule 3;
    • (d) imported a substance listed in Part 3 or Part 4 in a manufactured item shall provide the information requested in sections 4, 5, and 10 of Schedule 3.

SCHEDULE 3

Information required

10. (1) For each substance listed in Part 3 or Part 4 of Schedule 1 that a person imported in a manufactured item during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:

10. (2) Where code C105, C108 or C999 is provided for paragraph (1)(c), a written description of the manufactured item containing the substance must be provided.

11. For the purpose of section 8, the following are the substance function codes and their corresponding descriptions:
Substance function codes Title Description
U001 Abrasives Substances used to wear down or polish surfaces by rubbing against the surface.
U002 Adhesives and sealant substances Substances used to promote bonding between other substances, promote adhesion of surfaces, or prevent seepage of moisture or air.
U003 Adsorbents and absorbents Substances used to retain other substances by accumulation on their surface or by assimilation.
U004 Agricultural substances (non-pesticidal) Substances used to increase the productivity and quality of farm crops.
U005 Anti-adhesive agents Substances used to prevent bonding between other substances by discouraging surface attachment.
U006 Bleaching agents Substances used to lighten or whiten a substrate through chemical reaction, usually an oxidative process which degrades the colour system.
U007 Corrosion inhibitors and anti-scaling agents Substances used to prevent or retard corrosion or the formation of scale.
U008 Dyes Substances used to impart colour to other materials or mixtures by penetrating into the surface of the substrate.
U009 Fillers Substances used to provide bulk, increase strength, increase hardness, or improve resistance to impact.
U010 Finishing agents Substances used to impart such functions as softening, static-proofing, wrinkle resistance, and water repellence.
U011 Flame retardants Substances used on the surface of or incorporated into combustible materials to reduce or eliminate their tendency to ignite when exposed to heat or a flame.
U012 Fuels and fuel additives Substances used to create mechanical or thermal energy through chemical reactions, or which are added to a fuel for the purpose of controlling the rate of reaction or limiting the production of undesirable combustion products, or which provide other benefits such as corrosion inhibition, lubrication, or detergency.
U013 Functional fluids (closed systems) Liquid or gaseous substances used for one or more operational properties in a closed system. This code does not include fluids used as lubricants.
U014 Functional fluids (open systems) Liquid or gaseous substances used for one or more operational properties in an open system.
U015 Intermediates Substances consumed in a reaction to produce other substances for commercial advantage.
U016 Ion exchange agents Substances that are used to selectively remove targeted ions from a solution. This code also includes aluminosilicate zeolites.
U017 Lubricants and lubricant additives Substances used to reduce friction, heat, or wear between moving parts or adjacent solid surfaces, or that enhance the lubricity of other substances.
U018 Odour agents Substances used to control odours, remove odours, mask odours, or impart odours.
U019 Oxidizing and reducing agents Substances used to alter the valence state of another substance by donating or accepting electrons or by the addition or removal of hydrogen to a substance.
U020 Photosensitive substances Substances used for their ability to alter their physical or chemical structure through absorption of light, resulting in the emission of light, dissociation, discoloration, or other chemical reaction.
U021 Pigments Substances used to impart colour to other materials or mixtures by attaching themselves to the surface of the substrate through binding or adhesion.
U022 Plasticizers Substances used in plastics, cement, concrete, wallboard, clay bodies, or other materials to increase their plasticity or fluidity.
U023 Plating agents and surface treating agents Substances applied to metal, plastic, or other surfaces to alter physical or chemical properties of the surface.
U024 Process regulators Substances used to change the rate of a reaction, start or stop the reaction, or otherwise influence the course of the reaction.
U025 Processing aids, specific to petroleum production Substances added to water, oil, or synthetic drilling muds or other petroleum production fluids to control foaming, corrosion, alkalinity and pH, microbiological growth or hydrate formation, or to improve the operation of processing equipment during the production of oil, gas, and other products or mixtures from beneath the earth's surface.
U026 Processing aids, not otherwise covered in this table Substances used in applications other than the production of oil, gas, or geothermal energy to control foaming, corrosion or alkalinity and pH, or to improve the operation of processing equipment.
U027 Propellants and blowing agents Substances used to dissolve or suspend other substances and either to expel those substances from a container in the form of an aerosol or to impart a cellular structure to plastics, rubber, or thermo set resins.
U028 Solids separation agents Substances used to promote the separation of suspended solids from a liquid.
U029 Solvents (for cleaning or degreasing Substances used to dissolve oils, greases and similar materials from textiles, glassware, metal surfaces, and other articles.
U030 Solvents (which become part of formulation or mixture) Substances used to dissolve another substance to form a uniformly dispersed solution at the molecular level.
U031 Surface active agents Substances used to modify surface tension when dissolved in water or water solutions, or reduce interfacial tension between two liquids or between a liquid and a solid or between liquid and air.
U032 Viscosity adjustors Substances used to alter the viscosity of another substance.
U033 Laboratory substances Substances used in a laboratory for chemical analysis, chemical synthesis, extracting and purifying other chemicals, dissolving other substances, and similar activities.
U034 Paint additives and coating additives not otherwise covered in this table Substances used in a paint or coating formulation to enhance properties such as water repellence, increased gloss, improved fade resistance, ease of application or foam prevention.
U061 Pest control substances Substances used as active ingredients in products, mixtures or manufactured items used for directly or indirectly controlling, destroying, attracting or repelling a pest or for mitigating or preventing its injurious, noxious or troublesome effects.
U062 Active ingredients in health products Substances used as active ingredients in natural health products or prescription or non-prescription drugs.
U063 Flavourants Substances used as non-medicinal ingredients or excipients in foods, natural health products, and drugs that impart a certain flavor to the food, natural health product or drug.
U064 Contaminants Substances naturally present in a reactant or substances that are produced as a result of the manufacturing process and have no beneficial properties in the final product, mixture or manufactured item.
U065 By-products Substances resulting from the manufacturing process that can be partially or completely removed from the intended product, mixture or manufactured item and have commercial value on their own or when added to another product, mixture or manufactured item.
U066 Wastes Substances that are removed from the final product, mixture or manufactured item during the manufacturing process and have no commercial value.
U999 Other (specify) Substances with a function not otherwise described in this table. A written description must be provided when using this code.

12. For the purpose of sections 8 and 10, the following are the consumer and commercial codes and their corresponding descriptions:

Table 1: Furnishings, cleaning, treatment or care
Consumer and commercial codes Title Description
C101 Floor coverings Substances contained in floor coverings. This code does not include wood and pressed wood flooring products included in Building or construction materials — Wood and engineered wood code.
C102 Foam seating and bedding Substances contained in foam mattresses, pillows, cushions, and any seating, furniture and furnishings containing foam.
C103 Furniture and furnishings not otherwise covered in this table Substances contained in furniture and furnishings made from metal, wood, leather, plastic or other materials. This code does not include foam seating and bedding products.
C104 Fabric, textile and leather articles not otherwise covered in this table Substances contained in fabric, textile and leather products to impart color and other desirable properties such as water, soil, stain repellence, wrinkle resistance, or flame resistance.
C105 Cleaning and furnishing care (specify) Substances contained in products, mixtures or manufactured items that are used to remove dirt, grease, stains, and foreign matter from furniture and furnishings, or to cleanse, sanitize, bleach, scour, polish, protect, or improve the appearance of surfaces. A written description must be provided when using this code.
C106 Laundry and dishwashing Substances contained in laundry and dishwashing products, mixtures or manufactured items.
C107 Water treatment Substances contained in water treatment products, mixtures or manufactured items that are designed to disinfect, reduce contaminants or other undesirable constituents, and condition or improve aesthetics of water. Excludes any substance contained in pest control products as defined under the Pest Control Products Act.
C108 Personal care and cosmetics (specify) Substances contained in personal care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair, or teeth. A written description must be provided when using this code.
C109 Air care Substances contained in products, mixtures or manufactured items that are used to odorize or deodorize indoor air in homes, offices, motor vehicles, and other enclosed spaces.
C110 Apparel and footwear care Substances contained in apparel and footwear care products, mixtures or manufactured items that are applied post-market.
C160 Pet care Substances contained in pet care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair or teeth and intended for animal use.
Table 2: Construction, paint, electrical or metal
Consumer and commercial codes Title Description
C201 Adhesives and sealants Substances contained in adhesive or sealant products or mixtures used to fasten other materials together or prevent the passage of liquid or gas.
C202.01 Paints and coatings Substances contained in paints or coatings.
C202.02 Paint thinners and removers Substances contained in paint thinners and removers.
C203 Building or construction materials — Wood and engineered wood Substances contained in building and construction materials made of wood and pressed or engineered wood products, mixtures or manufactured items.
C204 Building or construction materials not otherwise covered in this table Substances contained in building and construction materials not otherwise covered in this table.
C205 Electrical and electronics Substances contained in electrical and electronic products, mixtures or manufactured items.
C206 Metal materials not otherwise covered in this table Substances contained in metal products, mixtures or manufactured items not otherwise covered in this table.
C207 Batteries Substances contained in non-rechargeable and rechargeable batteries including dry and wet cell units that store energy.
Table 3: Packaging, paper, plastic or hobby
Consumer and commercial codes Title Description
C301 Food packaging Substances contained in single or multi-layered packaging consisting of paper, plastic, metal, foil or other materials which have or may have direct contact with food.
C302 Paper products, mixtures or manufactured items Substances contained in paper products, mixtures or manufactured items.
C303.01 Plastic materials not otherwise covered in this table Substances contained plastic products, mixtures or manufactured items not otherwise covered in this table.
C303.02 Rubber materials not otherwise covered in this table Substances contained in rubber products, mixtures or manufactured items not otherwise covered in this table.
C304 Toys, playground and sporting equipment Substances contained in toys, playground, and sporting equipment made of wood, metal, plastic or fabric.
C305 Arts, crafts and hobby materials Substances contained in arts, crafts, and hobby materials.
C306 Ink, toner and colourants Substances contained in ink, toners and colourants used for writing, printing, creating an image on paper; and substances contained in other substrates, or applied to substrates to change their colour or hide images.
C307 Photographic supplies, film and photo-chemicals Substances contained in photographic supplies, film, photo-processing substances, and photographic paper.
Table 4: Automotive, fuel, agriculture or outdoor use
Consumer and commercial codes Title Description
C401 Automotive care Substances contained in products, mixtures or manufactured items used in automotive cleaning and care of exterior and interior vehicle surfaces. This code does not include antifreeze, de-icing products, or lubricants.
C402 Lubricants and greases Substances contained in products, mixtures or manufactured items to reduce friction, heat generation and wear between solid surfaces.
C403 Anti-freeze and de-icing Substances added to fluids to reduce the freezing point of the mixture, or substances applied to surfaces to melt or prevent build-up of ice.
C404 Fuels and related products, mixtures or manufactured items Substances burned to produce heat, light or power, or added to inhibit corrosion, provide lubrication, increase efficiency of use, or decrease production of undesirable by-products.
C405 Explosive materials Substances capable of producing a sudden expansion, usually accompanied by the production of heat and large changes in pressure upon ignition.
C406 Agricultural products, mixtures or manufactured items (non-pesticidal) Substances used to increase the productivity and quality of plants, animals or forestry crops, produced on a commercial scale. Includes animal feed (any substance or mixture of substances for consumption by livestock, providing the nutritional requirements of livestock, or the purpose of preventing or correcting nutritional disorders of livestock, as defined in the Feeds Act and Regulations).
C407 Lawn and garden care Substances contained in lawn, garden, outdoor or potted plant and tree care products, mixtures or manufactured items. Excludes any substance contained in pest control products as defined under the Pest Control Products Act.
C461 Pest control Substances contained in any product, mixture or manufactured item for directly or indirectly controlling, preventing, destroying, mitigating, attracting, or repelling any pest.
C462 Automotive, aircraft and transportation Substances contained in automobiles, aircraft and other types of transportation, or used in their manufacture.
C463 Oil and natural gas extraction Substances that are, or are contained in, any mixtures, products or manufactured items, used for oil and natural gas drilling, extraction and processing.
Table 5: Items for food, health or tobacco
Consumer and commercial codes Title Description
C562 Food and beverage Substances contained in food and beverage products, mixtures or manufactured items.
C563 Drugs Substances contained in prescription and non-prescription drugs intended for humans or animals.
C564 Natural health Substances contained in natural health products, mixtures or manufactured items intended for humans or animals.
C565 Medical devices Substances contained in products, mixtures or manufactured items used for either the diagnosis, treatment, mitigation or prevention of a disease, disorder, or an abnormal physical state; or those used in restoring, correcting or modifying organic functions in humans or animals.
C566 Tobacco products, mixtures or manufactured items Substances contained in products, mixtures or manufactured items composed in whole or in part of tobacco, including tobacco leaves and any extract of tobacco leaves.
Table 6: Products, mixtures or manufactured items not described by other codes
Consumer and commercial codes Title Description
C999 Other (specify) Substances contained in products, mixtures or manufactured items that are not described within any other consumer and commercial code.

EXPLANATORY NOTE

(This note is not part of the notice.)

Announced as a key component of the Chemicals Management Plan (CMP), an update to the commercial status of substances of interest in Canada is critical to support priority setting and decision making for work post-CMP. To date, two inventory updates have been conducted. The first phase of the Domestic Substances List (DSL) Inventory Update (IU) was conducted in 2009 and gathered information on approximately 500 inanimate and 50 animate substances. Building on the first phase, the second phase of the DSL IU was carried out to collect information on approximately 2 700 substances. Whereas previous IUs were limited to DSL substances, the scope has been expanded and now considers emerging science, evolving domestic and international programs and the need to keep pace with chemical landscape fluctuations in order to ensure future priorities are reflective of Canada's dynamic market.

The Notice with respect to substances included as part of the 2017 Inventory Update applies to approximately 1 500 substances. The scope of the notice allows the Government of Canada to capture critical information on commercial status, downstream use and yearly market fluctuations between 2012 and 2015.

Substances included in Part 4 of Schedule 1 are currently on the revised In Commerce List (ICL). The scope of the information being collected on these substances is limited to Food and Drugs Act–related activities, such as therapeutic products (including human and veterinary drugs, and medical devices), natural health products, foods (including food additives) and cosmetics. Substances in Part 4 of Schedule 1 that are imported or manufactured with respect to use patterns beyond the scope of the Food and Drugs Act are subject to notification requirements under the New Substances Notification Regulations of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”).

Pursuant to subsection 71(3) of the Act, every person to whom this notice applies shall comply with this notice within the time specified in the notice. The time specified in this notice is July 17, 2017, 3 p.m., Eastern Daylight Saving Time. Any person making a written request pursuant to subsection 71(4) of the Act should include the name of the party requiring an extension, the Chemical Abstracts Service Registry Number (CAS RN) of the substances for which the person will provide information, as well as the reason of the extension request.

Any person making a written request pursuant to section 313 of the Act should identify each part of the information that is to be considered confidential, and provide a rationale for the sensitivity of the information.

Persons not subject to this notice who have a current or future interest in a substance set out in Schedule 1 to this notice may identify themselves as a “stakeholder” for the substance by completing the voluntary Declaration of Stakeholder Interest using the online reporting system via Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/. The person may be contacted for further information regarding their interest in the substance.

Persons who do not meet the requirements to respond and have no commercial interest in the substances covered by this notice may submit a Declaration of Non-Engagement for the notice using the online reporting system via Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/.

The Minister of the Environment and the Minister of Health are also inviting interested stakeholders to submit additional information that is deemed beneficial. Organizations that may be interested in submitting additional information in response to this invitation include those that manufacture, import, export or use these substances whether alone, in a mixture, in a product or in a manufactured item.

Compliance with the Act is mandatory and specific offences are established by subsections 272(1), 272.1(1), 272.2(1), 272.4(1) and 272.5(1) of the Act. Amendments to the fine scheme of the Act came into force on June 22, 2012. Subsections 272(2), (3) and (4) and 272.1(2), (3) and (4) of the Act set the penalties for persons who commit an offence under the Act. Offences include the offence of failing to comply with an obligation arising from the Act and the offence of providing false or misleading information. Penalties for the most serious offences include minimum fines, and the amount of the fine can range from a minimum of $5,000 for an individual convicted following summary proceedings to a maximum of $6,000,000 for a large corporation convicted on indictment. The fine range doubles for second or subsequent offences and individuals may also be liable to a term of imprisonment of up to three years. Offences other than those in the category of “serious offences” are punishable by fines capped at a maximum that ranges from $25,000 for an individual convicted following summary proceedings to $500,000 for a large corporation convicted on indictment. The maximum fines are doubled for second or subsequent offences.

The current text of the Act, including the most recent amendments, is available on the Department of Justice's website: http://laws-lois.justice.gc.ca/eng/acts/C-15.31/.

The Act is enforced in accordance with the Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999 available at www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5082BFBE-1. Suspected violations under the Act can be reported to the Enforcement Branch by email at ec.dale-enviroinfo-eed-enviroinfo.ec@canada.ca.

Responses to the notice must be provided no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time, using the online reporting system available through Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/.

An electronic copy of this notice is available at the following website: www.chemicalsubstanceschimiques.gc.ca.

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

WILD ANIMAL AND PLANT PROTECTION AND REGULATION OF INTERNATIONAL AND INTERPROVINCIAL TRADE ACT

Notice of intent to modify the Wild Animal and Plant Trade Regulations

Notice is hereby given that the Minister of the Environment intends to recommend to the Governor in Council that amendments be made to the Wild Animal and Plant Trade Regulations (WAPTR), pursuant to section 21 of the Wild Animal and Plant Protection and Regulation of International and Interprovincial Trade Act.

The purpose of these amendments is to update domestic regulations in order to meet international obligations. These amendments will reflect changes to the Appendices of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) agreed to by the Parties to the Convention during the 17th Conference of the Parties (CoP17). These changes include additions, deletions and reclassifications of species listings as well as nomenclature modifications.

The 49 amendments to the CITES Appendices that were adopted at CoP17 and that will be reflected in Schedule I of WAPTR affect 72 taxa in total. Depending on the amendment, taxa can refer to a family, genus, species, subspecies or population. In total, these amendments involve over 400 species or subspecies. Amendments that result in a decrease of trade controls have been adopted either because the controls are no longer needed or because they are not providing a conservation benefit. These amendments include

In addition, modifications to the CITES Appendices will also take into account changes that have been made to Appendix III, as requested by the Parties between January 2016 and November 2016. These amendments include the addition of 15 taxa to Appendix III (new export controls), including 2 species listed by the United States that are also found in Canada: the Spiny softshell turtle (Apalone spinifera) and the Common snapping turtle (Chelydra serpentina). One taxon was also deleted from Appendix III (removal of all trade controls). Other minor changes to Schedule I of WAPTR, such as nomenclature updates and changes to address miscellaneous issues identified by the Standing Joint Committee for the Scrutiny of Regulations, will also be made.

The Convention was established to help ensure that international trade in specimens of wild animals and plants does not threaten their survival. More than 35 000 species of animals and plants are listed in the three Appendices to CITES and are also listed in Schedule I to WAPTR. Species listed in Appendix I are considered threatened with extinction and generally may not be traded for commercial purposes. However, these species may be traded for non-commercial purposes such as educational, scientific and reintroduction purposes, under strict conditions. These conditions include the prior issuance of import and export permits by the importing and exporting countries, respectively. Appendix II species are those that are not considered threatened with extinction but that may become so if their trade is not regulated. Species may also be listed in Appendix II if they are similar in appearance to Appendices I and II species, to ensure the protection of the species of concern. Only export permits issued by the exporting country are required for Appendix II species. Species listed in Appendix III are under special management in a country and are listed unilaterally by that country in order to receive the assistance of other countries in preventing unauthorized exports. The export of Appendix III species requires either an export permit or a certificate of origin, depending on the circumstances.

For more information on these amendments, please refer to the following address: http://www.ec.gc.ca/cites/default.asp?lang=En&n=46CAFD9E-1.

Robert McLean
Director General
Assessment and Regulatory Affairs
Canadian Wildlife Service

[2-1-o]

DEPARTMENT OF FINANCE

POOLED REGISTERED PENSION PLANS ACT

Effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

Notice is hereby given, pursuant to paragraph 6(4)(b) of the Pooled Registered Pension Plans Act, that the effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans is March 31, 2017.

William Francis Morneau
Minister of Finance

[2-1-o]

DEPARTMENT OF FINANCE

POOLED REGISTERED PENSION PLANS ACT

2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

Between

Canada, represented by the Minister of Finance;

British Columbia, represented by the Minister of Finance;

Nova Scotia, represented by the Minister of Finance and Treasury Board;

The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;

The Autorité des marchés financiers, represented by the President and Chief Executive Officer;

and

Saskatchewan, represented by the Minister of Justice and Attorney General;

RECITALS

Whereas Canada, British Columbia, Nova Scotia, Quebec, the Autorité des marchés financiers and Saskatchewan (hereinafter referred to as the “parties”) entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “Agreement”) which came into effect on June 15, 2016, and a copy of which is attached as Annex 1;

Whereas Quebec and the Autorité des marchés financiers agree to be bound by only Parts I, with the exception of subsections 2(6) and (7), II, VI, and VII of the Agreement;

Whereas, in accordance with Section 18 of the Agreement, Ontario wishes to become a party to the Agreement, as it will be amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “2017 Agreement”);

Whereas, in accordance with Section 18 of the Agreement, the parties unanimously consent to Ontario becoming a party to the Agreement, as it will be amended by the 2017 Agreement;

Whereas the parties unanimously consent to entering into the 2017 Agreement, in accordance with Section 21 of the Agreement;

Now, therefore, the parties agree as follows:

Additional Party

1. The parties, in accordance with Section 18 of the Agreement, unanimously consent to Ontario becoming a party to the Agreement, as amended by the 2017 Agreement.

Amendments to the Agreement

2. In the list of parties to the Agreement, appearing directly before the recitals to the Agreement:

(1) The word “and” is deleted; and

(2) The following words are included at the end of the list:

and Ontario, represented by the Minister of Finance;

3. The title of Part III in the section “Contents of Agreement” of the English version of the Agreement is replaced by the following:

PART III PLAN REGISTRATION

4. The definitions “federal PRPP Act” and “voluntary retirement savings plan” in subsection 1(1) of the English version of the Agreement are replaced by the following, in alphabetical order:

“federal PRPP Act” means the Pooled Registered Pension Plans Act (S.C. 2012, c. 16) and any subordinate legislation made under that Act, both as amended from time to time.

“voluntary retirement savings plan” or “VRSP” means a plan registered under the VRSP Act.

5. The title following section 2 of the English version of the Agreement is replaced with the following

PART II LICENSING

6. Subsection 9(3) of the Agreement is replaced by the following:

(3) A decision that is made by the Superintendent under the authority of this Agreement and that relates to the application of a provincial PRPP Act that determines a matter addressed in Schedule C, subsection 11(4) or subsection 11(5) is deemed to be a decision of the supervisory authority of the applicable province and is not subject to judicial review under the Federal Courts Act (R.S.C., (1985) c. F-7), but instead is subject to the processes for review and appeal under the laws of that province.

7. Subparagraph 11(1)(b)(ii) of the French version of the Agreement is replaced by the following:

(ii) est un employé ou un travailleur indépendant ou, s'il n'est pas actuellement un employé ou un travailleur indépendant, le dernier emploi qu'il occupait ou le dernier travail qu'il effectuait et pour lequel il participait au RPAC était au Yukon, dans les Territoires du Nord-Ouest ou au Nunavut, et il contribuait au RPAC.

8. Subsection 11(2) of French version of the Agreement is replaced by the following:

(2) Pour l'application de cet article, « dernier emploi qu'il occupait » ou « dernier travail qu'il effectuait » fait référence uniquement à un emploi ou à un travail indépendant dans une autorité législative liée par la présente partie.

9. The Agreement is amended by adding the following after subsection 11(4):

(5) Despite anything in the Agreement, the valuation or division of funds, on the breakdown of a spousal or common-law relationship, in a PRPP member's account or funds that have been transferred from a PRPP account is governed by the law of a jurisdiction that would otherwise apply to a member and their spouse, former spouse, common-law partner, or former common-law partner if this Agreement did not exist.

10. Section 13 of the French version of the Agreement is replaced by the following:

13. Il est entendu que le présent accord ne s'applique pas aux dispositions de la Loi fédérale sur les RPAC ou des Lois provinciales sur les RPAC concernant les autorisations à obtenir et les exigences qui doivent être satisfaites pour conclure le présent accord, de le modifier ou d'y ajouter des Parties, ainsi que les dispositions concernant l'effet de l'accord.

11. Subsection 14(2) of the French version of the Agreement is replaced by the following:

(2) Lorsqu'une décision du Surintendant fait l'objet d'une révision ou d'un appel en vertu des lois d'une province tel qu'il est prévu en vertu du paragraphe 9(3), le Surintendant, sur demande, communique à l'organisme de surveillance de cette province le dossier dont il disposait lorsqu'il a pris cette décision.

12. Section 15 of the French version of the Agreement is replaced by the following:

15. À la suite de la résiliation du présent accord ou du retrait d'une Partie, l'article 14 continue d'avoir effet aux seules fins de répondre aux demandes en cours.

13. Section 18 of the Agreement is replaced with the following:

18. A province may become a party

14. Section 19 of the Agreement is replaced with the following:

19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in paragraph (a) or (b) of section 17.

15. Subsection 20(4) of the French version of the Agreement is replaced with the following:

(4) Si une Partie autre que le Canada a transmis un avis aux autres parties de son intention de se retirer de l'accord, le Surintendant doit, dans un délai raisonnable et sous réserve de toute restriction législative, transmettre à l'organisme de surveillance de cette Partie les copies des documents concernant les RPAC touchés transmis au Surintendant en vertu de la Loi fédérale sur les RPAC par l'administrateur du régime qui sont nécessaires à la surveillance continue des RPAC et informer les organismes de surveillance des décisions administratives prises par le Surintendant concernant les RPAC touchés.

16. Schedule A of the Agreement is amended by adding the following at the end of the list of “Provincial PRPP Acts”:

Ontario

Pooled Registered Pension Plans Act, 2015, S.O. 2015, c. 9

17. Paragraphs (a), (b), (d) and (e) of Schedule B of the English version of the Agreement are replaced by the following:

18. Paragraphs (d) and (g) of Schedule B of the French version of the Agreement are replaced by the following:

Execution in Counterparts

19. The 2017 Agreement may be executed in counterparts.

Execution in English and French

20. The 2017 Agreement shall be executed in both English and French, each text being equally authoritative.

Effective Date

21. This 2017 Agreement comes into force on March 31, 2017. Upon its coming into force, and providing Ontario has signed a signature page agreeing to join the Agreement as amended by this 2017 Agreement, Ontario will become one of the parties, and its signed signature page will be included as Annex 2 to this 2017 Agreement.

Agreement Unaffected

22. Except as set forth in the 2017 Agreement, the Agreement is unaffected and shall continue in full force and effect in accordance with its terms.

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Canada

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Ottawa,

The 8th day of December, 2016.

The Honourable William Francis Morneau

Minister of Finance

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For British Columbia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Victoria,

The 6th day of December, 2016.

The Honourable Michael de Jong

Minister of Finance

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Nova Scotia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Halifax,

The 13th day of December, 2016.

The Honourable Randy Delorey

Minister of Finance and Treasury Board

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Québec,

The 14th day of December, 2016.

For the government of Quebec

The Honourable Carlos Leitão

Minister of Finance

The Honourable Jean-Marc Fournier

Minister responsible for Canadian Relations and the Canadian Francophonie

For the Autorité des marchés financiers

Louis Morrisset

President and Chief Executive Officer

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Saskatchewan

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Regina,

The 13th day of December, 2016.

The Honourable Gordon Wyant

Minister of Justice and Attorney General

ANNEX 1

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

Between

Canada, represented by the Minister of Finance;

British Columbia, represented by the Minister of Finance;

Nova Scotia, represented by the Minister of Finance and Treasury Board;

The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;

The Autorité des marchés financiers, represented by the President and Chief Executive Officer;

and

Saskatchewan, represented by the Minister of Justice and Attorney General

RECITALS

Contents of Agreement

PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT

PART II LICENSING

PART III REGISTRATION

PART IV SUPERVISION

PART V APPLICABLE LAW

PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES

PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT

PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT

Definitions

1. (1) For the purposes of this Agreement, unless the context indicates a different meaning:

Schedules

(2) The following Schedules form part of this Agreement:

Application of this Agreement

PART II LICENCES

Licensing Requirements

Suspension or Revocation of a VRSP Licence

PART III PLAN REGISTRATION

Registration Requirements

Notification

7. The Superintendent shall notify the AMF as soon as practicable if, in relation to a federally-registered PRPP administered by a VRSP administrator, the Superintendent has ordered the VRSP administrator to transfer the federally-registered PRPP and all of its assets to an entity designated by the Superintendent, or has terminated the federally-registered PRPP.

PART IV SUPERVISION

Role of the Superintendent

PART V APPLICABLE LAW

Application of the Federal PRPP Act

10. Subject to section 11, the provisions of the federal PRPP Act apply to a federally-registered PRPP, including in respect of all members, and their spouses or common law partners, survivors and other beneficiaries (or the equivalent in the respective jurisdiction), its administrator, the Superintendent, and the employer offering the PRPP, instead of the provisions of a provincial PRPP Act in respect of corresponding matters that would otherwise apply if this Agreement did not exist.

Exceptions

PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES

Requests for assistance

Survival

15. Following the termination of this agreement or following the withdrawal of a party, section 14 shall survive only for the purposes of responding to pending requests.

Information on policy developments

16. Subject to any rules concerning Cabinet confidences and solicitor-client privilege, and any other confidentiality rule applicable to a party, each party shall provide to each other on a timely basis relevant information on policy developments in relation to the federal PRPP Act, a provincial PRPP Act, or the VRSP Act as applicable.

PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT

Effective Date

17. This Agreement comes into force:

Additional Parties

18. A province may become a party:

Effects

19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in clause (a) or (b) of section 17.

Withdrawal from Agreement

Amendments

Execution in Counterparts

22. This Agreement and any amendment to this Agreement may be executed in counterparts.

Execution in English and French

23. This Agreement and any amendment to this Agreement shall be executed in both English and French, each text being equally authoritative.

SCHEDULE A

Provincial PRPP Acts

British Columbia

Pooled Registered Pension Plans Act, S.B.C. 2014, c. 17

Nova Scotia

Pooled Registered Pension Plans Act, S.N.S. 2014, c. 37

Saskatchewan

The Pooled Registered Pension Plans (Saskatchewan) Act, S.S. 2013, c.P-16.101

SCHEDULE B

Requirements to be met under the VRSP Act for the AMF to Issue a VRSP Licence to the Holder of a Federal PRPP Licence

In order to obtain a licence to act as administrator pursuant to the VRSP Act, a corporation must:

SCHEDULE C

Matters for the Purposes of Subsection 11(1)

For the purposes of subsection 11(1), a matter is any of the following:

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Canada

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Ottawa,

The 10 day of June, 2016.

The Honourable William Francis Morneau

Minister of Finance

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For British Columbia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Victoria,

The 9th day of June, 2016.

The Honourable Michael de Jong

Minister of Finance

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Nova Scotia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Halifax,

The 7 day of June, 2016.

The Honourable Randy Delorey

Minister of Finance and Treasury Board

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

IN WITNESS WHEREOF, the undersigned, being duly authorized, agree to be bound by Parts I, with the exception of subsections 2(6) and (7), II, VI and VII of the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Québec,

The 15th day of June, 2016.

For the government of Quebec

The Honourable Carlos Leitão

Minister of Finance

The Honourable Jean-Marc Fournier

Minister responsible for Canadian Relations and the Canadian Francophonie

For the Autorité des marchés financiers

Louis Morrisset

President and Chief Executive Officer

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Saskatchewan

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Regina,

The 26 day of, May 2016.

The Honourable Gordon Wyant

Minister of Justice and Attorney General

ANNEX 2

Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans, as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

For Ontario

Ontario hereby agrees to become a party to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans;

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Effective March 31, 2017.

Signed at Toronto,

The 9th day of January, 2017.

The Honourable Charles Sousa

Minister of Finance

EXPLANATORY NOTE

Proposal

Pursuant to subsection 6(1) of the Pooled Registered Pension Plans Act (PRPP Act), this Order authorizes the Minister of Finance to enter into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans with Ontario.

Objective

To enable the Government of Ontario to join the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Background

The federal PRPP Act applies to pooled registered pension plans (PRPPs) that are linked to employment that falls under federal jurisdiction. Areas of employment that fall under federal jurisdiction include work in connection with navigation and shipping, banking, inter-provincial transportation and communications, and work in the Yukon, Northwest Territories or Nunavut.

PRPPs are a new, accessible, large-scale and low-cost pension option for employers, employees and the self-employed. A PRPP is administered by a corporation that holds a PRPP administrator licence. The Office of the Superintendent of Financial Institutions (OSFI) is responsible for supervising PRPPs offered to areas of employment under federal jurisdiction.

Self-employed individuals and employers in provincially regulated sectors may also join a PRPP if their respective province has PRPP legislation in place. British Columbia, Alberta, Saskatchewan, Ontario and Nova Scotia have passed PRPP legislation. Quebec has passed similar legislation called the Voluntary Retirement Savings Plans Act (VRSP). Provincial pension supervisors would normally supervise the aspects of multi-jurisdictional PRPPs that relate to members in provincially regulated employment areas. In order to streamline the supervision of PRPPs, the federal PRPP Act allows the Minister of Finance to enter into a multilateral agreement with provinces that have passed similar legislation.

Effective June 15, 2016, the Minister of Finance entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (the Agreement) with British Columbia, Saskatchewan, Quebec and Nova Scotia. Ontario's PRPP legislation is now in force, and regulatory amendments to the Pooled Registered Pension Plans Regulations have been made to designate Ontario as a province with whom the Minister can enter into the Agreement.

Implications

The Agreement helps make an attractive new retirement savings option available to those millions of Canadians — roughly 60% — who do not have access to a workplace pension plan. Additional provinces, such as Ontario, who join the Agreement, will facilitate the creation of large PRPPs with members across multiple jurisdictions, thereby increasing the number of Canadians with workplace pension plans and generating economies of scale and reducing costs.

In addition to amendments to the Agreement to include Ontario, the Agreement has also been amended to clarify that it doesn't dictate which jurisdiction's legislation would apply to the valuation or division of funds in a PRPP member's account on the breakdown of a spousal or common-law relationship and to make minor edits to the text.

Consultation

In December 2010, Canada's finance ministers agreed on a framework for PRPPs to provide Canadians with a new, low-cost, efficiently managed, portable and accessible savings vehicle that will help them meet their retirement objectives. The federal PRPP legislative framework was therefore developed in consultation with the provinces. The governments of British Columbia, Alberta, Saskatchewan, Ontario, Quebec and Nova Scotia have been involved in the drafting of the Agreement.

On June 25, 2016, the Agreement was published in the Canada Gazette, Part I, and was tabled in Parliament on August 17, 2016. The current signatory provinces have been consulted and unanimously support Ontario entering the Agreement. OSFI has also been consulted and supports the proposal.

Contact

Lisa Pezzack
Director
Financial Systems Division
Department of Finance Canada
90 Elgin Street, 13th Floor
Ottawa, Ontario
K1A 0G5
Email: Lisa.Pezzack@canada.ca

[2-1-o]

DEPARTMENT OF INDUSTRY

BOARDS OF TRADE ACT

North Battleford Chamber of Commerce

Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated December 2, 2016, has been pleased to change the name of the North Battleford Chamber of Commerce to the Battlefords Chamber of Commerce and to change its boundaries to City of North Battleford, Town of Battleford, Rural Municipality of Battle River # 438, Rural Municipality of North Battleford # 437 and Rural Municipality of Meota # 468, in Saskatchewan, upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.

December 20, 2016

Virginie Ethier
Director

For the Minister of Industry

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the New Westminster Police Department as a fingerprint examiner:

David Stengert

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Saskatoon Police Service as fingerprint examiners:

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Windsor Police Service as fingerprint examiners:

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

(Erratum)

GLOBAL AFFAIRS CANADA

Consultations on the fifth review of the Record of Discussion on Trade in Pharmaceutical Products

Notice is hereby given that the email address of the point of contact for questions or comments regarding Canadian tariffs in the French version of the notice bearing the above-mentioned title published in the Canada Gazette, Part I, Vol. 150, No. 52, dated Saturday, December 24, 2016, contained an error on page 4164, and should have read as follows:

fin.tariff-tarif.fin@canada.ca

[2-1-o]

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada's diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).

Position Organization Closing date
Chairperson Canadian Centre on Substance Abuse January 16, 2017
Director Canadian Centre on Substance Abuse January 16, 2017
Members Canadian Institutes of Health Research January 16, 2017
Chairperson Canadian Museum for Human Rights January 23, 2017
Chairperson Canadian Museum of History January 23, 2017
Vice-Chairperson Canadian Museum of History January 23, 2017
Chairperson Canadian Museum of Immigration at Pier 21 January 23, 2017
Chairperson Canadian Museum of Nature January 23, 2017
Permanent Members Canadian Nuclear Safety Commission January 29, 2017
Chairperson Great Lakes Pilotage Authority Canada February 19, 2017
Clerk of the House of Commons House of Commons February 26, 2017
Chief Science Advisor Innovation, Science and Economic Development Canada January 27, 2017
Directors The Jacques Cartier and Champlain Bridges Incorporated February 3, 2017
Chairperson Laurentian Pilotage Authority Canada February 5, 2017
Directors Marine Atlantic Inc. January 22, 2017
Members National Film Board January 15, 2017
Chairperson National Gallery of Canada January 23, 2017
Vice-Chairperson National Gallery of Canada January 23, 2017
Director of Public Prosecutions Office of the Director of Public Prosecutions January 22, 2017
Executive Vice-Chairperson and Member Parole Board of Canada February 5, 2017
Chairperson Payment in Lieu of Taxes Dispute Advisory Panel January 15, 2017
Members Payment in Lieu of Taxes Dispute Advisory Panel January 15, 2017
Chief Public Health Officer Public Health Agency of Canada February 12, 2017
Directors Royal Canadian Mint January 29, 2017
Member Telefilm Canada January 15, 2017
Directors VIA Rail Canada Inc. January 29, 2017

Upcoming opportunities

New opportunities that will be posted in the coming weeks.
Position Organization
President (Chief Executive Officer) Atomic Energy of Canada Limited
Commissioner for Workers Canada Employment Insurance Commission
Chairperson Canada Foundation for Innovation
President Canadian Centre for Occupational Health and Safety
Chairperson Canadian International Trade Tribunal
Directors Canadian Race Relations Foundation
Citizenship Judges Citizenship Commission
Directors Farm Credit Canada
Directors First Nations Financial Management Board
Sergeant-at-Arms House of Commons
Members National Arts Centre Corporation
Chairperson National Battlefields Commission
Commissioner National Battlefields Commission
Full-time Member National Energy Board
Procurement Ombudsman Office of the Procurement Ombudsman
Chairperson Patented Medicine Prices Review Board
Member Patented Medicine Prices Review Board
Chairperson and Member Standards Council of Canada

Ongoing opportunities

Opportunities posted on an ongoing basis.
Position Organization
Full-time and Part-time Members Immigration and Refugee Board
Members — All regional divisions (full-time positions and part-time positions) Parole Board of Canada
Full-time and Part-time Members (Appeal Division) Social Security Tribunal
Full-time and Part-time Members (General Division — Employment Insurance Section) Social Security Tribunal
Full-time and Part-time Members (General Division — Income Security Section) Social Security Tribunal

[2-1-o]